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Summary
Asymmetric conjugate addition to a,P-unsaturated organic compounds is one of the 
most useful methods for producing p-substituted products in a stereoselective manner. It 
was shown that Grignard reagents add in a conjugate manner to A,Af'-fumaroylbis[(2R)- 
bomane-10,2-sultam] i, readily available from Oppolzer’s (2i?)-bomane-10,2-sultam ii.
The fumaramide system i was treated with a series o f Grignard reagents to produce 
diastereomers iii in excess for a range of different Grignard reagents incorporating alkyl 
and aromatic groups. This selectivity results from attack on the re face o f i.
The mixtures of diastereomers were hydrolysed to the corresponding (2R)- 
substituted succinic acids iv. Enantiomeric excesses were determined by conversion o f the 
diacids into dianilides v and analysis using chiral HPLC. Substituted succinic acids are 
important intermediates in organic synthesis. They are building blocks for the synthesis of 
enantiomerically pure P-substituted, p-amino acids. They also have a role as structural 
components in natural products. Using our methodology (2i?)-benzylsuccinic acid was 
obtained in high 92% ee. (2^)-Benzylsuccinic acid has previously been shown to be an 
inhibitor o f carboxypeptidase A.
The extent o f diastereofacial differentiation o f the conjugate addition was also
system of the succinamide protons resonated at different frequency for each pair o f 
diastereomers.
The mixture o f diastereomers were also reduced producing the (IR)-substituted 
butane-1,4-diols vi.
AuxH
ii iii
O R
iv v
determined by analysis of the NMR spectra of the diastereomeric mixtures. The ABX
The enantiomeric excesses of the diols were estimated from 19F NMR spectra o f the 
corresponding Mosher’s esters vii.
o
vii
The addition of Grignard reagents to two differentially protected fumarates viii and 
ix was carried out.
The Grignard reagent did not add exclusively in a 1,4 manner to viii and a mixture 
o f 1,2-addition and 1,4-addition products was observed. The reaction of fumarate ix with 
Grignard reagents gave only conjugate addition products. Diastereomeric excesses could 
not be determined from the proton NMR spectra of the reaction mixtures. Therefore the 
diastereomeric excess was determined from the bis-Mosher ester o f each diol. The 
stereoselectivity obtained with fumarates viii and ix was not as good as that observed using 
fumaramide i.
The diastereomers iii were used to synthesise enantiomerically pure 2-substituted 
putrescines x.
Removal o f the chiral auxiliaries from iii using lithium aluminium hydride 
produced the corresponding enantiomerically enriched 2-substituted butane-1,4-diols vi. 
The enantiomeric excess o f these diols was improved to >95% by separation of the 
diastereomers o f iii using column chromatography or by recrystallisation. The diols vi
V Ul IX
R
X
IX
were converted into the disulfonate esters xi, followed by substitution by sodium azide. 
The diazides were directly reduced to the diamines using lithium aluminium hydride and 
isolated as the dihydrochloride salts xii. Racemic 2-substituted putrescines were also 
prepared.
HO.
OH PhSOoCl
R
vi
P h 0 2S 0
pyridine
0 S 0 2Ph
R
xi
NaN3
LiAlH4
H ,N
NH-
H,N
NH2.HC1
R
XUl XU
Diamine oxidase (DAO) enzymes are involved in the terminal catabolism o f 
polyamines, and putrescine xiii is a natural substrate for DAO. DAO catalyses the 
oxidation o f diamines to aminoaldehydes. Some of the 2-substituted putrescines produced 
were shown to be substrates for pea seedling DAO. Part o f this work has been published 
(G. P. Reid, K. W. Brear and D. J. Robins, Tetrahedron: Asymmetry, 2004, 15, 793).
1. Asymmetric synthesis
1.1 Introduction
Asymmetric synthesis is a term that can be used to describe a wide variety o f 
transformations. The original definition of asymmetric synthesis by Marckwald in 1904 
stated that it is a process that produces an optically active compound from the reaction o f 
an achiral substrate with a chiral reagent.1 This definition has now evolved to describe 
asymmetric synthesis as a reaction where an achiral unit in an ensemble o f substrate 
molecules is converted by a reactant into a chiral unit in order to produce stereoisomeric 
products in unequal amounts. Nature provides the best examples o f chiral compounds 
where proteins, carbohydrates, and nucleotides all have chiral monomers present. The 
requirement to prepare chiral compounds in enantiomerically pure form has increased 
recently as a result o f several factors, mainly driven by the stereodiscrimination o f chiral 
compounds by most biological systems and therefore the pressure on the pharmaceutical 
industry to develop nonracemic drugs.
1.2 Various Methods of Asymmetric Synthesis
As mentioned before in order to achieve an enantioselective synthesis, at least one 
o f the reagents in the system must be homochiral. There are essentially two major methods 
to produce a chiral compound: resolution or asymmetric synthesis. These methods involve 
the use of chiral starting materials, chiral auxiliaries or chiral reagents.
1.2.1 Why does asymmetric induction occur?
Asymmetric synthesis is a kinetic phenomenon. The interaction o f a chiral substrate 
or reagent with a prochiral substrate gives rise to two diastereomeric transition states. The 
difference in energy between the transition states of the two diastereomers determines the 
ratio of diastereomers. The major diastereomer will be formed from the transition state 
with the lower energy pathway. I f  the free energy of the reaction can be manipulated then 
the stereoinduction can be tuned. The most popular way to achieve this is to carry out
reactions at low temperature thus reducing the contribution from the higher energy 
pathway.
1.2.2 Ch iral Substrates
This term refers to the use o f homochiral starting material in order to control the 
stereoselective outcome of the reaction. At the start o f a synthetic route there are limited 
sources o f chirality and most come from nature providing the chiral pool. This approach 
can be extremely limited by means o f source and price. Another drawback to this method 
can be the chemical reactions involved in transforming the natural product to a useful 
starting material. However with all these difficulties addressed it is by far the best method 
as it avoids resolution and enantiospecific reactions in the synthetic route. It is also a 
methodology that is increasingly used as more natural products are identified. Naturally 
occurring amino acids I [e.g. L-(-)-phenylalanine, L-(+)-valine and L-(-)-proline)] have 
been used in the synthesis o f enantiomerically pure heterocycles (Scheme 1.1).
R
HOOC NCbz
I
c h 3
R = H, Bn or CH(CH3)2 
I
Bn1
CH,
Scheme 1.1
The amino acids were used as chiral inducers in the diastereoselective synthesis of 1- 
benzyltetrahydroisoquinoline derivatives 2 .
1.2.3 Ch iral Auxiliaries
Chiral auxiliaries are a source o f chirality that arises from the attachment o f a chiral 
compound to an achiral molecule. These groups then produce stereoselectivity via a 
chemical reaction and subsequent removal of the auxiliary to produce a product enriched in 
one enantiomer. The drawback to this method is the two extra steps involved in the 
addition and removal of the auxiliary, which must be high yielding and should provide a 
means of auxiliary recycling.
A number o f different auxiliaries are available mainly derived from camphor, 
amino acids, and oxazolidinones. In some instances the auxiliary does not need to be chiral 
but just requires the absence of symmetry in the form of mirror or inversion symmetry. It is 
highly recommended to use auxiliaries with a C2 symmetry axis as this cuts down the 
number o f possible competing diastereomeric transition states.
The use o f chiral auxiliaries in asymmetric aldol reactions has proved highly 
successful (Scheme 1.2).3 The titanium(IV) enolates of 3 gave predominately syw-aldol 
products 4 with the selone having a role in determining the stereoselectivity.
O Se
r ‘\ A  A  TiC|4
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Scheme 1.2
1.2.4 Regeneration o f Stereocentres
This involves the transfer of a chiral centre within a molecule to another part of the 
molecule. This creates a new chiral centre which provides control for a stereoselective 
reaction, where a new centre o f asymmetry can be created or the original chirality o f the 
starting material can be re-established.4
1.2.5 Chiral Reagents
This method can involve many different sources o f chiral reagents arising from 
nature as in enzymes, or prepared synthetically and used stoichiometrically, or as chiral 
catalysts. The reagent that is used must be selective for the substrate it reacts with in terms 
of induction of chirality and also specificity for the functional group. The use o f a chiral 
reagent must justify the expense and the means o f recycling or the turnover rate must be 
carefully considered and this is where chiral catalysts lead the field. However in order to 
develop a chiral catalyst the catalytic cycle must be well understood. An example of a
chiral reagent is the use o f an asymmetric bidirectional allylboration reagent 5 to prepare 
C2 symmetric 1,5-diols 6 (Scheme 1.3).5
OX
i-Pr H
reagent 5
Scheme 1.3
OHOH
i-Pri-Pr
6
41% yield 
d.r. 97:3 
ee >95%
1.2.6 Chiral Environments
The environment o f a chemical reaction can be made chiral by introducing a chiral 
solvent or chiral additives. Chiral solvents have not been very successful, but the use o f 
chiral ligands can produce good levels o f stereoselectivity. A new class o f ligands 7 has 
been developed incorporating a fluxional group which controls the stereochemical 
induction.6
1
R 1 R 1 R 1
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The ligand contains a dihydropyrazole core with two nitrogen atoms that can form a five- 
membered chelate 8 with Lewis acids. The chiral source arises from R3 (examples include 
chiral amines) and this dictates the orientation of the fluxional group R  in 8 or 9. The 
fluxional group R  can be varied by a simple alkylation reaction. These ligands have been 
used successfully to induce face selectivity in Diels-Alder reactions.
2. Conjugate Addition Reactions
2.1 Introduction
Conjugate additions were first reported over a century ago when Komnenos 
described the conjugate addition o f diethyl sodiomalonate 10 to diethyl ethylidenemalonate 
11 in 1883 (Scheme 2.1) 7’8
Et02C ^ p  + 
C02Et
10 11
Et02C C02Et
Et02C C 02Et
Scheme 2.1
The real significance o f this reaction was first realised by an American chemist called 
Arthur Michael. In 1887 he reported the base-promoted additions o f sodium salts o f 
malonates 12 and P-ketoesters 13 to ethyl cinnamate (Scheme 2 .2).9 When we refer to a 
Michael addition or a Michael reaction the terminology has emerged from this original 
study.
Et02C
C 02Et
J  ♦
12
C 02Et
+
O 13
C 02Et
1. NaOEt, EtOH, 
heat on a steam bath, 
6 h
 ►
2. H30 +
1. NaOEt, EtOH, 
heat on a steam bath, 
-30 min
C 02Et
E t02C
C 02Et
2. H30  
Scheme 2.2
C 02Et
O Ph
C 02Et
C 02Et
6The conjugate addition is sometimes referred to as 1,4-addition but throughout this 
thesis the term conjugate addition will be used. “Conjugate addition refers to the addition 
of any class of nucleophile to an unsaturated system in conjugation with an activating 
group, usually an electron-withdrawing group.”10
2.2 Mechanism
The reason why nucleophiles add to the P-carbon of an a,p-unsaturated system is 
to do with the activation from the carbonyl group. The carbonyl group is responsible for 
polarizing the C=C double bond which is shown by the resonance structures (Figure 2.1).
£-101 
11 p 
C
Electrophilic sites
Figure 2.1
The configuration o f the C=C double bond with the C =0 group makes the P-carbon 
electrophilic and hence susceptible to attack from nucleophiles.
We can also use the frontier molecular orbital approach to help explain why the P- 
carbon is the preferred site o f attack. For successful addition o f nucleophile electrons must 
move from the HOMO o f the nucleophile to the LUMO of the a,p-unsaturated system. The 
orbital coefficients for acrolein have been calculated and the largest coefficient is on the P- 
carbon which is where the nucleophile attacks (Figure 2.2).11
-0.39 0.51
/
0.59 -0.48
O
Orbital coefficients for the LUMO of acrolein 
Figure 2.2
We have explained orbital overlap to account for why conjugate addition takes place and 
we can also introduce the terms ‘hard’ and ‘soft’ to refer to the reagents being added. Hard 
nucleophiles have a high charge density and react by electrostatic attractions whereas soft 
nucleophiles are either uncharged or have more diffuse orbitals. The a,|3-unsaturated 
system can also be classified in terms of hard and soft electrophiles. The carbon atom of 
the carbonyl group carries a partial positive charge due to polarization o f the C =0 bond 
thus classing it as a hard electrophile. On the other hand the p carbon is a soft electrophile 
as it does not have a high partial charge and as shown in figure 2.2 it is the site o f the 
largest coefficient in the LUMO. A hard nucleophile will always react with a hard 
electrophile and likewise a soft nucleophile will react with a soft electrophile. The 
conjugate addition to an a,p-unsaturated system can be tuned by the careful selection o f the 
nucleophile. For example hard nucleophiles are NH 3 , RMgX and RLi whereas soft 
nucleophiles are RSH, R^CuLi and R3P.
Something that has not been mentioned yet is the possibility o f producing the direct 
addition product resulting from addition o f the nucleophile to the carbon o f the carbonyl 
group. There are three main factors that have to be considered in an attempt to minimise 
this side reaction:
• the conditions o f the reaction;
• the reactivity of the carbonyl carbon;
• the nature o f the nucleophile;
It is widely accepted that the reaction conditions should allow the reaction to reach 
an equilibrium. At this equilibrium the conjugate product is favoured over the direct 
product as it is more stable because the C =0 71 bond is stronger than the C=C 71 bond. The 
direct product will form faster but this reaction is reversible. The conjugate product can 
also form and this reaction is irreversible allowing an accumulation o f the conjugate 
product over time (Figure 2.3). If  the reaction temperature is increased this also increases 
the rate of reaction so favouring the conjugate product.
8°  C N ^  m CN NCV ,0 H
CN
slow but fast but A\r^ r\
conjugate irreversible reversible , .
addition addition
product product
Figure 2.3
However the direct addition o f organometallic reagents to a,p-unsaturated systems 
is not reversible and the proportion o f direct addition versus conjugate addition depends on 
the reactivity o f the carbonyl group. The more reactive the carbonyl group the more 
susceptible it is to attack. For the a,P-unsaturated system the order is:
COC1 > CHO > COR > C 0 2R > CONR2
Another structural factor that has shown some effect in the proportion o f products formed 
relates to the substituents attached to the P-carbon. This produces steric hindrance that can 
block the incoming nucleophile.
There is a large array of conjugate acceptors which are composed o f the activating 
group (carbonyl derivative) and the part containing the C=C double bond. There are many 
carbonyl activating groups such as RCHO, RCOR, RCOCOR, RCOCOOR, RCOCN, 
RCOOH and RCOOR. Other conjugate acceptors are sulfone derivatives, phosphonate 
derivatives, nitriles, enamines, nitroso compounds and aromatic compounds. The nature of 
the nucleophile is very wide with reactions being carried out using cyanides, amines, 
alcohols, thiols, halides and organometallic reagents. The most popular o f these 
nucleophiles used in conjugate additions are probably organometallic reagents due to the 
variety o f substituents that can be prepared in this way.
2.3 Asymmetric Conjugate Additions
In attempts to induce stereoselectivity in the product of a conjugate addition 
reaction the reaction can be carried out in the presence o f chiral catalysts, with chiral 
reagents, or using substrates that have chiral moieties attached. The use o f chiral catalysts
9and chiral reagents will be discussed briefly and the use of chiral moieties attached to the 
electrophile will be discussed in greater detail.
2.3.1 Chiral Catalysts
The research carried out on the catalysis o f asymmetric conjugate additions has 
mainly focused on cyclic a,p-unsaturated systems. The catalytic aspect comes from the use 
o f a chiral ligand and usually catalytic amounts o f Cu(I) salts together with stoichiometric 
amounts of organomagnesium or organozinc reagents.
Tomioka et al. reported the addition o f Grignard reagents to cyclohexenone in the 
presence o f a catalytic amount o f Cu(I) salts together with a chiral bidentate 
amidophosphine 14 (Scheme 2.3).12
O O
RMgCl (1.2 eq), Cul (8 mol%),
 ►-
14 (32 mol%), Et20 , -78 °C
PPh
14
Scheme 2.3
The amidophosphine ligand 14 has a diphenylphosphino group which coordinates to 
copper and an amide group which coordinates to the magnesium. The chiral bidentate 
amidophosphine was prepared easily from commercially available L-proline. It was found 
that good levels o f stereoselectivity were obtained when n > 2 for R(CH2)wMgCl. The 
chiral phosphine would be recovered for reuse without any loss of optical purity.
Diphosphonites have been used as chiral ligands for the copper catalysed 
asymmetric conjugate addition o f diethylzinc to cyclic a,P-unsaturated systems. The 
ligands 15 and 16 are BINOL-based and have been previously used to induce excellent
13enantioselectivity in rhodium catalysed hydrogenations o f alkenes (97-99% ee).
10
R = H 
R = CH3
r = c 6h 5
16
Ligand 15 displays good levels o f stereoselectivity (87-99% ee) and conversion at 
temperatures o f -30  °C (Scheme 2.4). However ligand 16 shows low levels of 
stereoselectivity suggesting that the nature of the achiral backbone is important in 
achieving asymmetric induction.14
O
Et2Zn, Cu(OTf)2 (1 mol%),
 ►
Ligand (2 mol%), THF, -30 °C
O
n = 1
n = 2
Scheme 2.4
n = 1 
n = 2
Hird and Hoveyda have reported the use o f a novel amino acid based phosphine 
amide 17 as an effective chiral ligand for asymmetric conjugate addition.15 Catalytic 
asymmetric conjugate addition of alkyl zinc reagents to unsaturated 7V-acyloxazolidinones 
18 was achieved with excellent levels o f stereoselectivity (76->98% ee) (Scheme 2.5).
NHBu
alkyl OPPh2
2.4-6 mol %
Me Me
N
0.5-2.5 mol % (CuOTQCgHg, [Zn(alkyl)2]
R = Me, «Pr. zPr
Scheme 2.5
Ligand 17 is a triamide containing an L- and D-amino acid dipeptide. The amino acids in 
this ligand 17 are D-threonine and L-valine. This showed better results than the 
corresponding L,L-dipeptide. This methodology allows the use o f a range o f alkyl zinc 
reagents not just diethyl zinc, and the optically enriched /?-alkyl TV-acyloxazolidinones 19 
can be converted into other carbonyl derivatives that have not previously been accessible 
by catalytic asymmetric conjugate addition reactions.
In an attempt to develop an enantioselective synthesis o f an enodothelin-A 
antagonist ABT-546 a highly selective catalytic asymmetric conjugate addition was 
discovered.16
MeO
CONBu2
ABT-546
The conjugate addition o f ketoester 20 to nitrostyrene derivative 21 is catalysed by the 
complex bis(oxazoline) 22 together with Mg(OTf)2 and an amine cocatalyst N- 
methylmorpholine (NMM) (Scheme 2.6).
12
MeOMev Me
22 (4.4 mol%)
OEt Mg(OTf) 2 (4 mol%) 
NMM (5.5 mol%)
n -  Pr
20 Mev Me
NO'NO
CHC13 (ethanol free) 
sieves
OMe
Scheme 2.6
A range o f dicarbonyl substrates and nitroalkenes have been used in this reaction. This 
methodology has been applied to the multikilogram synthesis o f ABT-546 and also the 
antidepressant rolipram 23.
OMe
)
N
(i?)-rolipram (23)
2.3.2 Chiral Reagents
Lithium amides derived from enantiomerically pure amines have been shown to 
add to a,p~unsaturated systems in an conjugate fashion with excellent levels o f 
stereoselectivity. The research group o f Davies has made extensive progress in this field by 
developing useful asymmetric methodology for the synthesis o f homochiral P-amino acids. 
It was first shown that when amines 24, 25 and 26 were converted into their corresponding 
lithium amides they added to methyl crotonate 27 in high yield and high 
diastereoselectivity (95 - >99%) (Scheme 2.7).17
13
JLPh N Ph 
H
JL
Ph N Ph 
H
24 25 26
O JL R2
OR1 + P h ' ^ N '
BuLi, THF 
 ►
27 H -78°C
Ph'
OR
t 2R = Me R = see above
CH2Ph
'Bu
Scheme 2.7
The adducts 28 can be converted into homochiral P-amino acids by debenzylation and 
subsequent hydrolysis as shown for (iS)-P-tyrosine.HCl 29 (Scheme 2 .8).
The lithium (a-methylbenzyl)benzylamide 24 was shown to be a very good 
homochiral ammonia equivalent in the synthesis o f homochiral P-amino acids. The use of 
this lithium amide is limited by the deprotection carried out by hydrogenolysis. Selective 
removal of one o f the vV-benzyl groups can be achieved; however it is somewhat 
problematic.18 In an attempt to solve this problem Davies et al. have developed a 
differentially protected homochiral ammonia equivalent 30.
14
PhCH20
OMe
X PhPh" R N q  Li©  
THF
-78°C
OMe
HO
de = > 99%
Pd(OH2)/C/H2 quant.
OMe
.HC1HO
29
aq. HC1
quant.
OMe
HO
Scheme 2.8
The advantage o f this lithium amide 30 is that the Af-allyl group can be selectively 
deprotected to yield the secondary amine which can then be utilised in further 
transformations. The lithium amide 30 has been used in the stereoselective conjugate 
addition to (E)-a,p-unsaturated acyl(cyclopentadienyl)-dicarbonyliron complexes 31 and 
applied to the synthesis o f P-lactams 32 (Scheme 2.9).19 The conjugate additions proceeded 
with good diastereoselectivities (82:18-95:5) and moderate yields. However one limitation 
was that conjugate additions had to be carried out at a temperature o f -100 °C and then 
warmed to -78  °C due to instability o f the intermediate ferra-enolate adduct. I f  the lithium 
amide is replaced by the equivalent magnesium amide, conjugate addition occurs with 
greater diastereoselectivity (>95% when R = CH3); however the reactivity o f the amide is 
compromised.
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These lithium amides can be a very good source for introducing stereoselectively at an 
amine group at the p-carbon o f an a,P-unsaturated system. Just to show the versatility in 
organic synthesis o f these amides the key step in the asymmetric total synthesis o f (+)- 
negamycin 33 utilised the asymmetric conjugate addition of lithium (R)-(a- 
methylbenzyl)benzylamide 34 (Scheme 2.10).20 Negamycin 33 was discovered in 1970 by 
Hamada et al.21 and was found to be a pseudopeptide antibiotic possessing strong 
inhibitory activity against Gram-negative bacteria together with very low acute toxicity.
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2.3.3 Chiral moieties attached to the electrophile
This section will focus on a,p-unsaturated systems which contain chiral moieties 
attached by a covalent bond. The chiral moieties mainly consist o f chiral auxiliaries. The 
use of chiral auxiliaries to control stereochemistry is a valuable tool for an organic chemist. 
The strategy o f using an auxiliary is very simple (Scheme 2.11).
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Scheme 2.11
The optically active chiral auxiliary is attached to the achiral substrate by a covalent bond. 
It is then used to control the stereochemistry in a bond forming reaction (in the above 
example an alkylation reaction). The chiral auxiliary can be removed unchanged to be used 
again.
2.3.3.1 a,p-U nsaturated esters
Chiral enoates 35 derived from (-)-8-phenylmenthol were shown to direct the
• * • 22 conjugate addition o f boron trifluoride-mediated organocopper reagents (Scheme 2.12).
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Scheme 2.12
It was proposed that the boron trifluoride coordinates to the oxygen of the C =0 group 
producing a transition state where the C =0 is antiperiplanar to the C=C bond. The 
aromatic ring can shield one enantiotopic face o f the enoate. The results were shown to 
support this and when R 1 = H, R2 = Me and R3 = C6H5 or n- C4H9 the stereoselectivity was 
greater than 99%. The advantage o f this methodology is that a rigid substrate conformation 
can be achieved without the need for chelation with a metal. The chiral auxiliary can be 
removed easily by saponification to yield the corresponding enantiomerically enriched 0- 
substituted alkanoic acids 36 together with the recovered auxiliary in 98% yield.
A modification to the above methodology was to introduce a camphor based 
auxiliary and see if  this produced good levels o f 71-face differentiation for BF3-promoted 
conjugate additions o f alkyl copper reagents. The chiral enaote 37 was synthesised and the 
conjugate adducts showed high levels o f stereoselectivity (94-99%) when reacted with 
alkenylcopper reagents.23
O
37
The use o f chiral auxiliaries with a C2 axis o f symmetry is thought to be beneficial 
in directing stereochemical control. Alexakis et al reported the use o f chiral acetals which 
possess a C2 axis o f symmetry to direct the diastereoselective conjugate addition of 
cuprates to a,P-ethylenic esters 38 containing a chiral acetal (Scheme 2.13).24
COOEtv  v  COOEt 
38
R = Me, Ph, -CH2OMe
Scheme 2.13
This reaction produced low levels of diastereomeric excesses (15-20%). The chiral acetal 
moiety was modified by replacing one or both of the oxygen atoms with nitrogen in order 
to promote better stereochemical control (Figure 2.4). It was thought that the nitrogen 
would act as a better c  donor than oxygen or create a more sterically crowded centre. 
Compound 39 was shown to be the most effective at asymmetric induction (90-96% de) 
and also overall yield o f reaction (84-90%). The chiral moiety o f compound 39 consists o f 
an imidazolidine ring synthesised from 1,2-bis(methylamino)cyclohexane.
Therefore cinnamates that have a chiral oxazolidine or imidazolidine ring attached undergo 
conjugate additions of organocopper reagents with high levels o f stereoselectivity.
MeMe
Me'Me
Me
'"COOEt
Me
'"COOEt
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39
Figure 2.4
The use o f a chiral cyclic diol as a chiral auxiliary has been used to induce 
stereoselectivity o f the conjugate addition o f organocuprates to a,p-unsaturated esters 40 
giving diastereomeric excesses of 88% (Scheme 2.14).25
minormajor
Scheme 2.14
This example contains the chiral moiety derived from an a,P-unsaturated carboxylic acid 
and the corresponding chiral diol. The proposed stereochemical outcome was rationalised 
by the proposed transition state which shows that a free hydroxy and the ester carbonyl 
chelate with the diakylcuprate which is believed to have a square planar dimeric structure 
(Figure 2.5).26 This leads to the formation o f a copper(I)-alkene 7r-complex allowing the R 
group to attack from the re-face in a stereocontrolled manner.
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Figure 2.5
This chiral cyclic diol has also been used in the asymmetric synthesis o f (7?)-(-)-muscone 
41 based on diastereoselective conjugate addition previously described.27
O
(CH2)fr
41
Ogawa et al. have extended the use o f cyclohexane diols to incorporate their 
stereoinduction effect in the synthesis o f 1,3-polymethyl functions which have been 
observed in the structures o f antibiotic macrolides and insect pheromones.28 Synthesis o f 
the optically active phosphonate 42 followed by a Homer-Emmons reaction with aldehyde 
43 produced 44 which underwent another diastereoselective conjugate addition o f 
dimethylcopper lithium to produce a 1,3-methyl function in 45 (Scheme 2.15). This 
synthetic route can be repeated in order to produce 1,3-polymethyl functions.
P(OEt)2
45 44
Cu — R
R1— flu —
Scheme 2.15
The selectivity produced by this method was 77 : 23 to favour attack from the re-face.
conjugate addition o f organocuprates to a,P-unsaturated esters 46 displaying similar
The chiral auxiliary (2R,3i?)-dihydroxytetrahydronaphthalene is readily prepared in an 
enantiomerically pure form by an efficient chemoenzymatic procedure from naphthalene 
using a modified strain o f Pseudomonas fluorescens30
Camphor-derived concave alcohols 47 and 48 have been used as chiral auxiliaries 
for the diastereoselective addition o f organocopper reagents to enoates 49 and 50 to give P- 
branched esters with stereoselectivity o f 96->98% (Scheme 2.16).
A derivative of the above auxiliary has been used for the diastereoselective
diastereomeric excesses.29
R = Me and Ph
46
R Cu BF
O O
49 51
R Cu BF
R
50 52
Scheme 2.16
The conjugate adducts 51 and 52 are crystalline and the diastereomers are separable by 
HPLC allowing the determination o f the diastereoselectivity.
OH
47 48
The chiral auxiliaries 47 and 48 have been shown to induce addition o f organocuprates 
diastereoselectively to 2-oxo-cyclopentanecarboxylates and 2-oxo- 
cyclohexanecarboxylates to give enantiomerically pure 5-substituted 2-oxo- 
cyclopentanecarboxylates and the corresponding 6-substituted cyclohexanecarboxylates 
(Scheme 2.17).32'33
organocopper
compound
R H
H
O
a
organocopper
compound R 0
O O
n=  1,2
Scheme 2.17
The camphor-derived chiral auxiliary 47 has been utilized in the formal synthesis o f 
Paroxetine 53. Paroxetine is a disubstituted piperidine used in the treatment of depression, 
obsessive compulsive disorder and panic disorder. The key step to a formal synthesis o f 
paroxetine involved the conjugate addition of an organocopper reagent to a chiral 
unsaturated ester 54 with diastereoselectivity o f >98% (Scheme 2.18).34 The organocopper 
reagent adds to the less hindered face o f the s-tram enoate double bond.
(4 equiv.)
Paroxetine 53
R*OH 47
Scheme 2.18
Vetiver oil is used in the manufacture of expensive perfumery compositions and 
soap perfumes due to its strong woody aroma. In order to determine the structure/odour 
relationship of khusimone 55, one of the main odour-donating compounds o f vetiver oil, an 
analogue o f it was synthesised. In an attempt to identify if the ethano bridge was essential 
for the odour component the ethano bridge was removed to produce a bicyclic system 56 
(Scheme 2.19).35 The key step in the synthesis of 56 involved a diastereoselective 
conjugate addition of an appropriate nucleophile 57 to a chiral olefinic keto ester 58 which 
incorporates the previously discussed camphor-derived concave alcohol. The presence of 
the geminal dimethyl group next to the exocyclic alkene bond decreased the reactivity of 
the conjugate addition. The use o f the highly reactive diorganocuprates, known as
23
Gilman’s reagents (R^CuLi), proved unsuccessful. However using the method o f Piers et 
a l36 successful addition was observed to produce diastereomerically pure product. The 
organolithium reagent is produced by reaction o f the halide with two equivalents o f /-BuLi, 
followed by MgBr2 Et20 and CuBrMe2S, BF3Et20. Unlike the Gilman’s reagent this 
method consumes only one equivalent of 57. The diastereomeric excess was high with no 
diastereomeric impurities detected by and 13C NMR spectrometry.
55 56
58
Scheme 2.19
+ Br
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The availability o f both enantiomers o f camphor- 10-sulfonic acid allowed access to 
another camphor-based chiral auxiliary 59 synthesised by amidation and carbonyl 
reduction o f the corresponding sulfonic acid.37 This auxiliary has been used to provide 
excellent rc-face differentiation for the conjugate addition o f organocopper reagents to 
enoates 60 (Scheme 2.20).38
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Scheme 2.20
The homochiral a,P-unsaturated system 60 was synthesised by acylating the auxiliary 59 
with the corresponding acid chloride 61. The conjugate addition of the organocopper 
reagent occurred with high levels o f stereoselectivity (>94%) and this was accounted for 
by the steric bulk o f the sulfonamide group blocking one face o f the a,p-unsaturated 
system.
Another simple but useful chiral auxiliary 62 is generated from the reaction o f 1- 
naphthylmagnesium bromide with camphor. This auxiliary has shown good levels of 
stereoselection (95%) for the conjugate addition o f organocopper reagents to crotonate 
esters 63 (Scheme 2.21).39 A number o f different groups (R = H, Me, phenyl and benzyl) 
were investigated with the naphthyl substituent being the best at inducing stereoselectivity.
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Scheme 2.21
The use o f carbohydrate based templates as chiral auxiliaries was reported by 
Totani et a l40 The derivatives o f methyl a-D-glucopyranoside act as chiral auxiliaries for 
the diastereoselective conjugate additions o f organocopper reagents to a,P-unsaturated 
esters (Scheme 2.22). A noteworthy observation was that the configuration obtained for the 
I 6-0-crotonyl derivative 65 was the opposite to that of the 4-0-crotonyl derivative 64. It is
i
f
ifI
25
still unclear what leads to this stereochemical change but it is believed that the pivaloyloxy 
group at C-4 is essential, because when this is substituted for a benzyloxy group the 
diastereoselectivity is lowered considerably.
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R = vinyl or ethyl
The incorporation o f ethyl(i?)-mandelate as a chiral auxiliary has been utilised in 
the synthesis of a-amino acids.41 The conjugate addition o f Grignard reagents to the (S)- 
isomer 66 followed by selective protonation occurs with moderate selectivity o f 70% de 
(Scheme 2.23).
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The synthesis o f an a,p-unsaturated ester derived from D-glucose 67 has been the 
subject o f a study showing that the diastereoselective conjugate addition o f substituted 
amines 68 occurs with moderate stereoselectivity (40-52%) (Scheme 2.24).42 However 
changing the Michael donor to the more nucleophilic lithium jV-benzylamide resulted in 
the production of only one diastereomer under kinetically controlled conditions.
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2.3.3.2 a,p-Unsaturated amides
In an attempt to produce a chiral auxiliary that is relatively cheap, and also capable 
o f inducing another new asymmetric centre with high levels o f stereoselectivity, a chiral 
auxiliary derived from (2R)-aminobutan-1 -ol 69 and 2-fluorobenzyl chloride was 
synthesised. The auxiliary 70 was attached to cinnamoyl or crotonoyl chloride to 
synthesise the corresponding amides 71 (Scheme 2.25). These systems underwent 
conjugate additions with various Grignard reagents to give adducts with high 
diastereomeric excesses o f 92-97%.43,44
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The mechanism o f addition o f the Grignard reagent is postulated to occur by a 
pseudocyclic structure produced by the binding o f the magnesium to the amide oxygen and 
also to the alkoxy group. This allows another equivalent to add to the double bond (Figure 
2.5). It was observed that when the primary hydroxy group was protected as a benzyl ether 
this led to a decrease in the diastereomeric excess.
Figure 2.5
The benefit o f introducing the fluorobenzyl group into the chiral auxiliary is that it 
increases the stereoselectivity induced by the chiral auxiliary. There is also an added
NMR spectrometry due to the presence of the fluorine atom on the aromatic ring.
Optically pure oxazolidinones, known as “Evans auxiliaries”, with the general 
structure 72 are commercially available. Because of their ease o f removal and recovery 
they are o f potential interest in asymmetric synthesis.45
72
R = Ph, Bn and *Pr
Oxazolidinones similar to 72 have been used to synthesise iV-enoyloxazolidinones 73 and
stereoselectivity for alkyl and phenyl cuprates (Scheme 2.26). The conjugate reactions 
were carried out by generating the cuprate using the Grignard reagent and copper(I) 
bromide dimethylsulfide together with boron trifluoride diethyl etherate as the Lewis acid. 
It is not fully understood why there is a divergence of stereoselectivity with these two N- 
enoyloxazolidinones; however it is postulated that it arises from the complexation o f the 
Lewis acid to both carbonyl oxygens or just to the carbonyl oxygen o f the crotonoyl 
moiety.
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O
74.46 These underwent conjugate additions o f organocopper reagents to give opposite
V-l
RMgBr
CuBr.DMS
BF3OEt2
Ph
74
R = Et, /Pr and PhPh
O O
O y
Ph
R
Scheme 2.26
The levels of diastereoselectivity are moderate to high (53-97%). The diastereoselectivity 
increases as the steric bulk o f the nucleophile increases (Ph > 'Pr > Et). Nicholas et al 
reported the addition of aryl-organocopper reagents to oxazolidinones 73 and 74. 
Oxazolidinones 74 were superior in terms o f inducing stereoselectivity.47 This has been 
applied to the asymmetric synthesis o f precursors o f unusual amino acids 75 to be used in 
the rational design o f peptide ligands (Scheme 2.27).48
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Oxazolidinone auxiliaries have also been applied successfully to radical reactions. 
Conjugate addition o f carbon radicals takes place with high diastereoselectivity to chiral 
a,(3-unsaturated TV-enoyloxazolidinones (Scheme 2 .28)49
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This methodology involves the use o f a novel diphenylmethyl-substituted oxazolidinone 
auxiliary which is superior to previous oxazolidinones in terms o f inducing 
stereoselectivity. A series of Lewis acids were screened and ytterbium triflate Yb(OTf)3 
was the best in terms o f chemical yield and diastereoselectivity. It was shown to be 
important to have a chelating Lewis acid that could bind both substrate carbonyls thus 
fixing the orientation of the system. This then allows radical addition to take place from the 
opposite face to the bulky diphenylmethyl substituent on the oxazolidinone ring. One 
practical advantage to using Yb(OTf)3 is that it does not require handling under inert 
conditions and reactions can be carried out without the need for predried solvents. Tributyl 
tin hydride was used as the radical chain carrier and triethylborane/oxygen as the radical 
initiator. A number o f carbon radicals added successfully; however electrophilic radicals 
were not successful. The reaction temperature must be maintained at -78 °C for successful 
addition displaying diastereoselectivity ratios of 46:1.
In attempts to synthesise optically pure p-branched carboxylic acids a new “quat” 
chiral auxiliary, ethyl 4,4-dimethylpyroglutamate 76, has been utilised (Scheme 2.29).50
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The a,P~unsaturated system 77 was obtained by treating 76 with butyllithium followed by 
addition o f crotonyl chloride. The conjugate addition was then carried out using the 
organocopper-Lewis acid reagent RCu-TMEDA-TMSCl. This produced excellent 
diastereomeric excesses (75->95%) and the corresponding enantiomerically enriched P- 
branched carboxylic acids could be synthesised by base hydrolysis o f 78.
Chiral auxiliaries have been developed from optically pure substituted 
imidazolidinones and have been employed in diastereoselective conjugate additions. They 
have been shown to be excellent auxiliaries for stereocontrol at the P-position o f an a,P- 
unsaturated system using organocopper reagents (Scheme 2.30).51
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In this example a new organocopper-Lewis acid system was applied to transfer the highly 
reactive benzyl ligand. Previous Lewis acids like BF3 were unsuccessful in achieving this 
and the organocuprate-trimethylsilyl chloride reagent, BnCu-TMEDA-TMSCl, achieved
31
successful transfer but was compromised by excessive reaction times. The use o f B ^B O T f 
as the Lewis acid dramatically reduced reaction times with no loss o f stereoselectivity 
(>94%). It is presumed that boron is a much stronger chelating agent than TMSC1 therefore 
lowering the LUMO energy o f the substrate and favouring 1,4-addition.
2.3.3.3 jV-Enoyl-sultams
By far the most well known class of A-enoyl-sultams are the examples that 
incorporate Oppolzer’s camphorsultam (Figure 2.6). They were first prepared by Oppolzer 
and coworkers in 1984 for use as chiral auxiliaries in asymmetric Diels Alder reactions.52 
The main advantage of Oppolzer’s sultams are that they are easy to prepare from both 
enantiomers o f camphorsulfonic acid. The auxiliary can be easily removed and recycled. It 
has been found to induce stereoselectivity in numerous different reactions.53
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(-)-D-camphorsultam (-)-L-camphorsultam
Figure 2.6
In particular conjugate additions o f organometallic reagents have taken place 
diastereoselectively with substrates containing Oppolzer’s sultam. Oppolzer and co­
workers published a paper outlining the synthesis of enantiomerically pure P-silylcarboxyl 
derivatives by the asymmetric conjugate addition to A-enoyl-sultams.54 Tributylphosphine- 
stabilized organocopper reagents R Cu added smoothly to A-[p-(silyl)enoyl] sultam 79 in 
the presence o f a Lewis acid to give a mixture o f diastereomers 80 and 81 (Scheme 2.31).
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It was reported that when BF3.0Et2 was used as the Lewis acid promoter as opposed to 
EtAlCh the opposite stereoselectivity was observed. This was attributed to the different 
transition states formed when the Lewis acid coordinates to the a,p-unsaturated system 
(Figure 2.7).
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Figure 2.7
The BF3.0Et2 forms a monocoordinated transition state 82 forcing the SC>2/C=0 groups 
anti whereas the EtAlCh coordinates to the SO2 and C =0 groups producing a cis- 
arrangement 83 forcing attack of the organocopper reagents from the re-face. Using 
EtAlCl2 as the Lewis acid together with various alkenyl- and alkylcopper reagents the 
conjugate adducts produced displayed stereoselectivity favouring the C(P)-re-face attack
33
The conjugate addition o f silylcuprates to Oppolzer TV-enoylsultams demonstrated 
that the nature o f the silylcuprate affects the stereoselectivity o f the reaction (Scheme 
2.32).55 The benefit o f the dimethylphenylsilyl substituent is two fold in that it can be 
removed after the stereochemical reaction has taken place or converted into a hydroxyl 
group with retention o f configuration. This was the first report that focused on the 
chemical nature o f the silylcuprate used [e.g. monocuprate R^SiCu, lower order cuprate 
(R2Si)2CuLi, or higher order cuprate (R2Si)2Cu(CN)Li2] (Scheme 2.32).
0 2
R1
[R2Si-Cu]
Xc" i ^ y r1
THF O SiR, O SiR2
-78°C, 6h
Xc: chiral auxiliary 
R1 = Me, Ph, 4-MePh, 
4-MeOPh, 4-ClPh and 2-Furyl
[ R2Si-Cu ]:
R2SiCu : R2SiLi, CuI, PBu3 (1:1:1) 
(R2Si)2Cu : R2SiLi, CuI, PBu3 (2:1:1) 
(R2Si)2Cu(CN)Li2 : R2SiLi, CuCN(2:l)
Scheme 2.32
Cuprates generally showed high reaction yields; however the stereoselectivity increased 
when higher order cuprates were used. The stereochemical outcome can be explained as 
previously discussed in which the SC>2/C=0 syn conformation together with s-cis 
C=0/C=C conformation invokes attack of the silylcuprate from the re-face.54
The conjugate addition o f Grignard reagents to TV-enoylsultams takes place with 
moderate to high levels o f stereoselectivity (72-90%). The p-substituted adducts can then 
undergo enolate trapping with M el to produce enantiomerically pure C(a,P)-substituted 
carbonyl compounds (Scheme 2.33).56
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A-Enoyl-sultams were prepared from (E)-Ca, CP-disubstituted enoyl chlorides 84 
with Gilman reagents and on protonation generated two new stereogenic centres at Ca and 
Cp (Scheme 2.34).57
This tandem reaction does not require the use o f a Lewis acid as for previously 
mentioned organocopper conjugate additions. In all cases the isomer 85 predominated in 
good excess. The stereochemical control stems from the carbonyl group being s-trans to
3-H2 group. Attack o f the Gilman reagent takes place from the re-face generating an E- 
enolate. Protonation of the enolate therefore occurs from the re-face forcing the methyl 
group up. An example of this stereoselection was observed when 1-cyclohexenoyl-sultam 
86 was reacted with the methyl Gilman reagent and Ca-protonation produced the (IS, 2R)~ 
isomer 87 as the sole product (Scheme 2.35).
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the C=C bond avoiding the steric repulsion o f the Ca methyl substituent with the camphor
O
86 87
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Scheme 2.35
In an attempt to synthesise carbon-13 labelled L-leucine a labelled Gilman reagent 
was added to a crotonyl unit attached to Oppolzer’s auxiliary 88 and a de o f 82% was 
achieved (Scheme 2.36).58
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It was very important that the synthesis o f 89 was accomplished with maximum 
diastereoselectivity and minimum isotopic label wastage. The labelled Gilman reagent was 
prepared from [13C]iodomethane, lithium metal and copper(I) iodide-tri-w-butylphosphine 
complex. The moderate stereoselectivity produced compromised this approach and another 
method was sought which involved a different camphor-based auxiliary producing the 
desired carbon-13 labelled adduct in 98% diastereomeric excess (Scheme 2.37).
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This approach utilises the Yamamoto reagent, 13CH3CuBF3, in an excess o f 7 equivalents. 
The commercial availability o f the chiral auxiliary in both enantiomeric forms allows 
access to both diastereomers in high diastereomeric purity and isotope yield.
The conjugate addition o f thiols to a,P-unsaturated amides derived from a novel 
camphor-based chiral auxiliary pyrazolidinone 90 has produced diastereoselectivities o f 
90% in the presence o f Lewis acids.59 The synthesis of both diastereomers can be achieved 
by changing the Lewis acid. The use o f SnCU as the Lewis acid produced the opposite 
diastereomer to that produced when TiCl4 was used.
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The role that the Lewis acid plays in changing the configuration can be accounted for by 
the steric bulk o f the Lewis acid together with the chelating ability to the carbonyl group 
(Figure 2.8). When SnCL* is used, the metal atom monocoordinates to the carbonyl oxygen 
o f the amide forming the complex A resulting in attack from the CP sz'-face. However TiCU 
is a bulkier Lewis acid due to the shorter bond length o f T i-0  compared with the Sn-0 
bond. As shown in the complex B the CO-C(a) bond twists to prevent steric repulsion 
between the metal and CP hydrogen resulting in addition of the thiol from the CP re-face.
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In the field o f organic synthesis the development o f stereoselective conjugate 
additions to prepare optically active chiral compounds has been achieved using various 
methodologies. The use o f chiral auxiliaries still remains the most popular approach and 
the development o f highly stereoselective conjugate additions using chiral auxiliaries is 
still an extensively researched area. Our group has made progress in the development of a 
homochiral fumaramide derived from Oppolzer’s sultam. Conjugate addition o f Grignard 
reagents to this fumaramide occurred with moderate to high levels of diastereoselectivity.
This is discussed in Chapter 4. The extension of this work to produce useful 
products namely optically active 2-substituted succinic acids and 2-substituted butane-1,4-
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diols is discussed in Chapter 5. For comparison the addition o f Grignard reagents to 
fumarates with one chiral auxiliary is discussed in Chapter 6
3. Polyamines and Diamine Oxidase
3.1 Polyamines
A Dutch microscopist Leeuwenhoek described crystals o f polyamines over three 
hundred years ago. It took two centuries for these crystals to be identified as an organic 
base known as spermine 91. Polyamines are ubiquitous in nature. Two polyamines, 
spermine 91 and spermidine 92, are found in all cells. Putrescine 93, and the less common 
diamine cadaverine 94, also contribute to the natural polyamines found in plants and 
animals.
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Polyamines are basic molecules which are positively charged at physiological pH. The 
physiological roles that these natural polyamines play are both numerous and widespread. 
One physiological role that highlights their importance is their involvement in cell growth 
and division.60
Putrescine has been identified in the biosynthesis of 5-membered rings containing 
nitrogen in many alkaloids including the pyrrolidine ring in nicotine. Polyamines have the 
ability to bind ionically to nucleic acids. This means that at physiological pH the 
protonated forms o f these polyamines bind with the phosphate anions of the nucleic acids. 
This creates a stabilising effect on the DNA and RNA, and it also speeds up steps of the 
transcription and translation sequence. The overall effect o f this is to improve the 
efficiency o f the manufacture of proteins.61
Polyamines can also be found as conjugates. These may take the form o f an amino 
acid as in putreamine or a peptide as in glutathionylspermidine. They have also been found 
forming part of an antibiotic as in bleomycin.62
3.1.1. Poly amine Biosynthesis
There are several biosynthetic routes to polyamines. Some o f these routes are shown in 
Figure 3.1 (modified from Tiburcio eta l.)62
Figure 3.1 Schematic pathway for the biosynthesis ofpolyamines in nature. Dotted arrows 
represent biosynthesis o f ornithine and arginine. Abbreviations: AGM agmatine; ARG 
arginine; 3-AAP 3-acetamidopropanal; AcSPD acetylspermidine; AcSPM 
acetylspermidine; dcSAM decarboxylated S-adenosylmethionine; MTA 5 - 
methylthioadenosine; ORN ornithine; PUT putrescine; SAM S-adenosylmethionine; SPD
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spermidine; SPM spermine; 1 ornithine decarboxylase; 2 spermidine synthase; 3 
spermidine synthase; 4 S-adenosylmethionine decarboxylase; 5 acetyl coenzyme A; 6 
polyamine oxidase; 7 arginine decarboxylase; 8 agmatine ureahydrolase; 9 agmatine 
iminohydrolase; 10'N-carbamoylputrescine amidohydrolase.
These routes apply to bacteria, fungi, plants and animals. Some observations can be made 
about these pathways. It was shown that fungi are able to synthesise putrescine by only one 
route. Plants and bacteria possess two pathways to putrescine. One o f these pathways 
involves ornithine and the other uses arginine. This dual pathway in plants provides a 
means for control o f harmful fungal infections when plants are affected with fungi. The 
enzyme ornithine decarboxylase (ODC; EC 4.1.1.17) decarboxylates ornithine forming 
putrescine. This is the first and usually the rate-limiting step in the pathway.63 This initiates 
the enzyme spermidine synthase to form spermidine 92 followed by the synthesis o f 
spermine 91. Catabolism degrades these polyamines by a process o f N-acetylation 
followed by oxidative cleavage which creates the cycle converting spermine into 
spermidine and spermidine into putrescine.
Antifungal compounds which inhibit ODC can prevent fungi from synthesising 
polyamines, thus affecting cell growth and ultimately causing cell death. Plants are 
unharmed as they can use the arginine pathway to synthesise polyamines.
The other main metabolic pathway for polyamines is terminal polyamine 
catabolism which is catalysed by Cu2+ dependent amine oxidases. The diamine can be 
converted into an aminoaldehyde by the oxidative deamination o f one primary amino 
group. The aminoaldehyde is then oxidised to an amino acid.
In summary bacteria and plants both have two pathways to polyamines. This is 
paramount in the synthesis o f antifungal compounds where inhibition o f the enzyme 
ornithine decarboxylase should lead to the eradication o f the fungi leaving the plants 
unharmed.
3.1.2. Poly amine Degradation
The breakdown of natural diamines via a catabolic pathway involves the use of amine 
oxidase enzymes. This catabolic pathway is shown in Figure 3.2.64
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Abbreviations: DAO diamine oxidase; GABA y-aminobutyric acid; PAO polyamine 
oxidase; PDH pyrroline dehydrogenase
In this scheme the diamine oxidase catalysed oxidation of putrescine produces 
pyrroline, hydrogen peroxide and ammonia, whereas polyamine oxidase produces 
pyrroline and 1,5-diazabicyclononane from spermidine and spermine, respectively, 
together with diaminopropane and hydrogen peroxide. Diaminopropane can then be 
converted into p-alanine, whereas pyrroline can be further catabolised to y-aminobutyric 
acid in a reaction catalysed by pyrroline dehydrogenase. The y-aminobutyric acid is then 
transaminated and oxidised to succinic acid, which is then used in the Krebs cycle.
3.1.3. Inhibition o f Polyamine Synthesis
Inhibitors o f polyamine biosynthesis were developed in the 1970s. These inhibitors 
were used to identify what happens if the concentrations of polyamines are reduced in a 
system. One of the inhibitors produced was a-difluoromethylornithine (DFMO) 95.
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This inhibitor was found to bind specifically and irreversibly to ODC thereby 
inhibiting its action. This inhibitor permanently inactivates the enzyme; therefore DFMO is 
known as a suicide inhibitor. It was shown that this inhibition of ODC reduced the 
formation o f polyamines therefore inhibiting cell growth. This property was seen to be 
beneficial in that DFMO is effective against tumours in vitro but this effect has not been 
seen in vivo 65
3.2 Diamine Oxidase
Diamine oxidases (DAO, EC 1.4.3.6) belong to a very large class o f enzymes 
called quinoproteins. These proteins have a quinone co-factor and contain two identical 
subunits. Diamine oxidases catalyse the oxidative deamination of a range o f primary 
diamines to their corresponding aminoaldehydes with the release of ammonium ion along 
with hydrogen peroxide (Scheme 3.1).
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H3N (CH2)nCH2 NH3 + H20  + 0 2
Diamine oxidase
u
© ©
H3N (CH2)nCHO + NH4 + H20 2
Scheme 3.1
Diamine oxidases are rather unspecific in that they catalyse the oxidation o f some 
monoamines as well as diamines. Diamine oxidase can be found in a wide variety o f 
biological tissues. There are two sources which are convenient for experimental use.
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Kidney diamine oxidase is a commercially available enzyme and pea seedling diamine 
oxidase is readily extracted from 10 day old pea seedlings.66
Diamine oxidases are copper-containing proteins. They contain topaquinone and 
are referred to as topaquinoproteins 96.
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If copper was removed by dialysis by chelating agents deactivation of the enzyme ensued. 
This was shown experimentally with diamine oxidase.67 The requirement of copper was 
confirmed as the activity was restored when copper was added back to the enzyme.
An organic cofactor was first identified in DAO over 50 years ago. The identity of 
this cofactor remained a mystery for many years. Studies showed that reagents capable of 
forming carbonyl derivatives were able to inhibit diamine oxidases. This suggested that the 
cofactor contained a carbonyl group.68 It was first thought that the cofactor was pyridoxal 
phosphate. It was then reported that the cofactor is pyrroloquinoline quinone.69 This idea 
has now been dismissed and the cofactor has been shown to be topaquinone.
3.2.1. Biosynthesis o f Topaquinone
It was not until the amine oxidase gene from the yeast Hansenula polymorpha had 
been cloned and sequenced that it was possible to identify the precursor to topaquinone as 
L-tyrosine 97.70 This was deduced by the comparison o f the DNA-derived sequence with 
the amino acid sequence. In other words the topaquinone co-factor is encoded by a tyrosine 
codon.
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A number o f possible pathways from tyrosine to topaquinone were postulated:71
• Post-translational modification of tyrosine by another enzyme, tyrosinase or 
tyrosine hydroxylase, or even by a yet undiscovered enzyme;
•  Post-translational modification o f tyrosine in situ by the copper.
The mechanism for the oxidation o f tyrosine to topaquinone is a six electron oxidation
nomechanism shown in Scheme 3.2.
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Scheme 3.2
From results o f kinetic and spectroscopic studies a mechanism has been suggested which 
still requires structural evidence. However it does provide a rational scheme for the 
biosynthesis of topaquinone from tyrosine. This mechanism is shown in Scheme 3.3.72
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In the first step o f Scheme 3.3 the Cu2+ binds to form a Cu(II) complex as shown by A. 
This complex is then in equilibrium with the Cu(I) radical B. The unpaired electron on the 
oxygen seen in B is delocalised over the aromatic ring with a resonance form B ', activating 
the ring carbons. The Cu(I) complex then reacts with dioxygen to produce an activated 
oxygen complex containing an oxygen superoxide bond shown in C. This complex then 
attacks the tyrosyl radical to form a dopaquinone bonded to a Cu(II) oxide/hydroxide/aqua 
complex D. This complex is in rapid exchange with solvent water thereby allowing solvent 
oxygen to be incorporated into topaquinone as shown by the transition o f E to F. Rotation 
o f the dopaquinone ring brings the C-2 carbon into close proximity to the water hydroxo
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ligand. Nucleophilic attack results from the Cu(II)-OIT on the dopaquinone producing G. 
Finally in the presence o f dioxygen, G  is oxidized to topaquinone and the Cu(II) atom 
picks up a water molecule.
At present it is believed that the synthesis o f topaquinone is a self-catalytic 
mechanism and does not require the presence o f any other enzyme. Work is presently 
being carried out to elucidate the mechanism fully with structural evidence.
3.2.2. Reaction Mechanism o f Copper Amine Oxidases
There have been a number of methods used to try to determine the mechanisms of 
amine oxidases in vivo. These have ranged from X-ray structures and Raman spectroscopy 
through to site directed mutagenesis o f amine oxidases. The cumulative results from 
various methods have been combined to give a generalised catalytic cycle as shown in 
Scheme 3.4.72
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This catalytic cycle shows the production o f two imine states; one is the substrate imine 
and the other is the product imine. The catalytic cycle can be thought o f as two separate 
processes. The first o f these processes involves the binding o f the amine to the quinone 
which then undergoes oxidation and cleavage. The second process involves the oxidation 
of the enzyme by dioxygen resulting in the loss of hydrogen peroxide and ammonia.
3.2.3. Structure of Amine Oxidases
The first amino acid sequence identified was that o f lentil seedling amine oxidase 
(LSAO) which was cloned from cDNA in 1992.73 It was not until a year later that the first 
crystals o f an amine oxidase were identified which were those o f pea seedling amine 
oxidase. It was found that each subunit had a Mx o f -72,000 and a weight o f -66  kDA.74 
The first X-ray structure of pea seedling amine oxidase was published in 1995. This 
represents a eukaryotic copper amine oxidase.75 The active site o f the enzyme is found 
buried deep in the structure which appears to be the trend for an enzyme that has a radical 
mechanism. A channel has been identified for access to this active site and it is also 
suggested that the active site has a gate mechanism.72
3.2.4. Stereoselectivity in Reactions catalysed by Copper Amine Oxidases
Copper amine oxidases appear to be different from most enzymes in that as a group 
they have no stereochemical selectivity in the removal o f the hydrogen in the oxidation of 
the CH2NH2 group. Some copper amine oxidases remove the pro-S while others remove 
the pro-R hydrogen and some show no selectivity at all. The two main enzymes o f interest 
in this particular research are pea seedling amine oxidase and pig kidney amine oxidase 
which have been shown to be selective in removing the pro-S hydrogen on oxidation in 
relation to the polyamines cadaverine 94, putrescine 93 and tyramine.
Derivatives of these amines have also been investigated in order to give some 
insight into the regiochemistry o f this oxidation. The first example showed that the amino 
group furthest away from the hydroxyl substituent of 2-hydroxyputrescine 98 and 2- 
hydroxycadaverine was oxidised.
OH
98
The next oxidation o f a putrescine derivative catalysed by diamine oxidase reported in the 
literature involved 2-methylputrescine 99.
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This gave very interesting results in that pig-kidney amine oxidase showed no 
regioselectivity. It catalysed the oxidation o f both ends of the diamine equally. However 
pea seedling diamine oxidase oxidised the less hindered C-4 end preferentially. The same 
group showed that when enantiomerically pure 2-methylputrescine was used in the same 
study that pea seedling amine oxidase showed no stereoselectivity and just displayed 
regioselectivity. On the other hand pig kidney diamine oxidase showed stereoselectivity in 
that both enantiomers o f 2-methylputrescine were oxidised regioselectivity. The pro-S
HH 79isomer was oxidised at the C-4 end and the pro-R at the C-l end. ’ This situation is 
summarized in Scheme 3.5.
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Using our methodology that we developed for the diastereoselective conjugate 
addition of Grignard reagents to a homochiral fumaramide derived from Oppolzer’s
sultam, we will synthesise a range of optically active 2-substituted putrescines. This should 
give us valuable insight into the selectivity o f the enzyme for different substrates. This 
work is discussed in Chapter 7.
4. Diastereoselective conjugate additions of Grignard reagents to a 
homochiral fumaramide derived from Oppolzer’s sultam
4.1 Background
Asymmetric conjugate addition reactions to a,p-unsaturated organic compounds are 
some of the most useful methods for producing P-substituted products stereoselectively.79 
The introduction o f chirality using a chiral auxiliary is a useful way o f producing a wide 
variety o f optically active organic compounds. Oppolzer et al. reported the 
diastereoselective conjugate addition o f Grignard reagents to A-enoylsultams (Chapter 
2.3.3.3).55
A,A'-Fumaroylbis[(2R)-bomane-10,2-sultam] 10080, is readily available from 
Oppolzer’s (2/?)-bomane-10,2-sultam. The C2 symmetrical fumaramide 100 containing 
two of Oppolzer’s camphorsultam moieties has previously been used in cycloaddition and 
dihydroxylation reactions.80,81,82
02 100
The [4 + 2] cycloaddition o f cyclopentadiene and similar dienes to fumaramide 100 
occurred with high levels o f diastereofacial 71-selection favouring attack on the C(a)-re 
face. Similarly the diastereoselective ^ -d ihydroxyla tion  o f fumaramide 100 using OSO4 
and 4-methylmorpholine-4-oxide occurred with excellent stereoselectivity (>98%) 
resulting from addition on the C(a)-re face. However no examples o f conjugate additions 
to 100 have been reported. It was our aim to carry out a study o f conjugate additions of 
Grignard reagents to fumaramide 100 (Scheme 4.1) and establish one diastereomer is 
produced in excess, either 101 or 102.
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If the conjugate addition occurs with a high level o f diastereoselectivity the chiral 
auxiliaries will be cleaved to yield enantiomerically enriched 2-substituted succinic acids 
103
O
O R 
103
Substituted succinic acids are important intermediates in organic synthesis. They are
• • • • • 33building blocks for the synthesis o f enantiomerically pure P-substituted P-amino acids.
OA
They also have a role as structural components of natural products.
Alternatively, reduction of the substituted succinamides would yield the 
corresponding 2-substituted butane-1,4-diols 104 together with the chiral auxiliary 105 
which could be converted into the 2-substituted butane-1,4-diamines 106 (putrescines) 
(Scheme 4.2). We could then use these enantiomerically enriched diamines as substrates 
for the enzyme diamine oxidase. This would allow the study o f the outcome of the 
oxidation of these enantiomerically enriched 2-substituted putrescines catalysed by DAO.
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4.2 Synthesis of Oppolzer’s sultam
As Oppolzer’s sultam was the auxiliary o f choice it was necessary to synthesise the 
auxiliary from cheap starting materials as a large amount of it was required in order to 
carry out our study. The chiral auxiliary is commercially available at a price of £30 per 
gram, which was not economically viable in the quantities required. There are various 
synthetic routes available in the literature.85,86 The route we used allowed the large scale 
production o f the chiral auxiliary in pure crystalline form (Scheme 4.3).
The chiral auxiliary was readily prepared from (+)-camphor-10-sulfonic acid 107. 
The sulfonyl chloride 108 was treated with ammonia and this generated the sulfonamide 
109. Azeotropic removal o f water using toluene together with the acid catalyst Amberlyst 
15 ion-exchange resin produced the camphorsulfonimine 110 in 95% yield. The use o f a 
Dean-Stark apparatus in this reaction forces the equilibrium towards the imine as the water 
is removed as soon as it is generated. The acidic ion exchange resin was used in order to 
keep the pH at a reasonably low level as this assists in protonation o f the OH group, 
making it a better leaving group. The final step was the reduction o f the sulfonimine 110 to 
the sultam 111 using the reducing agent lithium aluminium hydride (LiAlHj). This is a 
very good practical synthesis in that it avoids chromatography and each compound in the 
synthesis can be purified by crystallization.
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As the project progressed another synthetic method that had previously not been 
identified from the literature was used as it had the added benefit o f being a more efficient 
synthesis with fewer steps (Scheme 4.4).87
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This preparation o f Oppolzer’s sultam involved synthesising the sulfonylchloride 108, 
dissolving it in 1,4-dioxane and pouring this solution into cold concentrated ammonia 
solution. This produces an insoluble product which could be filtered off to yield the 
camphorsulfonimine 110. The imine required no purification and could be reduced by 
sodium borohydride in aqueous methanol to yield the chiral sultam 111. As well as being a 
more efficient synthesis the reduction step is much safer than the LiAlH* reduction and 
also avoids the use o f large amounts o f tetrahydrofuran. Due to the commercial availability 
o f both enantiomers o f camphor- 10-sulfonic acid this route allows access to both 
enantiomers of Oppolzer’s sultam.
4.3 Conjugate addition of Grignard reagents to the fumaramide 
system
The fumaramide 100 was prepared from fumaroyl chloride and (15)-(-)-2,10- 
camphorsultam in 81% yield using the literature method o f Bauer et a lm The fumaramide 
100 was treated with ethyl magnesium bromide in order to identify successful conjugate 
addition and also to determine the number o f equivalents of Grignard reagent required for 
successful conjugate addition (Scheme 4.5).
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The Grignard reagent adds via a conjugate addition; however Grignard reagents would 
normally add via direct addition as they are classed as hard nucleophiles. It was thought 
that the presence o f the bulky auxiliaries would direct the Grignard reagent, therefore 
producing the product of conjugate addition. The reaction took place cleanly with no direct 
addition products detected.
It appeared that the number of equivalents o f Grignard reagent used has a 
considerable effect on the chemical yield o f the reaction. The yield o f 112 observed when 
using 2.0 equivalents of Grignard reagent was 50%. A number o f exploratory reactions
were carried out looking at the influence o f the number o f equivalents. Further 
investigation into how the stereoselectivity is induced in this system indicated that the 
number o f equivalents required must be at least three. The evidence for this stereoselective 
conjugate addition relates to the magnesium chelation as discussed by Oppolzer et a l55 
One equivalent is required for chelation to the O atoms o f the C =0 and SO2 groups at each 
end and the C =0 group adopts a c/s-conformation with the C=C bond. This forces the 
camphor rings to block the s/'-face. The third equivalent then delivers its alkyl group in a 
conjugate manner from the re-face and the addition proceeds via a six-membered cyclic 
mechanism (Figure 4.1).
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Figure 4.1
Therefore in our bis fumaramide system the reaction should proceed via the 
transition state shown in Figure 4.2.
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Figure 4.2
This information together with our experimental findings showed that the optimum 
number o f equivalents of Grignard reagent required for successful addition was 3.5. Now 
that we had identified the best conditions to carry out the reaction we had to focus on the 
stereoselectivity o f the conjugate addition. There were two main points that had to be 
addressed:
• How to determine the stereoselectivity o f the conjugate addition.
Assignment of absolute configuration o f newly formed stereogenic centre to 
identify which diastereotopic face is being attacked.
One approach to address these points involves saponification o f the succinamide 
products 101 and 102 to yield the enantiomerically enriched 2-substituted succinic acids 
103 together with the chiral sultam 105 (Scheme 4.6). The stereoselectivity could be 
quantified by carrying out chiral HPLC analysis on the 2-substituted succinic acids. This 
might involve derivatisation o f the acids to decrease their polarity increasing their mobility 
for liquid chromatography. Enantiomerically pure 2-substituted succinic acids have been 
extensively reported in the literature. Therefore the absolute configuration and sign o f 
rotation reported could be used to identify the absolute configuration o f the newly formed 
stereocentre of the optically active 2-substituted succinic acid synthesised by our 
methodology.
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Scheme 4.6
A series o f diastereoselective conjugate additions using a range o f Grignard 
reagents were carried out on fumaramide 100. The methyl, phenyl and allyl Grignard 
reagents reacted with 100 to produce the direct 1,2-addition products. Oppolzer et al. 
observed the same result with the methyl Grignard reagent on A-enoylsultams.55
Table 4.1 Diastereoselective conjugate additions to fumaramide 100
Entry 2-substituted
succinamide
Isolated yield 
(% )
1 Ethyl 113 73
2 Isopropyl 114 89
3 Propyl 115 69
4 Butyl 116 76
5 Cyclohexyl 117 78
6 Octyl 118 97
7 Benzyl 119 71
8 Isobutyl 120 51
9 Hexyl 121 80
10 Cyclohexylmethyl
122
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4.3.1 Addition o f other organometallic reagents
Various different methods were attempted to add organocuprates to fumaramide 
100. However the fumaramide 100 was unreactive and only starting material was isolated 
from the reaction mixtures. Organolithium reagents were also used but again fumaramide 
100 was unreactive. Even when Oppolzer’s method was used which incorporated the use 
o f a Lewis acid and BuLi as the alkyl donor the fumaramide 100 did not react (Scheme 
4.7). Oppolzer had shown that this method o f cuprate addition was very successful in 
carrying out conjugate addition to an TV-enoylsultam system. By changing the Lewis acid 
both diastereomers could be obtained with good diastereoselectivities (Scheme 4.8).54
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It was disappointing that our system did not behave in a similar manner as this 
would have allowed access to both epimers without the need to use the other enantiomer o f 
the chiral auxiliary.
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Scheme 4.8: Oppolzer’s results
4.4 Synthesis of enantiomerically enriched 2-substituted succinic acids
This reaction involves the removal o f the chiral auxiliaries under hydrolysis 
conditions to yield the 2-substituted succinic acids 103 (Scheme 4.6). The method of 
hydrolysis used was the hydrogen peroxide-assisted lithium hydroxide saponification 
which has been previously used for this type o f hydrolysis.88 The reaction was reasonably 
straight-forward but the workup required careful control o f pH in order to extract both 
products successfully. On workup it was essential for the pH of the aqueous phase to be 
below 3 in order to get successful extraction of the succinic acid into ethyl acetate. The 
aqueous extract was then made basic to about pH 8 and extracted with ethyl acetate to 
yield the chiral auxiliary which could be recycled.
The first substituted succinic acid synthesised using this method was 2- 
ethylsuccinic acid 123. From the optical rotation of the 2-ethylsuccinic acid 123 its 
absolute configuration corresponded to the (R)-enantiomer by comparison with the optical 
rotation reported in the literature.89
O
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However the specific rotation observed for the ethyl succinic acid (+34) was much higher 
than the literature value (+24) which could be due to the following factors.
•  The original rotation in the literature was not of the pure enantiomer or there could 
be some error in the measurements reported.
•  The rotation obtained for our sample could be subject to errors in the 
measurements obtained (estimated to be ± 10%).
The next step was to quantify the enantiomeric excess of the optically active 2- 
substituted succinic acids. The analytical method that was appropriate for this was chiral 
HPLC. Chiral chromatography involves the use o f a chiral stationary phase in gas or liquid 
chromatography. The disadvantage in using chiral chromatography is that a sample o f the 
racemate is usually required in order to prove separation of enantiomers.
Chromatographic separation depends on the difference in affinity o f a mixture of 
compounds between the stationary phase and the mobile phase. The stationary phase is 
usually the solid material which the mixture is passed through such as silica. The mobile
phase is the solvent (eluent) travelling through the stationary phase. If we consider the two 
enantiomers o f a racemate they have the same physical properties. However when they are 
present in a chiral environment they can behave differently. Enantiomers usually have 
different biological properties when present in a biological system. In a biological system 
enantiomers are differentiated by interactions with enantiomerically pure molecules that 
are present in the system. This was realised in an unfortunate situation when the drug 
Thalidomide was administered to pregnant women and resulted in birth defects. The drug 
was manufactured and sold as a racemic mixture of A-phthalylglutamic acid imide 124. It 
was found that the (R)-(+)-isomer produced the desired physiologically activity whereas 
the corresponding (*S)-(-)-enantiomer was teratogenic and caused serious foetal 
malformations. This led to the United States Food and Drug Administration recommending 
that each enantiomer o f all new racemic drugs should be individually tested.
H
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Similarly in chromatography the stationary phase can be made chiral. The different 
enantiomers will have a different affinity for the chiral stationary phase thus allowing 
separation to occur. There are five general types o f chiral stationary phases:
• Protein based phases bonded to silica.
• Small molecular weight compounds bonded to silica (the Pirkle phases).
• Cellulose and amylose polymers that are coated onto silica gel.
• Macrocyclic glycopeptides that are bonded to silica.
• Cyclodextrin based materials that are also bonded onto silica.
The stationary phase is chemically bonded to a silica substrate and is stable to a wide range 
of solvents. The chiral stationary phase columns that are available in our department are 
celluose polymer coated silica. The cellulose is derivatized with tris(3,5-dimethylphenyl 
carbamate.
In order for the successful identification o f each enantiomer peak in the 
chromatograph samples of racemic 2-subtituted succinic acids were required. The racemic 
acid should give two peaks when run on a chiral LC column and would allow comparison
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with our mixture o f enantiomers. A literature synthesis was used for the preparation o f 
racemic 2-substituted succinic acids (Scheme 4 .9 )90
\ \= - °  f-BuOH ^ C 0 2'Bu
h i
0  125
NHS
H 0 2C
126
H 0 2C
c o 2h TFA
R
128
c h 2c i2
LDA
R-Br
R
127
Scheme 4.9
This route worked extremely well with inexpensive starting materials. Succinic anhydride 
125 was subjected to ring opening and one carboxyl group was protected as the tert-butyl 
ester 126. The advantage in using the te/7-butylsuccinate 126 is that it is soluble in ethereal 
solvents and thus minimizes self-condensation. The dianion produced from treatment o f 
ferf-butylsuccinate 126 with LDA in THF was alkylated at the a-carbon of the ester with 
various alkyl halides producing the 2-substituted succinate derivatives 127. It was found 
that for successful alkylation o f the isopropyl and propyl substituents the halide source had 
to be iodide, wheras the bromides o f the other R groups were successful in alkylation o f 
126. The ester protecting group was removed using trifluoroacetic acid in dichloromethane 
to yield the 2-substituted succinic acids 128 (Table 4.2).
The substituted succinic acids could not be analysed directly by chiral 
chromatography as they were too polar for the chiral columns available within the 
department and therefore they required derivatisation. In order to incorporate a 
chromophore that would show a good absorption in the ultraviolet detector o f the HPLC 
spectrometer and also decrease the polarity, the alkyl substituted succinic acids were 
converted into their dianilide derivatives 147. The aromatic substituted succinic acids were 
simply derivatised as their corresponding dimethyl esters 148 as they already contain a 
chromophore in the form of an aromatic ring.
Table 4.2 2-Substituted succinic acids
Entry Substituent Substituted tert- 
butyl ester (% yield)
Substituted succinic acid 
(% yield)
1 R = ethyl 129 (72) 138 (81)
2 R = isopropyl 130 (38) 139 (79)
3 R = propyl 131 (16) 140 (74)
4 R = butyl 132 (70) 141 (81)
6 R = octyl 133 (85) 142 (83)
7 R = benzyl 134 (89) 143 (81)
8 R = isobutyl 135 (14) 144 (52)
9 R = hexyl 136 (20) 145 (87)
10 R = cyclohexylmethyl 137 (14) 146 (94)
MeO,
OMe
O
PhHN
NHPh
O
147 148
R = alkyl
The preparation o f the dimethyl esters was carried out using diazomethane 
generated using the Aldrich MNNG (Af-methyl-N'-nitro-7V-nitrosoguanidine) Diazomethane 
Kit. We used the modified procedure previously described by Ngan et a l which replaces 
MNNG with Diazald (Af-methyl-Ar'-nitroso-/?-toluenesulfonamide) as the precursor to 
diazomethane.91 The Aldrich MNNG Diazomethane Kit was ideal for our purposes as it 
allowed the generation o f diazomethane in a closed system on a millimole scale without 
the need for distillation. Apparatus used to prepare diazomethane that requires distillation 
has the added risk o f the diazomethane exploding. Diazomethane has been known to 
explode both as a gas or in solution, and ground glass joints and alkali metals were found 
to be initiators. Due to the highly toxic and explosive nature o f diazomethane it was very 
important that the safest possible method was utilised.
The first stage in generating diazomethane involves saponification o f N-methyl-N- 
nitroso-/?-toluenesulfonamide 149 using potassium hydroxide to give a basic diazotate ion
150. This diazotate ion is rapidly converted to diazomethane 151 by the basic conditions o f 
the reaction (Scheme 4.10).
corresponding succinate diesters in moderate yields of 54-86%. The succinate diesters
racemic dimethyl 2-benzyl succinate 152 resolved well on the commercially available 
chiral stationary phase column, Diacel Chemical Industries CHIRALCEL-OD-H. The 
dimethyl 2-benzyl succinate 153 produced in our asymmetric Grignard reaction gave a 
good chromatograph displaying an enantiomeric excess of 92%. Racemic dimethyl 2- 
methylsuccinate was also synthesised in an attempt to identify if  it was resolvable by the 
HPLC system. It was detectable but did not give two distinct peaks corresponding to both 
enantiomers.
As previously mentioned the alkyl substituted succinic acids 154 can be derivatised 
as their corresponding dianilides 147 (Scheme 4.11). However it proved very problematic 
and time consuming to identify optimum reaction conditions for this coupling. A number 
of different coupling reagents were used such as DCC (dicyclohexylcarbodiimide), EDCI 
[l-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride] and cyanuric chloride
^  H3C
O
N = 0
' n - c h 3
150
strong acid basic diazotate ion
HO H
© © -  
H2C -N = N  + HjO M 0 ©
diazomethane
151
N.
£ o h
h n - c h 3
0
Scheme 4.10
As the diazomethane is generated it reacts with the 2-substituted succinic acid to give the
required no further purification and could be used directly for chiral HPLC anaylsis. The
(Table 4.3).
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Table 4.3 Summary of coupling reaction conditions attempted
Reaction conditions Reaction outcome
Aniline 2 equiv.,DCC 2 equiv. 
DMAP 10 mol %, acetonitrile 
Solvent: THF
reaction unsuccessful
Aniline 2.2 equiv., EDCI 2.2 equiv. 
Solvent: DCM
reaction unsuccessful
Aniline 2.2 equiv., EDCI 2.2 equiv. 
Solvent: THF
reaction unsuccessful
Aniline 4 equiv., cyanuric chloride 3 equiv. 
Triethylamine 2.2 equiv.
Solvent: Acetone
reaction successful but problems in 
purification
Aniline 4 equiv., EDCI 2.2 equiv. 
Solvent: DMF
reaction successful
The reactions attempted involved the use o f a coupling reagent, in our examples DCC and 
the water soluble equivalent EDCI. The coupling reagent reacts with the carboxylic acid to 
form an imidate which is susceptible to nucleophilic attack from aniline producing the 
corresponding dianilide and in the case o f DCC the by-product dicyclohexylurea. 
Dicyclohexylurea is difficult to remove from the product and purification usually requires 
chromatography. The benefit o f using EDCI is that excess reagent and the urea by-product 
can be easily removed by washing with dilute acid or water. In summary the coupling 
reagent activates the carboxyl group by transforming it into a good leaving group.
The use o f cyanuric chloride (CC) 155 as a reagent allows carboxylic acids to be 
converted into chlorides, esters, amides and peptides.92 It was shown that succinic acid was 
converted into the dianilide in 55% yield using CC. When CC is dissolved in dry acetone
along with the carboxylic acid and triethylamine the acid chloride 156 is formed from a 
nucleophilic attack of the carboxylate anion on CC. CC is then converted into the insoluble 
dichlorohydroxy- or chlorodihydoxy-s-triazine 157 (Scheme 4.12). The acid chloride is 
then subject to attack from the corresponding amine to form the amide.
The use of CC as a reagent to synthesise our dianilides did work but purification 
could not be achieved and as we wanted to carry out this coupling on a 50 mg scale 
purification must be straightforward. Use of EDCI and DMF (dimethylformamide) as the 
reaction solvent, was successful in synthesising the corresponding dianilides in good yield 
(57-85%).
Racemic N, jV-diphenyl-2-methylsuccinamide 158 was synthesised in order to check 
if  chiral HPLC could resolve the enantiomers. The enantiomers showed good separation. 
The racemic 2-substituted succinic acids previously synthesised were derivatised as the 
corresponding dianilides (Figure 4.3).
Cl Cl
©
+ HNEt3
155 R
H
Cl
157 156
Scheme 4.12
R = Et 159, iPr 160, Bu 161, Oct 162, 
iBu 163, iPr 164, Hex 165 
and cyHexMe 166
Figure 4.3
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Now with a system in place for determination o f the enantiomeric excesses o f the 
2-substituted succinic acids, a set of results was produced (Table 4.4).
Table 4.4 Removal of chiral auxiliaries yielding (R)-substituted succinic acids
Entry 2-substituted 
succinic acid
Isolated yield 
(% )
Configuration Ee (%)*
1 Ethyl 167 65 ( R f 63 177
2 Isopropyl 168 67 ( R f 0 178
3 Propyl 169 71 ( R f 52*’ 169
4 Butyl 170 67 ( R f 72" 179
5 Cyclohexyl 171 63 ( R f 9 180
6 Octyl 172 74 (R) 90 181
7 Benzyl 173 71 ( R f 92‘ 182
8 Isobutyl 174 76 (R) 8 183
9 Hexyl 175 65 ( R f 37 184
10 Cyclohexylmethyl
176
66 (R) 185
dianilide not 
resolved
determ ined by chiral HPLC of dianilide derived from diacid, ^ o t  resolved by chiral 
HPLC, % ee based on optical rotation o f substituted succinic acid compared with literature 
value, d ia c id  converted into dimethyl ester.
The results showed a range o f stereoselectivities relating to the conjugate addition 
o f Grignard reagents to fumaramide 100. There was no obvious trend and it was difficult to 
explain why there was no stereoselectivity for the isopropyl substituent and a high 
stereoselectivity for the benzyl substituent. A suggestion for the low levels o f 
stereoselectivity could be a result o f non-chelation of the magnesium. Comparative semi- 
empirical PM3 and ab initio STO 3 21G calculations suggest that at 193 K four 
conformations o f 100 can exist.100 There are two symmetrical and two unsymmetrical 
species with the symmetrical conformations making up 96% and the nonsymmetrical
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conformations 4% of the total. If chelation did not occur the existence of these other 
conformations could explain the low values obtained.
Attempts were also made to separate the diastereomeric mixtures of the substituted 
succinamides by column chromatography. It became apparent from the *H NMR spectra of 
the individual diastereomers that specific signals could be identified. The chemical shifts 
of these signals are characteristic for each diastereomer. This should allow determination 
of the diastereomeric excess from the NMR spectra of each crude mixture.
4.5 Determination of diastereomeric excess from *H NMR spectra
The conjugate addition of Grignard reagents to Ar,A-fumaroylbis[(2/?)-bornane- 
10,2-sultam] 100 produced a mixture of diastereomers 101 and 102 (Scheme 4.1). 
Attempts to determine the stereoselectivity of the conjugate addition from the mixture of 
diastereomers produced were made. Initially the technique of GC-MS was used which 
consists of coupling a mass spectrometer to the effluent of a gas chromatograph. This gives 
the combination of the analytical capability of mass spectrometry together with the high 
degree of separation by gas chromatography. However this technique was not successful as 
the compounds have too high molecular weights to be volatile for GC.
A method was developed to determine the diastereomeric excesses from the ]H 
NMR spectra of the crude mixtures (Figure 4 .4).
Aux
Aux
O
Aux
Aux
O
CON
CON
H a to Hb 17 Hz 
Ha to Hx 10 Hz 
Hb to Hx 4 Hz
Hy to HB 17 Hz 
H to Hx 4 Hz 
Hb to Hx 10 Hz
CON
Hb
R
CON
Figure 4.4
The ABX system of the succinamide protons resonated at different chemical shifts 
for each pair of diastereomers except for the benzylsuccinamide. The ABX system in our 
example arises from proton HA and Hb being diastereotopic giving an AB system which is 
further split by Hx to give a double doublet for both HA and HB (Figure 4.5). Hx also 
displays a double doublet but this is masked in Figure 4.5 as a result o f the CH2 SO2 signal 
of the camphorsultams. As shown in Figure 4.5 the chemical shift o f HB of the major 
diastereomer is lower than HA of the minor diastereomer. Integration of the signals for HA 
and Hb gives an estimate of the diasteromeric ratio from which the diastereomeric excess 
can be calculated. The ABX system of the major diastereomer was consistently at a lower 
5 value than the minor diastereomer. Therefore the ratio of diastereomers 101 and 102 was 
determined by ]H NMR spectroscopy (Scheme 4.1, Table 4.5). The table of results was 
both interesting and alarming as we were expecting to observe analogous results to those 
obtained from the chiral HPLC work on the derivatised 2-substituted succinic acids (Table 
4.4).
\ \ \ M  I I I I  1 7 1 ?
A i l
m i m  f l u  1/1/
Aux
Aux
O
O
major
Figure 4.5
Results from both methods are tabulated in Table 4.6. We consider that the results 
obtained from the NMR spectra o f the diastereomeric mixtures are more reliable as this 
is a direct method o f estimating the stereoselectivity. In summary the succinic acids with 
propyl, butyl and octyl substituents show an increase in optical purity after removal o f the 
chiral auxiliary, whereas succinic acids with isopropyl, cyclohexyl, isobutyl and hexyl 
substituents show a decrease in optical purity.
Table 4.5 Conjugate addition to fumaramide 100
Entry RMgX Isolated yield (%) Dra (major/minor) De (%)
1 R = ethyl 76 81:19(186/187) 62
2 R = isopropyl 89 66:34 (188/189) 32
3 R = propyl 69 68:32 (190/191) 36
4 R = butyl 76 77:23 (192/193) 54
5 R = cyclohexyl 87 66:34 (194/195) 32
6 R = octyl 62 76:24 (196/197) 52
7 R = benzyl 78 N/A (198) N/A
8 R = isobutyl 87 72:28 (199/200) 44
9 R = hexyl 80 76:24 (201/202) 53
10 R = cyclohexyl 
methyl
75 69:31 (203/204) 38
aDiastereomeric ratios were estimated from by H 400 MHz NMR spectra o f the crude
reaction mixtures.
Table 4.6 Comparison of stereoselectivity results
Entry Substituent Ee obtained from 2- 
substituted succinic acids
De obtained from 
NMR of succinamides
1 R = ethyl 63 62
2 R = isopropyl 0 32
3 R = propyl 52 36
4 R = butyl 72 54
5 R = cyclohexyl 9 32
6 R = octyl 90 52
7 R = benzyl 92 N/A
8 R = isobutyl 8 44
9 R = hexyl 37 53
10 R = cyclohexylmethyl N/A 38
The results suggest that there is epimerisation o f the succinate stereogenic centre 
during the basic hydrolysis. This can be explained by enolate B formation during the basic 
hydrolysis o f A. It is also likely that each amide group o f a diastereomer is hydrolysed at a 
different rate so C and D (less likely) could also be formed (Figure 4.6). The final product 
could also be present as an enolate E. It should be noted that the IR C =0 absorption o f 
succinamide A is 1680-1690 cm'1 and therefore A behaves like a ketone with a localised 
lone pair on the nitrogen.
o2s
0 ©o
E
Figure 4.6
The combination o f hydrogen peroxide and lithium hydroxide to cleave chiral
auxiliaries attached by an amide has been routinely used with no loss o f optical
•, 88 , 101,102  purity. ’ ’
Another explanation for change in optical purity could be a result o f epimerisation 
during the coupling o f aniline to the 2-substituted succinic acids. In the preparation o f 
peptides one problem that was encountered was racemization of the activated ester when 
DCC or other related carbodiimide coupling reagents were used. In an attempt to address 
this problem racemization suppressing additives were used; the most popular being 1- 
hydroxybenzotriazole (HOBt) 205.103 HOBt intercepts the activated ester forming a new 
intermediate which does not racemize, allowing the second amino acid to attack the HOBt 
ester producing the dipeptide. Even with the use o f additives a small amount of 
racemization can still occur. This problem could also apply to our system in which the 
stereogenic centre epimerises when the activated ester is formed. However this would only 
account for the decrease in stereoselectivity and not the increase observed for some 2- 
susbtituted succinic acids.
\
OH
205
It was decided to try the following modifications to the hydrolysis o f the 
succinamide and the coupling reaction to form the dianilide.
• Hydrolysis attempted under acidic conditions.
• Hydrolysis attempted in the presence of lithium hydroxide but without hydrogen 
peroxide.
• Coupling reaction attempted using HOBt as an additive.
Firstly we attempted to hydrolyse the octyl substituted succinamide by refluxing in 
dilute HC1 and 1,4-dioxane to give the succinic acid and chiral sultam. However this was 
unsuccessful with the starting succinamide being the only product isolated from the 
reaction. Although these hydrolysis conditions were vigorous it was disappointing as this 
was shown to be effective for hydrolysing substituted succinamides without any trace of 
racemization.104 The hydrolysis was attempted using only lithium hydroxide without the 
use o f hydrogen peroxide and the products displayed marginally less epimerisation. The
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use o f HOBt to promote the coupling reaction was unsuccessful in minimising 
epimerisation on forming the dianilide.
A better method was required that would confirm the results obtained from the 
initial conjugate addition. We decided to focus on the synthesis o f the 2-substituted diols 
104 where no epimerisation should occur from reduction o f the amides 101 and 102 with 
lithium aluminium hydride (Scheme 4.13).
LiAlH, NH
101+102
Scheme 4.13
105 104
4.6 Future Work
4.6.1 Asymmetric synthesis of aryloxobutanoic acids for treatment of 
neurodegenerative diseases
The neuronal damage that results from disorders like Alzheimer’s disease or 
Parkinson’s disease or following strokes cannot be prevented by currently available 
drugs.105 The kynurenines are metabolites o f tryptophan and inhibitors o f kynurenine 3- 
hydroxylase which should have a neuroprotective effect.105 The aryloxobutanoic acid 206 
is a good inhibitor of kynurenine 3-hydroxylase.106 It was shown that the (*S)-isomer was 
5x more active than the (R)-isomer.
Cl
Cl
206
We have developed a route to optically active (i?)-2-benzylsuccinic acid in high 
92% ee. The synthesis o f (R)- and (S)-2-benzylsuccinic acid and related compounds with 
substitutents on the aromatic ring (e.g. /?-methoxy, p-methyl, /7-fluoro) could be carried 
out. The optically active succinic acids could be converted into corresponding anhydrides
and these could be reacted with 1,2-dichlorobenzene using Friedel Crafts conditions to 
give optically active aryloxobutanoic acids. Testing o f these compounds for the inhibition 
o f kynurenine 3-hydroxylase could be carried out.
5. Synthesis of enantiomerically enriched 2-substituted butane- 1,4-diols
5.1 Background
Previous asymmetric syntheses of 2-substituted butane-1,4-diols have been 
accomplished by the use of chiral auxiliaries and chiral catalysts. Feringa et al. reported the 
synthesis o f (S)-2-methyl-l,4-butanediol 207 by hydrogenating enantiomerically pure y- 
(menthyloxy)butenolides 208 prepared from 5-hydroxy-2(5//)-fuaranone and (-)-menthol 
209 to produce enantiomerically pure lactones 210 (Scheme 5.1).107 These lactones were 
then reduced using lithium aluminium hydride to give the corresponding enantiomerically 
pure 2-methyl-1,4-butanediol.
r '  = c h 3, r 2 = h
*
R  = OH
209
1. 1.5 equiv 209, 150 °C
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Scheme 5.1
An alternative approach reported the conjugate addition of 
lithiotris(methylthio)methane to enantiomerically pure y-(menthyloxy)butenolides (R1 and 
R2 = H) 211 followed by quenching with NH4CI to give the corresponding lactone 212 
(Scheme 5.2).108 Desulfurization using Raney-nickel gave lactone 213 which was reduced 
using lithium aluminum hydride to give (2i?)-methylbutane-l,4-diol 214. Stereoselectivity 
of the conjugate addition was due to the bulky y-menthyloxysubstitutent R* which directs
attack from the less hindered bottom face producing selectively the R enantiomer o f 2- 
methylbutane-1,4-diol.
R *0
(SMe)3C,
1. LiC(SMe)3, THF, -90 °C
2. NH4C1, H20  R *0
R 1, R2 = H 211
OHR  =
CH3
214
LiAlH4, THF
'OH
H O 
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O
Raney Ni, 
M eO H /T H F
HaC,
R*Q
213
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Scheme 5.2
A modification o f this methodology led to the synthesis o f optically pure (R)- and 
(*S)-2-ethyl-, 2-propyl- and 2-isopropyl-1,4-butanediols (Scheme 5.3).109 It involved the 
hydrogenation of 5-(R)-[-(-)-menthyloxy]butenolide 215 to give the butyrolactone 216. 
The lactone was then lithiated with LDA followed by trapping the enolate with acetone, 
acetaldehyde or propionaldehyde producing the aldol products 217 and 218. The 
diastereomeric mixtures o f aldol products were treated with methanesulfonyl chloride to 
produce the mesylates which on heating at reflux underwent elimination to give exo-double 
bonded butenolides 219 (no detection o f ewdo-double bonded butenolides). It is suggested 
that the exo-double bonded butenolides are the thermodynamic products as attempts were 
made to convert exo products into endo isomers by treating with DBU using various 
solvents (dichloromethane, acetonitrile and 1,2-dichloroethane) at reflux which proved 
unsuccessful. These exo-butenolides were hydrogenated in the presence o f triethylamine. 
Hydrogenation occurred with complete stereocontrol to give the corresponding 
butyrolactone 220 and reduction using lithium aluminium hydride produced the 
corresponding (^)-2-alkyl-1,4-butanediols 221. The stereoselectivity results from delivery 
o f hydrogen from the opposite side to the bulky C-5 group o f the lactone 219.
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Scheme 5.3
Enantiomerically pure 2-substituted butane-1,4-diols can be used as precursors to 
1,3-substituted pyrrolidines 222.110 Chiral pyrrolidines have been shown to be subunits of 
natural and unnatural products which exhibit interesting and diverse biological activities. 
The enantiopure norbomene sultam 223 was an effective chiral auxiliary to induce 
stereoselectivity when 7V-acylnorbomene sultams 224 were alkylated with a -  
bromoalkanoates. Lithium aluminium hydride reduction of the alkylated iV-acylnorbomene 
sultams 225 produced the corresponding chiral 2-substituted butane-1,4-diols 226. 
Treatment of the diols with tosyl chloride yielded the corresponding ditosylates which 
could be reacted with the relative amine to yield the chiral substituted pyrrolidines 222 
(Scheme 5.4).
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Kamlage et al. reported the synthesis o f optically active aromatic 2-substituted 
butane-1,4-diols 227 via hydrogenation using chiral catalysts from aromatic 2-substituted 
butenediols 228.111 Various catalysts were used and Ir(I)-phosphinooxazoline catalysts A 
and B displayed the highest levels o f stereoselectivity (58-82% ee) (Scheme 5.5).
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Our approach would provide a quick and efficient synthesis to both epimers o f 
optically active 2-substituted butane-1,4-diols.
5.2 Synthesis of enantiomerically enriched 2-substituted butane-1,4-diols
In order to confirm the estimates for diastereomeric excesses obtained from the 
NMR spectra of the succinamide products from the conjugate addition o f Grignard 
reagents with fumaramide 100, the substituted succinamides were reduced with lithium 
aluminium hydride to produce the corresponding 2-substituted butane-1,4-diols 104 and 
camphorsultam 105, which were separated by column chromatography (Scheme 5.6).
LiAlH, NH
0,S
105
Scheme 5.6
104
The camphorsultam 105 was recovered in 90-95% yield and showed no loss o f 
enantiomeric purity. The diols were isolated in moderate yields and the absolute 
configuration of diols 229, 230, 231 and 233 was determined to be (R) by comparison o f 
the specific rotations with those reported in the literature (Table 5.1).
Table 5.1 Reduction of substituted succinamides yielding optically active 2- 
substituted butane-1,4-diols
Entry 2 -substituted diol Isolated yield (%) Configuration8
1 Ethyl (229) 44 ( R f
2 Isopropyl (230) 43 (.R)m
3 Propyl (231) 46 (R)m
4 Butyl (232) 56
5 Cyclohexyl (233) 38 (Rf
6 Octyl (234) 79
7 Benzyl (235) 75
8 Isobutyl (236) 85
9 Hexyl (237) 75
aCompared with specific rotations reported in the literature. 
b(5) previously reported with opposite sign.112
A method was required to determine the enantiomeric excess o f the optically active 
2-substituted butane-1,4-diols. From the literature there was no obvious method so we 
decided first to try chiral GC. Chiral GC can be used in the same way as chiral HPLC 
previously discussed. The columns are packed with a chiral stationary phase. It was found 
that the diols were not volatile enough for this technique. Attempts were made to 
trifluoroacetylate the diols in order to make the compounds more volatile and suitable for 
chiral GC (Scheme 5.7).
pyridine
F,C O CF,  ^equiv.
: OH + Y  Y  --------------^
0 0
Scheme 5.7
A lot o f time was spent on what appeared to be a straightforward reaction but we could 
never isolate the bis-trifluoroacetate, only a mixture of the mono- and bis-trifluoroacetate 
products. The mixture could not be separated as the mono- and bis- trifluoroacetylated 
compounds had the same Rf value. We then focused on synthesising the dibenzoate 
derivative and using chiral HPLC to determine the stereoselectivity.107 This method was 
used by Feringa et al. although the chiral column used [Chiracel OB (Daicel)] was not 
available within our department. We did however hope that the dibenzoate might be 
resolved on similar columns that are available. The racemic 2-methylbutane-l,4-diol was 
converted into the dibenzoate 238 but could not be resolved on the chiral columns 
available.
O
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An NMR technique was attempted which involved making bis Mosher esters 239 
o f the diols and then using 19F NMR spectroscopy to determine the enantiomeric excess o f 
each mixture of diatereomers.
MeO. -CF,\  -V
239
The presence o f the CF3 group would allow the ratio o f diastereomers to be measured from 
integration o f the two singlets in the 19F NMR spectrum.
The use o f a-methoxy-a-(trifluoromethyl)phenylacetic acid 240 (MTPA, Mosher’s 
acid) as a reagent for determination o f the enantiomeric excess o f alcohols or amines was 
pioneered by Mosher.113 This reagent is useful as it is resistant to racemization under 
reaction conditions o f acid, base or extreme temperatures during preparation o f derivatives. 
The presence of the trifluoromethyl group allows the use o f 19F NMR spectroscopy which 
produces fluorine signals that are simple and in uncongested regions. The disadvantage of 
using proton NMR spectra to determine enantiomeric excesses is that some proton signals 
can overlap other proton signals resulting in unreliable results.
R  enantiomer 240
Initially racemic 2-methylbutane-l,4-diol was esterified with both (R)- and (S)- 
MTPA but failed to produce diastereomeric mixtures observable by proton or fluorine 
NMR spectroscopy. It is proposed that the methyl substituent is too small to have an effect 
in the chemical environment of the two diastereomers. Esterification using both (R)- and 
(iS)- MTPA with the rest of the enantiomerically enriched 2-substituted butane-1,4-diols 
produced diastereomeric MTPA diesters as shown in Figure 5.1 for 27?-benzylbutane-1,4- 
diol 235.
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Figure 5.1
When using the R enantiomer o f Mosher’s acid the major diastereomer produced 
has the RRR configuration with the minor diastereomer having the RSR configuration. 
Alternatively using the S enantiomer of Mosher’s acid the major diastereomer has the SRS 
configuration with the minor being SSS. Each spectra displays four signals, two large
signals corresponding to the major diasteromer with two small signals corresponding to the 
minor diastereomer. By measuring the area o f the major signals in relation to the area of 
the minor signals the diastereomeric excess could be quantified which corresponds to the 
enantiomeric excess of the starting enantiomerically pure 2-substituted diol.
The coupling of the MTPA acid with the diols was straight forward using EDCI (5 
equiv.) as the coupling reagent together with a catalytic amount o f DMAP (10%) to give 
the corresponding MTPA diester in good yield (Table 5.2).
Table 5.2 Synthesis of MTPA diesters and determination of diasteromeric excess
Entry 2 -substituted
diol
(R) -M TPA  
diester 
(% yield)
De (%)a (S) -M TPA  
diester 
(% yield)
De (%)a Average 
de (%)
1 Ethyl 229 238 (87) 70 239 (77) 76 73
2 Isopropyl 230 240 (47) 28 241 (78) 30 29
3 Propyl 231 242 (77) 46 243 (82) 44 45
4 Butyl 232 244 (91) 56 245 (77) 56 56
5 Cyclohexyl 233 246 (84) 33 247 (92) 33 33
6 Octyl 234 248 (80) 56 249 (82) 52 54
7 Benzyl 235 250 (92) 89 251 (79) 90 90
8 Isobutyl 236 252 (6 6 ) 50 253 (6 6 ) 49 50
9 Hexyl 237 254 (48) 61 255 (82) 59 60
aDiastereomeric excesses were determined by analysis o f the fluorine NMR spectra o f the 
MTPA diester measured in CDCI3.
Now that we had a good method for determining the enantiomeric excess o f the 2- 
susbtituted butane-1,4-diols it allowed us to compare the different values of diastereomeric 
excesses obtained for each substituent using the chiral HPLC method and the *H NMR 
spectra o f the mixture of succinamides (Table 5.3).
Table 5.3 Comparison of diastereomeric excess values obtained by three different 
methods
Entry Substituent De obtained from 
derivatives of 2 - 
substituted succinic 
acids
De from 
NMR of 
succinamides
De from 1!,F NMR  
of MTPA diesters 
of 2 -substituted 
butane-1,4-diols
1 R = Ethyl 63 62 73
2 R = Isopropyl 0 32 29
3 R = Propyl 52 36 45
4 R = Butyl 72 54 56
5 R = Cyclohexyl 9 32 33
6 R = Octyl 90 52 54
7 R = Benzyl 92 N/A 90
8 R = Isobutyl 8 44 50
9 R = Hexyl 37 53 60
The table of results confirms that the determination of the diastereomeric excesses 
from the derivatives o f 2-substituted succinic acids gives the least reliable results. The 
diastereomeric excesses obtained from the !H NMR spectra of the succinamides and from 
the fluorine NMR spectra of the MTPA diesters complement each other in most cases. The 
latter method is taken to be more accurate as it is the average o f two independent 
measurements. This new method incorporating Mosher’s acid to produce the diesters has 
proved very useful as a technique for the determination o f the enantiomeric excess o f 
enantiomerically enriched 2-substituted butane-1,4-diols. This technique avoids the 
requirement o f a racemic sample o f the diol as was required with the chiral HPLC analysis 
o f the 2-substituted succinic acids. This technique should be applicable for other optically 
active diols.
5.3 Future Work
5.3.1 Asymmetric synthesis of novel 1,3-substituted pyrrolidines
An extension of this work could be to develop this methodology to the synthesis o f 
optically active 1,3-substituted pyrrolidines 222.
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The chiral 2-substituted butane-1,4-diols produced by the conjugate addition of a Grignard 
reagent on fumaramide 100 followed by reduction can be converted to the corresponding 
ditosylates. The ditosylates would be reacted with an amine to form the desired optically 
active 1,3-substituted pyrrolidine 222. These novel pyrrolidines could be assessed for 
biological activity.
6. Diastereoselective conjugate additions of Grignard reagents to 
differentially functionalised fumarates
6.1 Background
Differentially protected fumarates have been used as substrates to synthesise 
enantiomerically enriched succinamides. Evans et al. reported the stereoselective conjugate 
addition of enol silanes to oxazolidinone fumarates 256 using a chiral Cu(II)bis(oxazoline) 
catalyst 257 (Scheme 6.1).114
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Scheme 6.1
The use o f (Z)-enol silanes gave syw-adducts whereas using (£)-enol silanes gave anti- 
adducts. The use of hexafluoro-2-propanol (HFIP) greatly enhanced the rate of reaction 
without affecting the stereochemical outcome o f the reaction. It is believed that the alcohol 
acts as the silicon group acceptor, as the product 258 forms the dihydropyran intermediate 
259 transfers the silicon group to the alcohol (Scheme 6.2). The presence of intermediate 
259 suggests that the reaction could be thought o f as a hetero Diels-Alder reaction.
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Sibi et al. used a similar fumarate system to synthesise disubstituted succinates 
with high levels of diastereoselectivity.115 The differentially protected fumarate 260 was 
shown to undergo regio- and stereo-controlled radical additions with the radical 
intermediate being trapped with a variety of allystannes 261 to provide the corresponding 
syn 262 and anti 263 products (Scheme 6.3). The effect o f Lewis acids on the radical 
addition/trapping was investigated and it was found that the lanthanide triflates of yttrium 
and samarium produced the best chemical yields. The stereochemistry of the reactions 
always favoured the anti-product in a >99:1 ratio. Various different radical species were 
shown to give good yields with the exception o f the adamantyl radical. When the R  group 
of the allyl stannane was changed from H to CH3 the yield decreased only marginally, 
however when R = CLLOAc the reaction gave a low yield o f product (28%).
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6.2 Conjugate addition of Grignard reagents to two differentially 
protected fumarates
The initial aim o f the project was to investigate the diastereomeric conjugate 
addition o f Grignard reagents to a fumaramide system 100 containing two identical chiral 
auxiliaries.
0 2S
0 2
100
For comparative purposes we decided to apply the same methodology to two 
differentially protected fumarates 264 and 265.
264 265
Fumarate 264 is easily accessible from commercially available fumaric acid 
monoethyl ester 266.116 The fumaric acid was converted to the fumaroyl chloride 267 using
88
thionyl chloride and then coupled to Oppolzer’s sultam to give fumarate 264 in 77% yield 
(Scheme 6.4).
c | X ^ y < ®
266 0  267 0
1. chiral sultam
2. NaH77%
0 2
Scheme 6.4
In order to study the effect of using a sterically more hindered ester, fumarate 265 
was prepared from fumaric acid monoethyl ester 266. t-Butanol was coupled to the 
carboxylic acid using DCC. The ethyl ester 268 was selectively hydrolysed with lithium 
hydroxide and converted into the fumaroyl chloride 269 followed by coupling to 
Oppolzer’s sultam (Scheme 6.5).
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Scheme 6.5
The formation o f the fumarate 265 from the coupling o f Oppolzer’s sultam with the 
acid chloride 269 was low yielding due to a side reaction forming the product 270 from 
conjugate addition o f the sultam on 260. The only way this reaction could be minimised 
was by monitoring the reaction by tic and when the appearance o f the spot relating to 270 
was visible the reaction was worked up.
Aux
270
NHAux =
0 2
Diastereomeric conjugate additions were carried out on the protected fumarate 264 
using a series o f Grignard reagents. Diastereomeric excesses could not be determined from 
proton NMR spectra o f the reaction mixtures. The selectivity o f the Grignard reagent to 
add exclusively in a 1,4-manner with 264 was not observed and a mixture o f 1,2-addition 
products and 1,4-addition products could be identified from the proton NMR spectra. After 
column chromatography o f each reaction mixture the 1,4-addition product was always the 
major product isolated. In order to determine the stereoselectivity o f the conjugate addition 
the succinates were reduced to the corresponding diols using lithium aluminium hydride. 
This allowed the assignment o f the new stereocentre by comparing the optical rotations 
obtained with those in the literature. All the enantiomerically enriched 2-substituted 
butane- 1,4-diols displayed the R configuration. This is the same stereoselectivity as 
previously shown with 100 resulting from attack from the re-face. The diols were then 
converted into both (ft)-and (iS)-Mosher diesters and analysed by fluorine NMR 
spectroscopy to determine the diastereomeric excesses (Table 6.1). The fumarate 264 is not 
as good at inducing stereoselectivity as the fumaramide 100. It was expected that fumarate 
265 would produce better selectivity than 264 both from a regio- and stereo-chemical 
aspect due to the bulkier tertiary butyl protecting group.
Table 6 .1  Conjugate addition to fumarate 264 followed by reduction to 2 - 
substituted diols
Entry 2 -substituted
fumarate
Isolated Yield (%) Enantiomeric
excess*
1 R = Ethyl 271 79 50 ( R f1
2 R = Benzyl 272 41 63
3 R = Isoproyl 273 37 9 (R)lm
4 R = Butyl 274 52 59
aEnantiomeric excesses were determined by synthesis o f both (R)- and (^-M osher’s 
diesters o f each diol and were analysed by 19F NMR spectra.
The reaction o f fumarate 265 with Grignard reagents displayed only conjugate 
addition products. Once again diastereomeric excesses could not be determined from 
proton NMR spectra of the reaction mixtures. Therefore the diastereomeric excess was 
determined from the bis-Mosher diester o f each diol (Table 6.2). The stereoselectivity 
displayed using fumarate 265 was comparable to that observed for fumarate 264 (Tables
6.1 and 6.2).
Table 6.2 Conjugate addition to fumarate 265 followed by reduction to 2 - 
substituted diols
Entry 2 -substituted
fumarate
Isolated Yield (%) Enantiomeric
excess*
1 R = Ethyl 275 67 55 (R f’
2 R = Benzyl 276 75 56
3 R = Isoproyl 277 73 6 (R)lm
4 R = Butyl 278 75 68
aEnantiomeric excesses were determined by synthesis o f both (R)- and (S)-Mosher’s 
diesters of each diol and were analysed by 19F NMR spectra.
The stereoselectivity obtained with fiimarates 264 and 265 was not as good as the 
stereoselectivity observed using fumaramide 100. The presence of the two auxiliaries is
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clearly necessary for better stereoselective conjugate addition due to the bulk o f the 
camphorsultam. It was surprising that the tertiary butyl fumarate 265 was only marginally 
better at inducing stereoselectivity in the conjugate addition reaction than the ethyl 
fumarate 264.
7. Synthesis and enzymatic studies of optically active 2-substituted
putrescines
7.1 Background
The work carried out by Santaniello et a l discussed in Chapter Three described 
how the enantiomers o f 2-methylputrescine could be distinguished by PKAO, but not by
78PSAO. It was our aim to synthesise a series o f 2-substituted putrescines in an attempt to 
identify potential substrates for PSAO. This would allow the study o f the outcome o f the 
DAO catalysed oxidation o f these enantiomerically enriched 2-substituted putrescines. 
This should give us valuable insight into the selectivity of the enzyme for different 
substrates.
There have been no literature reports o f a general synthesis to optically pure 2- 
substituted putrescines (1,4-diaminoalkanes), however there have been a few papers 
published reporting the synthesis o f racemic 2-subtituted putrescines.
Frydman et al published the synthesis to 1-substituted putrescines prepared from 
pyrroles.117 Pyrroles 279 are easily substituted and are useful synthons for substituted 
putrescines (Scheme 7.1). Acylation o f pyrrole was facilitated under Vilsmeier conditions 
and the acylpyrroles 280 were reduced to the 2-alkylpyrroles 281 using potassium 
hydroxide and hydrazine. Ring opening o f the 2-alkylpyrroles 281 was achieved by heating 
with hydroxylamine hydrochloride in the presence o f sodium bicarbonate yielding the 
corresponding dioximes 282. The 1-substituted putrescines 283 were prepared by reduction 
of the dioximes 282 using sodium in ethanol at reflux. A number o f alkyl substituted 
putrescines were prepared in this way ranging from R = H to R = 72-C11H23.
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This methodology was extended to the synthesis of 2-substituted putrescines from
3-alkylpyrroles.118 The synthesis o f 3-alkylpyrroles is not as straightforward as that 
previous shown for 2-alkylpyrroles. The use o f Vilsmeier reaction conditions or Friedel- 
Crafts conditions produces the corresponding 2-substituted pyrrole. An indirect method is 
usually required to produce 3-substituted pyrroles. The preparation o f 2- 
(trichloroacetyl)pyrrole 284 made it possible under Freidel Crafts acylation conditions to 
produce 4-acyl-2-(trichloroacetyl)pyrroles 285. When treated with potassium hydroxide 
the corresponding 2-pyrrolecarboxylic acids 286 were prepared. Decarboxylation of 286 
was achieved by treating with iodine to give the triiodoacylpyrroles 287. Hydrogenation o f 
287 using 10% palladium on charcoal gave the 3-acylpyrroles 288. The 3-acylpyrroles 288 
were reduced using potassium hydroxide and hydrazine to give the 3-alkylpyrroles 289 
which were ring opened to the dioximes 290 and reduced to produce the corresponding 2- 
substituted putrescines 291 (Scheme 7.2).
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A different approach to 2-subtituted putrescines was reported by Carboni et al in 
which both alkyl and aryl substituted putrescines were prepared in three steps.119 The 
synthesis started from l,4-diaminobut-2-yne 292 which was protected as the N-di-tert-
butyloxycarbonyl derivative. A hydrostannylation reaction using tributylstannane and a
vinylstannane 293. Cross-coupling o f the vinylstannane 293 with a range o f electrophiles 
in the presence o f a palladium catalyst produced the 2-substituted- 1,4-di-fert- 
butyloxycarbonylaminobut-2-enes 294. Compounds 294 were hydrogenated using 
palladium on carbon (10%) and deprotected to give the corresponding 2-alkyl- and 2-aryl- 
putrescine dihydrochlorides 295 (Scheme 7.3).
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It was our aim to devise a new route to both racemic and optically pure 2- 
substituted putrescines in an attempt to identify potential substrates for PSAO and 
investigate the regio- and stereo-selectivity o f the enzyme.
7.2 Synthesis of Optically Active 2-Substituted Putrescines
Our synthetic approach to synthesise enantiomerically pure 2-substituted 
putrescines 106 is shown in Scheme 7.4.
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This route is based on the previous methodology developed in this work using 
Grignard reagents to add to fumaramide 100 stereoselectively in a conjugate manner. 
Removal o f the chiral auxiliaries using lithium aluminium hydride produced the 
corresponding enantiomerically enriched 2-substituted butane-1,4-diols 104. The 
enantiomeric excess o f these diols could be improved to >95% by separation of the major 
and minor diastereomers o f the adducts 101 and 102 using column chromatography or 
recrystallisation. The enantiomeric excesses o f the corresponding enantiomerically pure 
diols were determined by using fluorine NMR spectroscopy o f the Mosher diesters. The 
conversion o f the diols into the diamines 106 was achieved using a one-pot conversion of 
alcohols into amines devised by Golding et a l 120 It involves a Mitsunobu reaction using 
hydrazoic acid followed by an in situ Staudinger reaction.121,122
For purposes of the enzyme studies we also required racemic 2-substituted 
putrescines. We proposed to synthesise the racemic diamines from 2-substituted succinic 
acids prepared previously (Chapter 4). These can be converted into the corresponding diols 
by a borane reduction and subsequently converted into the diamines (Scheme 7.5).
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Use o f Oppolzer’s auxiliary 105 [(l 4S',2J^ )-(-)-2,10-camphorsultam] shown in 
Scheme 7.4 allows access to the (ft)-enantiomer o f the 2-substituted diol. Alternatively 
using the other enantiomer (17?,2*S)-(+)-2,l O-camphorsultam 296 o f the auxiliary allows 
access to the (iS)-enantiomer o f the 2-substituted diol. This enantiomer o f Oppolzer’s 
auxiliary was synthesised using the same synthetic route previously used (Scheme 7.6).
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Initially we selected two alkyl substituted and two aromatic substituted putrescines 
to synthesise in racemic form together with the corresponding enantiomers (Figure 7.1).
H2N .
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R  = rac, R and S  Et 
R  = rac, R and S  Ph 
R  = rac, R and S Bn
Figure 7.1
The starting 2-methyl and 2-phenyl substituted succinic acids were commercially available 
in racemic and enantiomerically pure form. The optically pure methyl and phenyl 
substituted putrescines could not be prepared by our stereoselective method. As previously 
discussed the methyl and phenyl Grignard reagents added in a 1,2-addition manner to 
fumaramide 100. It was proposed that we would prepare the optically pure ethyl and 
benzyl substituted putrescines using the diastereoselective conjugate addition of Grignard 
reagents to fumaramide 100.
The reaction in the synthetic route which concerned us the most was the conversion 
o f the diols into the diamines (Scheme 7.7). This transformation was carried out previously 
in the group with a low yield of product (29%). We were optimistic we could produce the 
desired products in higher yields.
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The transformation involves conversion o f the diol 104 into the corresponding 
diazide. The diazide formed is then reduced in situ by triphenylphosphine in a reaction 
known as the Staudinger reaction to the diamine which on workup yields the diammonium 
dihydrochloride salt 106. The Mitsunobu reaction is a method o f converting the hydroxyl 
group into an electrophile using phosphorus and then a Sn2 displacement with a
nucleophile can occur. Triphenylphosphine is used in the Mitsunobu reaction but is also 
the reducing agent in the Staudinger reaction so it plays a dual role in the above reaction.
A number o f attempts to convert 104 to 106 were made, but they were very low 
yielding. There were a number o f problems. One possible problem was the synthesis o f a 
cyclic ether by an intramolecular cyclization o f the activated alcohols. The two examples 
shown in the literature which involve a diol being converted into a diamine contained 
either an alkene bond or an alkyne bond in the aliphatic chain which enforces a rigidity 
preventing cyclization.120 Another problem of this route is that the diamines produced are 
extremely volatile so they are converted into their diamine dihydrochloride salts. This 
however prevents purification by chromatography. The drawback o f the Mitsunobu 
reaction is the requirement to remove excess triphenylphosphine, triphenylphosphine 
complexes and the by-product triphenylphosphine oxide by chromatography. The major 
impurity with the diamine dihydrochloride salts is triphenylphosphine oxide, which makes 
purification difficult. This problem can be addressed by using commercially available 
polymer-bound triphenylphosphine.123 The triphenylphosphine impurities are now 
polymer-bound and can be removed by filtration. As the triphenylphosphine is on a solid 
support this can reduce its reactivity due a sterically less accessible reactive centre. 
Attempts to counter the lower reactivity could be to use more equivalents of the reagent 
but as the polymer supported reagent is expensive this may not be desirable. It was also 
questionable if  the polymer bound triphenylphosphine would reduce the azide functionality 
successfully in the Staudinger reaction. Polymer bound triphenylphosphine proved 
successful in removal of the triphenylphosphine by-products; however the yields were still 
low.
In order to synthesise these diamines in good yields another synthetic approach was 
attempted. This involves the conversion o f the diols into the sulfonate diesters 300, then 
substitution by sodium azide. The sulfonate groups are very good leaving groups and can 
be easily displaced by different nucleophiles. The diazides are directly reduced to the 
diamines using lithium aluminium hydride (Scheme 7.8). This method has previously been 
applied successfully to 2-alkyl-l,3-propanediols.124 This method worked reasonably well 
with the ditosylates synthesised in 32-73% yield. The subsequent nucleophilic substitution 
with sodium azide yielded the diazides in 52-95% yield, however conversion of the azides 
into the diamines was much more problematic (Table 7.1).
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The diamine dihydrochloride salts 326, 328 and 329 were very hygroscopic and difficult to 
purify and handle. The benzyl substituted putrescines could not be isolated. The more 
stable o f the 2-substituted putrescine salts 325, 327 and 330 were tested as substrates for 
the enzyme PSAO.
Table 7.1 Synthesis of 2-substituted putrescines
Substituent Diol 
(% yield)
Ditosylate 
(% yield)
Diazide 
(% yield)
Substituted 
Putrescine (HC1 salt) 
(% yield)
rac-Methyl 301 (85) 309 (39)a 317 (95) 325 (40)
i?-Methyl 302 (75) 310 (26)a 318 (55) 326 (51)b
^-Methyl 303 (95) 311 (51) 319 (52) 327 (29)
rac-Ethyl 304 (81) 312 (73) 320 (81) 328 (6 6 )”
R-Ethyl 305 (58) 313 (65) 321 (65) extremely hygroscopic
S-Ethyl 306 (62) 314 (61) 322 (53) 329 (49)b
rac-Phenyl 307 (79) 315 (32) 323 (74) 330 (35)
rac-Benzyl 308 (58) 316 (38) 324 (53) extremely hygroscopic
aSynthesised as diphenylsulfonyl diester. 
bFound to be hygroscopic.
7.3 Enzymatic studies
The diamines produced were examined as substrates o f PSAO. Kinetic data was 
obtained through calculations o f Km and Vmax using the putrescines as substrates in an 
assay with PSAO.
PSAO is an enzyme, which is a biological catalyst. Catalysts increase the rate of 
chemical reactions but are chemically unchanged when the reaction is complete. A 
distinctive feature o f enzyme catalysed reactions is that their reaction rates V  have a 
saturation point known as V max. The reaction rate is first order for low substrate 
concentrations [S] although as the concentration o f the substrate increases reaction rate 
reaches a maximum known as V max (Figure 7.2).
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In 1913 Michaelis and Menten pointed out that these observations can be explained 
with the mechanism (Scheme 7.9).
K i K3
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Scheme 7.9
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The enzyme E and substrate S combine to give an enzyme substrate complex, ES. This 
complex can dissociate and form the starting materials or can release the products and 
enzyme. The Michaelis-Menten equation has been derived to explain enzyme kinetics and 
introduces Vmax and Km (Eq. 7.1). Km is the concentration of substrate that gives a reaction 
rate half its maximal value.
_  Vmax[S]
_ Km +[S]
Eq. 7.1
A graph o f the Michaelis-Menten equation is difficult to use for determination o f 
Vmax and Km as it is curved. It approaches the maximum point slowly and attempts to find 
three consistent points to determine the Vmax are difficult. As a result o f the line being 
curved values recorded for low [S] cannot be extrapolated. Other methods were sought and 
it was found that the best sets o f data to work with were those with a linear relationship 
known as a linear transform. In 1934 Lineweaver and Burke produced a linear relationship 
by inverting the Michaelis-Menten equation (Eq. 7.2). This relationship corresponded to 
the equation y = mx + c.
J_ = /IV _L
V Vmax W  Vmax
Eq. 7.2
This produces a straight line if 1/V is plotted against 1/[S] (Figure 7.3)
1/V
slope = Km/V,
y intercept = -1/K]
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Figure 7.3
The intercept o f the extrapolated straight line with the horizontal axis is used to obtain the
1 0^Michaelis constant, Km. The intercept with the vertical axis is used to determine Vmax- 
The values obtained from the Lineweaver-Burke equation were criticised as being 
unreliable as the measurements are recorded at low [S] values due to the reciprocal being 
taken. The smaller and more error prone experimental values now become the largest in 
the plot, which are the least accurate. Another method for determination o f Km and V max 
was derived by Eadie and Hofstee. The principle o f this is that Lineweaver-Burke equation 
is multiplied by V.Vmax (Eq. 7.3):
V.Vmax+max
maxmax
max
Eq. 7.3
A graph is obtained by plotting V against V/[S] (Figure 7.4).
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Figure 7.4
Vmax is obtained from the intercept on the vertical axis and Km is obtained from the 
gradient taking the opposite sign. The advantage of this method is that the value o f Km is
derived directly from the slope. However when data are scattered as a result o f errors 
intercepts can be inaccurate. Due to the substrate concentration being expressed in 
reciprocal form the Eadie-Hofstee method has the same drawback as the Lineweaver-Burk 
plot.
Another linear method is known as the W oolf Hanes plot. This method avoids 
taking reciprocal concentrations and is the preferred method for statistical correctness of 
data analysis. The x-axis is [S] and the y-axis is [S]/V. The gradient is 1/Vmax and the x 
intercept is KM/Vmax, (Figure 7.5).
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7.4 Kinetic Data
Three of the 2-substituted putrescines produced were tested as substrates in an 
assay with PSAO with putrescine as a reference. Kinetic data were obtained through 
calculations o f Km and Vmax. Km is the concentration of substrate that gives a reaction rate 
half its maximal value. Km can be used as a measure of the strength o f the complex: a high 
Km means that the complex is loosely bound and vice versa. Vmax is the maximal rate when 
the enzyme substrate binding sites are saturated. Rate data were analysed for Km and Vmax 
by least squares fitting of Lineweaver-Burke, Eadie-Hofstee and W oolf Hanes plots. All 
experiments were carried out three times with all data quoted being the mean o f nine 
determinations. The enzyme PSAO was isolated from pea-seedlings by a process of
extraction, dialysis and purification as described in the experimental section. The results 
are shown in Table 7.2.
Table 7.2 Determ ination of K M and Vmax values for various 2-subtituted 
putrescines
2-substitued Putrescine K m (mM) V m a x  (pmol mg 1 h '1)
Putrescine 1.97 0.47
(±)-2-methyl 325 3.14 0.22
(2S)-methyl 327 2.70 0.22
(±)-2-phenyl 330 52.9 0.26
The data show that the substituted putrescines tested all have an affinity for DAO 
They were compared to putrescine which is a natural substrate of DAO. The Vmax values of 
the substituted putrescines were about half that of putrescine. There was a difference in the 
extent of binding expressed as Km between the racemic 2-methylputrescine 325 and the (S) 
enantiomer 327. The 2-phenylputrescine 330 had a high Km value but displayed a good 
level of substrate reactivity towards the enzyme.
The following graphs are the plots generated for diamine 325 using the equations 
explained.
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7.5 Future Work
7.5.1 Experiments to isolate the products of the oxidation catalysed by
We did not progress as far as we had hoped with the kinetic studies o f the 2- 
substituted putrescines. The 2-substituted putrescines could be isolated as the oxalate salts
optically pure 2-substituted putrescines catalysed by DAO. It is proposed that 
biotransformations can be carried out for selected 2-substituted putrescines shown from 
kinetic studies to be good substrates for PSAO. The products o f these biotransformations 
could be isolated through product trapping experiments. This method uses another enzyme 
known as liver alcohol dehydrogenase (LAD) which converts the aldehyde into an alcohol 
(Scheme 7.9).
PSAO
which should not be hygroscopic. We would like to study the outcome o f the oxidation of
PSAO, catalase, LAD
R NADH, H20 , pH 6.3, 37°C R
Scheme 7.9
The products once isolated would be examined for optical purity. This would allow some 
insight into the stereo- and regio-selectivity o f PSAO.
8. Experimental
8.1 General Details
All reactions were carried out under nitrogen with anhydrous solvents unless otherwise 
stated. Tetrahydrofuran and diethyl ether were dried by distillation from sodium and 
benzophenone immediately before use. Toluene and dichloromethane were dried by 
distillation from CaFL immediately before use. Reagents were purchased from commercial 
suppliers and used without further purification unless otherwise stated.
Melting points were measured using a Gallenkamp melting point apparatus and are 
uncorrected. Nuclear magnetic resonance spectra were obtained on a Bruker DPX-400 
spectrometer or Bruker WP-200 spectrometer. Chemical shifts are given relative to 
residual chloroform (<5h= 7.27 and Sc= 77.2) as internal standards unless otherwise stated. 
All coupling constants are reported in Hertz (Hz). Infra red spectra were recorded on either 
a Nicolet Impact 410 FT-IR or Perkin Elmer 500 spectrometer and mass spectra were 
obtained using a JOEL JMS-700 spectrometer. Combustion analysis was carried out using 
an Elemental Analyser MOD 1106. All of the thin layer chromatography plates used were 
Merck aluminium oxide 60 F254 neutral (type E) with layers o f 0.2 mm thickness or Merck 
silica gel 60 F254 with layers o f 0.25 mm thickness. The plates were visualised by 
illumination with UV light, or staining with permanganate or vanillin solution. Optical 
rotations were recorded on a Polaar 2000 polarimeter with path length 10 cm. [a]o values 
are measured in 10'1 deg cm2 g '1.
For known compounds the only spectroscopic data given are the *H NMR spectra, 
except where new data are being reported.
8.2 Experimental for Chapter 4
i on r s8.2.1 Synthesis of chiral auxiliary according to literature method
8 .2 .1 .1  (lS)-(+)-10-CamphorsuIfonyl chloride 108127
SOoCl
108
Compound 108 was prepared in 95% yield on a 43 mmol scale by the method of 
Knox and co-workers127 and gave mp 67-68 °C (lit.127 65-66 °C); 5h (400 MHz; CDCI3) 
0.93 (3 H, s, C//3CCH3), 1.14 (3 H, 3, CH3CCH3), 1.46-1.52 (1 H, m, alkyl-H), 1.74-1.81 
(1 H, m, alkyl-H), 1.97 (1 H, d, J  18.6, alkyl-H), 2.05-2.18 (2 H, m, alkyl-H), 2.40-2.50 (2 
H, m, alkyl-H), 3.71 (AB system, 1 H, d, J  14.6, CHtfS02) and 4.29 (AB system, 1 H, d, J
14.6, CH//SO2).
8.2.1.2 (LR)-(-)-10-Camphorsulfonyl chloride 298127
298
Compound 298 was prepared in 95% yield on a 0.17 mol scale by the method of 
Knox and co-workers127 and gave mp 66-68 °C (lit.80 65-66 °C). Spectral data were 
identical to enantiomer 108.
8.2.1.3 (l.S)-(+)-10-Camphorsulfonamide 10985
109
Compound 109 was prepared in 70% yield on an 80 mmol scale by the method of 
Davis and co-workers85 and gave mp 127-129 °C (lit.85 127-130 °C); 5H(400 MHz; CDC13) 
0.93 (3 H, s, C //3CCH3), 1.01 (3 H, s, C //3CCH3). 1.44-1.51 (1 H, m, alkyl-H), 1.60 (1 H, 
d, 720 .0 , alkyl-H), 2.03-2.10 (2 H, m, alkyl-H), 2.15-2.22 (1 H, m, alkyl-H), 2.39-2.46 (1 
H, m, alkyl-H), 3.11 (AB system, 1 H, d, J  15.0, CH//SO2), 3.47 (AB system, 1 H, d, J
15.0, CH//SO2) and 5.41 (2 H, broad s, NH2).
8.2.1.4 (LS, 2R)-(-)-10-Camphorsulfoniininc 11085
0 2
110
Compound 110 was prepared in 95% yield on a 23 mmol scale by the method of 
Davis and co-workers85 and gave mp 222-224 °C (lit.85 mp 225 °C); [a]o -34.3 (c 1.89, 
CHCI3) [lit.86-32.73 (c 1.89, CHC13)]; 5H(400 MHz; CDC13) 0.87 (3 H, s, C //3CCH3), 1.09 
(3 H, s, C //3CCH3) 1.46-1.53 (1 H, m, alkyl-H), 1.72-1.80 (1 H, m, alkyl-H), 2.02-2.13 (2 
H, m, alkyl-H), 2.26-2.28 (1 H, m, alkyl-H), 2.38 (1 H, d, J  19.3, alky-H), 2.74-2.80 (1 H, 
m, alkyl-H), 2.96 (AB system, 1 H, d, J  13.3, CH//SO2) and 3.18 (AB system, 1 H, d, J
13.3, CHffSOi).
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8.2.1.5 (1/?, 2vS)-(+)-2,l0-Camphorsulfonimine 29985
0 2
299
Compound 299 was prepared in 90% yield on a 0.17 mol scale by the method of 
Davis and co-workers85 and gave mp 224-226 °C (lit.85 mp 225 °C); [a]o +31.0 (c 1.0, 
CHCI3) [lit.85+31.47 (c 2.11, CHCI3)]. Spectral data were identical to enantiomer 110.
8.2.1.6 (LV,2/?)-(-)-2,l0-C am phorsultam  11185
NH
o2
111
Compound 111 was prepared in 45% yield on a 18 mmol scale by the method of 
Davis and co-workers85 and gave mp 182-183 °C (lit.85 183-184 °C); [a]o -31.2 (c 2.0, 
CHCI3) [lit.85 -30.5, (c 4.0, CHCI3)]; 5h(400 MHz, CDC13) 0.94 (3 H, s, Ctf3CCH3), 1.14 
(3 H, s, Ctf3CCH3), 1.29-1.36 (1 H, m, alkyl-H), 1.42-1.49 (1 H, m, alkyl-H), 1.84-2.02 (5 
H, m, alkyl-H), 3.08 (AB system, 1 H, d, J  13.7, CH7/SO2), 3.13 (AB system, 1 H, d, J
13.7, C H tfS02), 3.42-3.45 (1 H, m, CHN) and 4.12 ( 1H, broad s, NH).
8.2.1.7 (l/?,2iS)-(+)-2,10-Camphorsultam 29685
HN
02
296
Compound 296 was prepared in 80% yield on a 0.17 mol scale by the method of 
Davis and co-workers85 and gave mp 177-179 °C (lit.85 183-184 °C); [a]o +32.1 (c 1.0, 
CHCb) [lit.85+32.5, (c 1.0, CHCI3)]. Spectral data were identical to enantiomer 111.
8.2.2 Synthesis of racemic 2-substituted succinic acids according to 
literature methods.90
8.2.2.1 tert-Butyl succinate 126128
O
O
126
Compound 126 was prepared in 51% yield on a 20 mmol scale by the method of 
Miller and co-workers128 and gave mp 51 °C (lit.128 49-51 °C); 5h (400 MHz; CDCI3) 1.45 
(9 H, m, (CH3)3) and 2.45-2.58 (4 H, m, CH2CH2); 6c(CDC13) 28.4 (3 x CH3), 29.6 (CH2),
30.4 (CH2), 81.4 (Q , 171.8 (C=0 ) and 179.0 (C=0 ).
8.2.2.2 tert-Butyl (±)-2-benzylsuccinate 13490
HO
O
134
Compound 134 was prepared in 89% yield on an 8.6 mmol scale by the method of 
Bergmeier and co-workers.90 5h (400 MHz; CDCI3) 1.40 (9 H, s, CC//3), 2.42 (ABX 
system, 1 H, dd, J 4.4 and 17.0, COCHtfCH), 2.67 (ABX system, 1 H, dd, J  8.8 and 17.0, 
COCHtfCH), 2.74-2.81 (1 H, m, COCH2CH), 2.99-3.06 (2 H, m, PhCtf2) and 7.19-7.33 (5 
H, m, ArCH).
8.2.2.3 tert-Butyl (±)-2-ethylsuccinate 12990
HO
0
129
Compound 129 was prepared in 72% yield on an 8.6 mmol scale by the method of 
Bergmeier and co-workers.90 5H(400 MHz; CDCI3) 0.94 (3 H, t, 77.2, C#3CH2), 1.45 (9 H, 
s, CCH3), 1.58-1.68 (2 H, m, CH3CH2), 2.42 (ABX system, 1 H, dd, 7  3.0 and 14.4, 
COCHtfCH) and 2.64-2.74 (ABX system, 2 H, m, 1 from COCH//CH and 1 from 
COCH2Ctf)
8.2.2.4 tert-Butyl (±)-2-isopropylsuccinate 13090
HO
O
130
Compound 130 was prepared in 38% yield on an 8.6 mmol scale by the method o f 
Bergmeier and co-workers 90 5H(400 MHz; CDC13) 0.93 (3 H, d, 76.8, Ctf3CH), 0.96 (3 H, 
d, 76 .8 , Ctf3CH), 1.45 (9 H, s, CCH3\  1.98-2.02 (1 H, m, CH3Ctf), 2.40 (ABX system, 1 
H, dd, 73 .6  and 16.4, COCHtfCH), 2.55-2.61 (ABX system, 1 H, m, COCH2Ctf) and 2.71 
(ABX system, 1 H, dd, 710.8 and 16.4, COCHtfCH).
8.2.2.5 tert-Butyl (±)-2-propylsuccinate 131
HO
O
131
Compound 131 was prepared in 16% yield on an 8.6 mmol scale by the method of 
Bergmeier and co-workers90 and was isolated as a colourless oil. UmaxCNaCiycm' 1 3060 
(OH), 2962 (CH3), 2873 (CH) and 1714 (C=0); 5H(400 MHz; CDC13) 0.92 (3 H, t, 7  7.2,
Ctf3CH2), 1.26-1.40 (3 H, m, CH3Ctf2CHff), 1.44 (9 H, s, CCH,), 1.57-1.68 (1 H, m, 
CH3CH2CH//), 2.40-2.47 (1 H, m, COCHffCH) and 2.64-2.74 (2H, m, COCHHCH); 
6c(100 MHz) 13.9 (CH3), 20.1 (CH2), 27.0 (3 x CH3), 34.1 (CH2), 35.8 (CH2), 41.7 (CH),
80.8 (C), 174.2 (C=0) and 177.6 (C=0); m/z (FAB+) 217 [(M+H)+, 30%] and 161 
((M+H)+-'fi«, 100); [Found (FAB+): (M+H)+217.1440; C nH 20O4 requires 217.1440],
8.2.2.6 tert-Butyl (±)-2-butylsuccinate 13290
HO
O
132
Compound 132 was prepared in 70% yield on an 8.6 mmol scale by the method of 
Bergmeier and co-workers 90 5h (400 MHz; CDCI3) 0.90 (3 H, t, 76.8, C//3CH2), 1.31-1.66 
(15 H, m, alkyl-H), 2.40-2.47 (1 H, m, COCHtfCH) and 2.66-2.73 (2 H, m, COCBHCH).
S.2.2.1 tert-Butyl (±)-2-octylsuccinate 13390
HO
O
133
Compound 133 was prepared in 85% yield on an 8.6 mmol scale by the method of 
Bergmeier and co-workers 90 5H(400 MHz; CDC13) 0.88 (3 H, t, 77.0, Ctf3CH2), 1.22-1.29 
(12 H, m, alkyl-H), 1.44 (9 H, s, CCH3), 1.81-1.89 (2 H, m, alkyl-H), 2.38-2.45 (1 H, m, 
COCHtfCH) and 2.64-2.72 (2 H, m, COCBHCH).
8.2.2.8 tert- Butyl (±)-2-isobutylsuccinate 135
HO
O
135
Compound 135 was prepared in 14% yield on an 8.6 mmol scale by the method of 
Bergmeier and co-workers and was isolated as a colourless oil. omax(NaCl)/cm'1 2960 
(CH3), 2873 (CH) and 1716 (C=0); 6H(400 MHz; CDC13) 0.91 (3 H, d, J  6.4, 
C //3CHCH3), 0.95 (3 H, d, J  6.4, C //3CHCH3), 1.24-1.31 (1 H, m, CH3C//CH3), 1.45 (9 
H, s, CCHi), 1.55-1.67 (1 H, m, CH3CHCHfl), 2.43 (ABX system, 1 H, dd, 7 4 .7  and 16.5, 
COCH//CH) and 2.62-2.81 (ABX system, 2 H, m, COCHHCH and COCihCH), 6C(100 
MHz) 22.6 (CH3), 23.0 (CH3), 26.2 (CH), 28.3 (3 x CH3), 29.5 (CH2), 40.5 (CH), 41.6 
(CH2), 81.2 (C), 174.8 (C=0) and 178.0 (C=0); m/z (FAB+) 231 [(M+H)+, 29%] and 175 
((M+H)+-'B«, 100); [Found (FAB+): (M+H)+231.1597; Ci2H220 4 requires 231.1596],
8.2.2.9 M -B u ty l (±)-2-hexylsuccinate 136
HO
O
136
Compound 136 was prepared in 20% yield on a 5.7 mmol scale by the method of 
Bergmeier and co-workers90 and was isolated as a colourless oil. rw fN aC iy cm ' 1 2929 
(CH3), 2860 (CH) and 1713 (C=0); 5H(400 MHz; CDC13) 0.89 (3 H, t, J  7.0, C tf3CH2), 
1.28-1.31 (8 H, m, alkyl-H), 1.41-1.66 (11 H, m, alkyl-H), 2.44 (ABX system, 1 H, dd, J
8.7 and 20.4, COCHHCH) and 2.68-2.74 (ABX system, 2 H, m, COCHtfCH and 
COCH2Ctf); 5c(100 MHz) 14.5 (CH3), 23.0 (CH2), 27.1 (CH2), 28.4 (3 x CH3), 29.4 
(CH2), 32.0 (CH2), 32.3 (CH2), 36.2 (CH2), 42.2 (CH), 81.2 (C), 174.6 ( C O )  and 178.1 
(C O ); m/z (CI+ mode, isobutane) 259 [(M+H)+, 66%], 203 ((M+H)+-'5«, 100) and 185 
(25); [Found (CI+ mode, isobutane): (M+H)+259.1907; C i4H 260 4 requires 259.1909],
8.2.2.10 tert-Butyl (±)-2-cyclohexylmethylsuccinate 137
HO
O
137
Compound 137 was prepared in 14% yield on a 5.7 mmol scale by the method o f 
Bergmeier and co-workers90 and was isolated as a colourless oil. iw CN aCiycm ' 1 2924 
(CH3), 2852 (CH) and 1712 (C=0); 5H(400 MHz; CDC13) 0.84-0.92 (3 H, m, alkyl-H), 
1.12-1.32 (5 H, m, alkyl-H), 1.44 (9 H, s, CCH3), 1.50-1.83 (5 H, m, alkyl-H), 2.42 (ABX 
system, 1 H, dd, J 4.7 and 16.7, COCHtfCH), 2.65 (ABX system, 1 H, dd, J  9.5 and 16.7, 
COCHtfCH) and 2.76-2.81 (ABX system, 1 H, m, COCH2CH); 5C(100 MHz) 26.6 (2 x 
CH2), 26.9 (CH2), 28.4 (3 x CH3), 33.3 (CH2), 33.6 (CH2), 35.6 (CH), 36.7 (CH2), 39.7 
(CH), 40.0 (CH2), 81.1 (C), 175.0 (C=0) and 178.0 (C=0); m/z (CI+ mode, isobutane) 271 
[(M+H)+, 8%], 215 ((M+H)+-*#w, 100) and 197 (35); [Found (CI+ mode, isobutane): 
(M+H)+271.1908; Ci5H260 4 requires 271.1909].
8.2.3 Conversion of terl-butyl 2-substituted succinates into 2-substituted 
succinic acids.
8.2.3.1 (±)-2-Ethylsuccinic acid 13890
OH
HO
O
138
Compound 138 was prepared in 81% yield on a 1.5 mmol scale by the method o f 
Bergmeier and co-workers90 and gave mp 96-97 °C (lit.90 93 °C). 5h (400 MHz; d6-DMSO) 
0.86 (3 H, t, J  7.5, Ctf3CH2), 1.47- 1.58 (2 H, m, CH3Ctf2), 2.32 (ABX system, 1 H, dd, J
4.7 and 16.2, COCHtfCH) and 2 .49-2.68 (ABX system, 2 H, m, COCHtfCH and 
COCH2C//)
8.2.3.2 (±)-2-Isopropylsuccinic acid 13990
OH
HO
O
139
Compound 139 was prepared in 79% yield on a 0.9 mmol scale by the method of 
Bergmeier and co-workers90 and gave mp 108-109 °C (lit.90 110-111 °C). 5h (400 MHz; &e- 
DMSO) 0.86 (3 H, d, J 6.8, C tf3CHCH3), 0.89 (3 H, d, J 6.8, Ctf3CHCH3), 1.86- 1.94 (1 H, 
m, CH3C #CH 3), 2.31 (ABX system, 1 H, dd, J 3.0 and 15.8, COCHtfCH) and 2 .42-2.54 
(ABX system, 2 H, m, COCHtfCH and COCH2CH).
8.2.3.3 (±)-2-Propylsuccinic acid 140
OH
HO
O
140
Compound 140 was prepared in 74% yield on a 1.2 mmol scale by the method of 
Bergmeier and co-workers90 and gave white plates from water, mp 95-98 °C; (Found: C, 
52.45 H, 7.5%; C7H12O4 requires C, 52.5 H, 7.55%); u ^ K B rV c m '1 3433 (OH), 1625 
(C=0); 5h(400 MHz; d6-DMSO) 0.86 (3 H, t, J  7.3, CH3CH2), 1.22- 1.34 (2 H, m, 
CH3Ctf2), 1.40- 1.55 (2 H, m, CH3CH2Ctf2), 2.32 (ABX system, 1 H, dd, J  5.0 and 16.6, 
COCtf2CH), 2 .44-2.51 (ABX system, 1 H, m, COCHtfCH), 2 .57-2.64 (ABX system, 1 H, 
m, COCRjCH) and 12.18 (2 H, br s, COOH); 5C(100 MHz; d6-DMSO) 14.2 (CH3), 20.0 
(CH2), 33.9 (CH2), 36.0 (CH2), 40.8 (CH), 173.5 (C=0) and 176.3 (C=0); m/z (FAB+) 161 
[(M+H)+, 100%] and 143 (70); [Found (FAB+): (M+H)+ 161.0813; C7H i204 requires 
161.0814].
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8.2.3.4 (±)-2-Butylsuccinic acid 14190
OH
HO
O
141
Compound 141 was prepared in 81% yield on a 1.5 mmol scale by the method of 
Bergmeier and co-workers90 and gave mp 82-84 °C (lit.90 83 °C). 5h (400 MHz; d6-DMSO) 
0.86 (3 H, t, J  6.5, C //3CH2), 1.25-1.56 (6 H, m, alkyl-H), 2.32 (ABX system, 1 H, dd, J
5.0 and 16.5, COCH2CH) and 2.42-2.62 (ABX system, 2 H, m, COCHtfCH and 
COCH2Ctf).
1908.2.3.5 (±)-2-Octylsuccinic acid 142
0  (CH2)7Me 
OH
HO
O 
142
Compound 142 was prepared in 83% yield on a 1.5 mmol scale by the method of 
Bergmeier and co-workers90 and gave mp 88-91 °C (lit.90 89-90 °C). 5h (400 MHz; d6- 
DMSO) 0.86 (3 H, t, J  7.0, CH3CH2), 1.24 (12 H, s, alkyl-H), 1.36-1.50 (2 H, m, alkyl-H), 
2.32 (ABX system, 1 H, dd, J  5.0 and 16.0, COCHtfCH), 2.45 (ABX system, 1 H, dd, J  
6.3 and 16.0, COCH//CH), 2.56-2.63 (ABX system, 1 H, m, COCH2C//) and 12.18 (2 H, 
br s, COOH).
8.2.3.6 (±)-2-Benzylsuccinic acid 14390
OH
HO
O
Compound 143 was prepared in 81% yield on a 1.5 mmol scale by the method of 
Bergmeier and co-workers90 and gave mp 164-166 °C (lit.129 165-166 °C). §h (400 MHz; 
de-DMSO) 2.25 (ABX system, 1 H, dd, 74 .4  and 16.8, COCHtfCH), 2.43 (ABX system, 1 
H, dd, J  8.8 and 16.8, COCHtfCH), 2 .70-2.77 (ABX system, 1 H, m, COCH2Ctf), 2 .87- 
2.94 (2 H, m, ArCCtf2), 7.13-7.39 (5 H, m, aromatic H) and 12.25 (2 H, br s, COOH).
8.2.3.7 (±)-2-Isobutylsuccinic acid 144 130
.OH
HO
O
144
Compound 144 was prepared in 52% yield on a 0.8 mmol scale by the method of 
Bergmeier and co-workers90 and gave mp 97-98 °C (lit.131 95-96 °C). 5h (400 MHz; d6- 
DMSO) 0.85 (3 H, d, 77 .3 , C tf3CHCH3), 0.88 (3 H, d, 76.5, CH3CHC/73) 1.18-1.27 (1 H, 
m, alkyl-H), 1.38-1.47 (1 H, m, alkyl-H), 1.53-1.61 (1 H, m, alkyl-H), 2.32 (ABX system, 
1 H, dd, 75.1 and 16.6, COCH//CH), 2.42-2.51 (ABX system, 1 H, m, COCHtfCH), 2.61- 
2.68 (ABX system, 1 H, m, COCH2C//) and 12.20 (2 H, br s, COOH).
8.2.3.8 (±)-2-Hexylsuccinic acid 145132
O (CH2)5Me 
OH
HO
O
145
Compound 145 was prepared in 87% yield on a 1.2 mmol scale by the method o f 
Bergmeier and co-workers90 and gave mp 77-79 °C (lit.132 78-80 °C). (Found: C, 59.5 H, 
9.1%; Ci0H i8O4 requires C, 59.4 H, 9.0%); ^ (K B rV c m '1 2956 (CH3), 2856 (CH) and 
1695 (C=0); 5h(400 MHz; d6-DMSO) 0.86 (3 H, t, 77.0, CH3CH2), 1.24 (8 H, s, alkyl-H), 
1.38-1.49 (2 H, m, alkyl-H), 2.32 (ABX system, 1 H, dd, 75 .0  and 16.5, COCHtfCH), 2.47 
(ABX system, 1 H, dd, 7  9.3 and 16.5, COCHtfCH), 2.55-2.62 (ABX system, 1 H, m, 
COCH2CH) and 12.18 (2 H, br s, 2 x COOH), 5C(100 MHz; d6-DMSO) 14.3 (CH3), 22.4 
(CH2), 26.7 (CH2), 28.9 (CH2), 31.4 (CH2), 36.0 (CH2), 41.0 (CH), 173.5 (C =0) and 176.4
(C=0); m/z (CI+ mode, isobutane) 203 [(M+H)+, 5%] and 85 (100); [Found (M+H)+ 
203.1285; C10H 18O4 requires 203.1283].
8.2.3.9 (±)-2-Cyclohexylmethylsuccinic acid 146
,OH
HO
146
Compound 146 was prepared in 94% yield on a 0.8 mmol scale by the method of 
Bergmeier and co-workers90 and gave mp 118-120 °C. Um^KBrycm'1 3419 (OH), 2924 
(CH2) and 1699 (C=0); 6H(400 MHz; d6-DMSO) 0.82-0.85 (2 H, m, alkyl-H), 1.09-1.27 (5 
H, m, alkyl-H), 1.39-1.45 (1 H, m, alkyl-H), 1.62-1.75 (5 H, m, alkyl-H), 2.31 (ABX 
system, 1 H, dd, J  5.0 and 16.6, COCH/7CH), 2.41-2.47 (ABX system, 1 H, m, 
COCHtfCH), 2.58-2.67 (ABX system, 1 H, m, COCH2C7/) and 12.19 (2 H, br s, 2 x 
COOH); 6C(100 MHz; d6-DMSO) 26.0 (2 x CH2), 26.4 (CH2), 32.9 (CH2), 33.1 (CH2),
35.0 (CH), 36.6 (CH2), 38.6 (CH), 39.5 (CH2), 173.5 (C=0) and 176.7 (C=0); m/z (CI+ 
mode, isobutane) 215 [(M+H)+, 44%] and 197 (100); [Found (M+H)+215.1282; C nH i80 4 
requires 215.1283],
8.2.4 Synthesis of enantiomerically enriched 2-substituted succinic acids 
General procedure 1 for the saponification of succinamides.
Aqueous (30%) H20 2 (4.8 equiv.) and LiOH.H20  (2.4 equiv.) were added at 0 °C 
to a solution o f substituted succinamide (1 mol equiv.) in THF/H20 (4 :1 , 0.15 mmol/cm3). 
The mixture was stirred at 0 °C for 7 h, saturated aqueous Na2S03 was added and the 
mixture was extracted with ethyl acetate (2 x 10 cm3). The extracts were dried (M gS04) 
and concentrated under reduced pressure to give recovered auxiliary. The aqueous layer 
was then acidified with 1 M HC1 to pH 1 and extracted with ethyl acetate (2 x 1 0  cm3). The 
extracts were dried (M gS04) and concentrated under reduced pressure to produce the 
diacid.
1ZU
8.2.4.1 (2/?)-EthyIsuccinic acid 16793
O
HO,
OH
O
167
Using the mixture o f 186 and 187 (0.7 g, 1.29 mmol) in General procedure 1 gave 
(2i?)-ethylsuccinic acid 167 (0.12 g, 65%) as white needles, mp 95-97 °C (lit.93 96 °C); 
[a]o +34 (c 1.01, acetone) [lit.93 +24, (c 1.01, acetone)]; Sh(400 MHz; d6-DMSO) 0.86 (3 
H, t, J1.4, CH3CH2), 1.45-1.60 (2 H, m, CH3Ctf2), 2.31 (1 H, dd, J  4.7 and 16.2, CO CH) 
and 2.42-2.60 (2H, m, COCHHCH).
8.2.4.2 2-IsopropyIsuccinic acid 16894
O
HO,
OH
168
Using the mixture of 188 and 189 (0.7 g, 1.26 mmol) in General procedure 1 gave 
2-isopropylsuccinic acid 168 (0.13 g, 67%) as white needles, mp 110-112 °C (lit.94 95 °C); 
aw tK B rycm -1 2967 (OH), 2926 (OH) and 1698 (C=0); 6H(400 MHz; d6-DMSO) 0.86 (3 
H, d, J  6.8, Ctf3CHCH3), 0.89 (3 H, d, J  6.8, CH3CHCtf3), 1.86-1.94 (1 H, m, 
CH3CtfCH3), 2.31 (1 H, dd, J2 .8  and 16.0, COCHtf), 2.42-2.51 (2H, m, COCKHCH) and 
12.18 (2 H, br s, 2 x COOH), 5C(100 MHz; d6-DMSO) 19.6 (CH3), 20.3 (CH3), 29.7 (CH),
32.8 (CH2), 47.2 (CH), 173.9 (C=0) and 175.7 (C=0); m/z (CI+ mode, isobutane) 161 
[(M+H)+, 78%] and 143 (100); [Found (M+H)+ 161.0816; C7H i20 4 requires 161.0814],
8.2.4.3 (2/?)-Propylsuccinic acid 16995
O
HO,
OH
O
169
Using the mixtures o f 190 and 191 (0.6 g, 1.08 mmol) in General procedure 1 gave 
(2K)-propylsuccinic acid 169 (0.12 g, 71%) as white needles, mp 98-100 °C (lit.95 96 °C); 
[a]D +14 (c 1.0, EtOAc) [lit.95 +26.8, (c 1.1, H20)]; (Found: C, 52.3 H, 7.5%; C7H i20 4 
requires C, 52.5 H, 7.5%); Uma^KBrycm'1 2960 (OH) and 1700 (C=0); 8H(400 MHz; d6- 
DMSO) 0.86 (3 H, t, J  7.2, C tf3CH2), 1.25-1.33 (2 H, m, alkyl-H), 1.42-1.51 (2 H, m, 
alkyl-H), 2.32 (1 H, dd, J 4.8 and 16.4, COCHfl), 2.45 (1 H, dd, J 6.8 and 16.4, COCHff), 
2.57-2.64 (1 H, m, COCH2C/7) and 12.18 (2 H, br s, 2 x COOH); 5C(100 MHz; ds-DMSO)
14.2 (CH3), 20.0 (CH2), 33.9 (CH2), 36.0 (CH2) 40.8 (CH), 173.5 (C=0) and 176.4 (C=0); 
m/z (CI/NH3) 178 (M+NH4+), 100%).
8.2.4.4 (27?)-Butylsuccinic acid 17096
O
HO
OH
O
170
Using the mixtures o f 192 and 193 (0.7 g, 1.23 mmol) in General procedure 1 gave 
(2R)-butylsuccinic acid 170 (0.2 g, 67%) as white needles. 79-81 °C (lit.96 81-82 °C); [a]d 
+12 (c 1.0, EtOAc) [lit.96 +18.8, (c 4.16, H20)]; 6H(400 MHz; d6-DMSO) 0.86 (3 H, t, J
6.5, Ctf3CH2), 1.25-1.56 (6 H, m, alkyl-H), 2.32 (1 H, dd, J 5 .0  and 16.5, COCHtfCH) and 
2.42-2.62 (2 H, m, COCH/7CH and COCH2Ctf).
8.2.4.5 2-Cyclohexylsuccinic acid 17197
O
HO,
OH
171
Using 194 and 195 (1.16 g, 1.95 mmol) in General procedure 1 gave 2- 
cyclohexylsuccinic acid 171 (0.26 g, 67%) as white needles, mp 94-96 °C (lit.97 91-92 °C);
5h(400 MHz; d6-DMSO) 1.00-1.24 (5 H, m, alkyl-H), 1.50-1.70 (6 H, m, alkyl-H), 2.33 (1 
H, dd, J 2.5 and 15.2, COCH//), 2.45-2.53 (2 H, m, COCHHCH).
8.2.4.6 (2J?)-Octylsuccinic acid 172
O
O (CH2)7Me 
112
Using the mixture o f 196 and 197 (0.5 g, 0.8 mmol) in General procedure 1 gave 
(2K)-octylsuccinic acid 172 (0.11 g, 61%) as white needles, mp 83-85 °C; [a]o +14 (c 1.0, 
EtOAc); (Found: C, 62.8 H, 9.7%; C12H22O4 requires C, 62.6 H, 9.6%); umax(KBr)/cm'1 
2917 (OH), 2853 (OH) and 1690 (C=0); 8H(400 MHz; d6-DMSO) 0.92 (3 H, t, J  6.4, 
C //3CH2), 1.30 (12 H, m, alkyl-H), 1.48-1.61 (2 H, m, alkyl-H), 2.38 (1 H, dd, J  5.0 and 
16.5, COCH//), 2.48-2.56 (1 H, m, COCH//) and 2.62-2.69 (1 H, m, COCH2C//); 5C(100 
MHz; d6-DMSO) 14.3 (CH3), 22.4 (CH2), 26.7 (CH2), 28.9 (CH2), 29.1 (CH2), 29.2 (CH2),
31.6 (CH2), 31.7 (CH2), 36.0 (CH2) 41.0 (CH), 173.5 (C=0 ) and 176.3 (C=0 ); m/z (CI+ 
mode, isobutane) 231 [(M+H)+, 93%] and 213 (100); [Found (M+H)+231.1597; C12H22O4 
requires 231.1596],
8.2.4.7 (2/?)-Benzylsuccinic acid 17398
O
HO,
OH
O
173
Using the mixture o f 198 and other diastereomer (2.0 g, 3.32 mmol) in General 
procedure 1 gave (2/?)-benzylsuccinic acid 173 (0.49 g, 71%) as white needles, mp 162- 
164 °C (lit.98 162-163 °C); [ct]D +17.7 (c 2.9, EtOAc) [lit.98+27, (c 1.5, EtOAc)]; (Found: 
C, 63.6 H, 5.8%; C nH ,204 requires C, 63.5 H, 5.8%); iJmax(KBr)/cm'‘ 2964 (OH), 2882 
(OH) and 1694 (C=0); 5H(400 MHz; de-DMSO) 2.25 (1 H, dd, J  4,3 and 16.8, COC//2),
2.43 (1 H, dd, J 8.6 and 16.7, COCH2), 2.74 (1 H, dd, J  10.0 and 15.6, PhCH/7), 2.87-2.94 
(2 H, m, PhCHff and COCH2CH), 7.18-7.39 (5 H, m, ArH) and 12.25 (2 H, br s, 2 x
COO//); 8C(100 MHz; de-DMSO) 35.2 (CH2), 37.3 (CH2), 42.8 (CH), 126.7 (ArCH), 128.7 
(2 x ArCH), 129.3 (2 x ArCH), 139.1 (A rQ , 173.3 (C=0) and 175.5 (C=0); m/z (El) 280 
(M f, 12%), 162 (62) and 91 (100); (Found M* 208.0736; C uH i20 4 requires M+ 208.0736).
8.2.4.8 2-Isobutylsuccinic acid 174
O
HO.
OH
174
Using the mixture of 199 and 200 (1.61 g, 2.8 mmol) in General procedure 1 gave 
2-isobutylsuccinic acid 174 (0.37 g, 76%) as white needles, mp 96-97 °C; [a]o 0 (c 0 .1, 
EtOH); umax(KBr)/cm' 1 2960 (OH) and 1712 (C=0); 5H(400 MHz; ds-DMSO) 0.85 (3 H, d, 
J  7.3, C//3CHCH3), 0.88 (3 H, d, J  6.5, CH3CHC//3) 1.18-1.27 (1 H, m, alkyl-H), 1.38-
1.47 (1 H, m, alkyl-H), 1.53-1.61 (1 H, m, alkyl-H), 2.32 (1 H, dd, J  5.1 and 16.6, 
COCH/7CH), 2.42-2.51 (1 H, m, COCH//CH), 2.61-2.68 (1 H, m, COCH2CH) and 12.20 
(2 H, br s, COO//); 5C(100 MHz; d6-DMSO) 22.5 (CH3), 22.8 (CH3), 25.6 (CH), 36.5 
(CH2), 39.5 (CH), 41.1 (CH2), 173.4 (C=0) and 176.6 (C=0); m/z (CI/NH3) 192 
(M +N H /), 25%), 102 (88), 85 (100) and 79 (60).
8.2.4.9 (2/?)-IIexylsuccinic acid 17599
O
O (CH2)5Me 
175
Using the mixture o f 201 and 202 (2.1 g, 3.5 mmol) in General procedure 1 gave 
(2R)-hexylsuccinic acid 175 (0.49 g, 71%) as white needles, mp 77-79 °C (lit.99 83 °C); 
[a]D +8 (c 1.5, EtOAc) (lit.99 +14.3, (H20)]; umax(KBr)/cm'' 2923 (OH), 2856 (OH) and 
1693 (C=0); 5h(400 MHz; d6-DMSO) 0.88 (3 H, t, J 6 .8, C //3CH2), 1.29-1.36 (9 H, m, 
alkyl-H), 1.50-1.57 (1 H, m, alkyl-H), 2.49-2.57 (1 H, m, alkyl-H), 2.69-2.77 (1 H, m, 
alkyl-H) and 2.81-2.88 (1 H, m, alkyl-H); 8C(100 MHz; d«-DMSO) 14.0 (CH3), 22.5 
(CH2), 26.8 (CH2), 29.0 (CH2), 31.5 (CH2), 31.6 (CH2), 35.5 (CH2), 41.1 (CH), 178.7
(C =0) and 181.6 (C=0); m/z (FAB+) 203 [(M+H)+, 9%], 147 (25) and 74 (100); [Found 
(FAB+): (M+H)+203.1285; Ci0H 18O4 requires 203.1283],
8.2.4.10 (2/?)-CyclohexyImethylsuccinic acid 176
O
HO,
OH
O
176
Using the mixture of 203 and 204 (1.88 g, 3 mmol) in General procedure 1 gave 
(2R)-cyclohexylmethylsuccinic acid 176 (0.42 g, 66%) as white needles, mp 118-120 °C. 
[a]D +6 (c 1.0, EtOH); iw fK B ry cm '1 3419 (OH), 2924 (CH2) and 1699 (C=0); 5H(400 
MHz; ds-DMSO) 0.82-0.85 (2 H, m, alkyl-H), 1.09-1.27 (5 H, m, alkyl-H), 1.39-1.45 (1 H, 
m, alkyl-H), 1.62-1.75 (5 H, m, alkyl-H), 2.31 (1 H, dd, J 5.0 and 16.6, COCHHCH), 2.41-
2.47 (1 H, m, COCH//CH), 2.58-2.67 (1 H, m, COCH2C //) and 12.19 (2 H, br s, COOH); 
8C(100 MHz; d6-DMSO) 26.0 (2 x CH2), 26.4 (CH2), 32.9 (CH2), 33.1 (CH2), 35.0 (CH),
36.6 (CH2), 38.6 (CH), 39.5 (CH2), 173.5 (C =0) and 176.7 (C=0); m/z (CI+ mode, 
isobutane) 215 [(M+H)+, 44%] and 197 (100); [Found (M+H)+ 215.1282; Cu H 180 4 
requires 215.1283],
8.2.5 Conversion of diacids into dimethyl esters
General procedure 2 for the conversion of diacids into dimethyl esters using the 
Aldrich MNNG Diazomethane Generator.91,133
The sample (50 mg) was dissolved in diethyl ether (4 cm3) and added to the outside 
tube of the diazomethane generator. The two parts were assembled and held together by 
tightening the 32 mm screw cap. Diethyl ether (1 cm3) and carbitol (1 cm3) were added to 
the inside tube. Diazald (0.6 g) was placed in the inside tube through the 8 mm open top 
screw cap. The lower part o f the apparatus was immersed in ice water and about 1.5 cm3 of 
KOH (37%) was injected dropwise through the silicone septum with a No. 23 needle to 
prevent back pressure. The apparatus was shaken by hand every 10 min to ensure
completion o f reaction. After ~ 2 h the ether solution in the outside tube was shaken to 
remove ether in a warm water bath (60 °C) in a fume cupboard. Any unreacted 
diazomethane in the inside tube was destroyed by using silicic acid (0.2 g).
8.2.5.1 Dimethyl (±)-2-ethylsuccinate 331134
,OMe
MeO
O
331
Using 2-ethylsuccinic acid 138 (50 mg, 0.34 mmol) in General procedure 2 gave 
dimethyl (±)-2-ethylsuccinate 331 as a colourless oil (43 mg, 86%); 5h(400 MHz; CDCI3) 
0.92 (3 H, t, J  1.4, C//3CH2), 1.54-1.73 (2 H, m, CH3Gtf2), 2.44 (ABX system, 1 H, dd, J
4.8 and 16.0, COCHtfCH), 2.72 (ABX system, 1 H, J  9.3 and 16.0, COCHtfCH), 2.77-
2.84 (ABX system, 1 H, m, COCHHCtf), 3.67 (3 H, s, OCH3) and 3.70 (3 H, s, OCH3).
8.2.5.2 Dimethyl (±)-2-benzylsuccinate 152135
OMe
MeO
O
152
Using 2-benzylsuccinic acid 143 (50 mg, 0.24 mmol) in General procedure 2 gave 
a crude oil which was chromatographed [S i02, EtOAc-hexane (1:1)] to give dimethyl (±)- 
2-benzylsuccinate 152 (31 mg, 54%). 5h(400 MHz; CDCI3) 2.40 (ABX system, 1 H, dd, J
5.0 and 16.8, ArCtf2CH), 2.68 (ABX system, 1 H, dd, J  9.0 and 16.8, ArCHtfCH), 2.76 
(ABX system, 1 H, dd, J 8.4 and 13.4, COCHtfCH), 3.06 (ABX system, 1 H, dd, J 6.0 and
13.4, COCHtfCH), 3.10-3.16 (ABX system, 1 H, m, COCH2CH), 3.64 (3 H, s, OCH3), 
3.67 (3 H, s, OCH3) and 7.07-7.30 (5 H, m, aromatic).
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8.2.5.3 Dimethyl (2i?)-benzylsuccinate 153136
OMe
MeO
O
153
Using (2K)-benzylsuccinic acid 173 (50 mg, 0.24 mmol) in General procedure 2 
gave dimethyl (2R)-benzylsuccinate 153 as a colourless oil (33 mg, 58%). [a]o +20 (c 1.2, 
EtOAc); Umax(NaCl)/cm"1 3028 (aryl C-H), 2952 (CH3) and 1737 (C=0); 5H(400 MHz; 
CDC13) 2.41 (ABX system, 1 H, dd, 7 5 .0  and 16.8, ArCHtfCH), 2.68 (ABX system, 1 H, 
dd, 7 9 .0  and 16.8, ArCHtfCH), 2.76 (ABX system, 1 H, dd, 7  8.3 and 13.4, COCHtfCH),
3.06 (ABX system, 1 H, dd, 76 .3  and 13.4, COCHtfCH), 3.11-3.17 (ABX system, 1 H, m, 
COCH2C/O, 3.62 (3 H, s, O C//3), 3.67 (3 H, s, OCH3) and 7.14-7.30 (5 H, m , aromatic); 
6 c ( 1 0 0  MHz; CDC13) 35.3 (CH2), 38.1 (CH2), 43.4 (CH), 52.1 (OCH3), 52.3 (OCH3), 
127.1 (ArCH), 128.9 (2 x ArCH), 129.4 (2 x ArCH), 138.5 (ArC), 172.7 (C O )  and 175.1 
(C O ).
8.2.6 Conversion of diacids into dianilides
General procedure 3 for the coupling reaction of aniline to diacids.
The diacid was dissolved in dry DMF (10 cm3) under N2 and stirred at room 
temperature. Added to this was EDCI (2.2 equiv.) and aniline (4 equiv.). The mixture was 
stirred at room temperature for 24 h, quenched with H20  (10 cm3) and extracted with ethyl 
acetate (3 x 20 cm ). The combined extracts were washed with 1M HC1 (10 cm ), sodium 
hydrogen carbonate (10 cm3) and with brine (10 cm3), dried (MgS04) and concentrated 
under reduced pressure.
8.2.6.1 iV,/V-Diphenylsuccinamide 302137
302
Using succinic acid (0.5 g, 4.23 mmol) in General procedure 3 gave N,N- 
diphenylsuccinamide 302 as white needles from ethanol (0.32 g, 28%). mp 224-225 °C 
(lit.137 mp 226 °C); (Found: C, 71.45 H, 6.0 N, 10.5%; Ci6H ,6N20 2 requires C, 71.6 H, 6.0 
N, 10.4%); umax(KBr)/cm'1 3316 (N-H), 3058 (aryl C-H), 1662 (C=0), 1596 (benzene ring) 
and 1527 (C=0); 5H(400 MHz; d6-DMSO) 2.50 (4 H, s, COCH2CH2), 7.02 (2 H, t, J  7.4, 
para-ArCH), 7.27 (4 H, t, J  7.9, meta-ACH), 7.59 (4 H, d, J  7.8, ortho-ACH), and 9.96 
(2 H, s, Nfl); 5C(100 MHz; d6-DMSO) 31.6 (2 x CH2), 119.3 (4 x ArCH), 123.2 (2 x 
ArCH), 129.0 (4 x ArCH), 139.7 (2 x ArC) and 170.7 (2 x C=0); m/z (El) 268 (M 1, 19%), 
176 (M+-ArNH2, 36) and 93 (ArNH2, 100); (Found M" 268.1210, C16Hi«N20 2 requires M* 
268.1212).
8.2.6.2 (±)-jV,:V-Diphenyl-2-methylsuccinamide 158138
158
Using (±)-2-methylsuccinic acid (0.1 g, 0.76 mmol) in General procedure 3 gave 
(±)-A,,Ar-diphenyl-2-methylsuccinamide 158 as white needles from ethyl acetate (0.12 g, 
57%). mp 215-217 °C (lit.138 mp 214-217 °C); (Found: C, 72.2 H, 6.4 N, 9.8%; 
Ci7H i8N 20 2 requires C, 72.4 H, 6.4 N, 9.9%); iw lK B ry cm -1 3282 (NH), 1649 (C=0), 
1597 (benzene ring) and 1529 (C=0); 8h(400 MHz; d«-DMSO) 1.17 (3 H, d, J  7.0, 
C ftC H ), 2.43 (ABX system, 1 H, dd, J  6.6 and 15.0, COCHHCH), 2.74 (ABX system, 1 
H, dd, J  7.8 and 15.0, COCHffCH), 3.02 (ABX system, 1 H, dd, J  7.1 and 14.0, 
COCH2Ctf), 7.02 (2 H, t, J  7.2, para-ArCH), 7.28 (4 H, t, J  7.4, meta-ACH), 7.58 (2 H, 
d, J  8.0, ortho-ACH), 7.61 (2 H, d, J  8.0, ortho-ACH), 9.96 (1 H, s, N //) and 9.97 (1H, 
s, N //); 6C(100 MHz; d6-DMSO) 18.3 (CH3), 37.4 (CH), 40.5 (CH2), 119.3 (2 x ArCH),
128
119.4 (2 x ArCH), 123.3 (2 x ArCH), 128.9 (2 x ArCH), 129.0 (2 x ArCH), 139.6 (ArC),
139.8 (ArC), 170.1 (C=0) and 174.4 (C=O); m/z (El) 282 (M+, 20%), 190 (M^ArNHz, 50) 
and 93 (ArNH2, 100); (Found M*282.1367; C17H 18N2O2 requires M* 282.1368).
8.2.6.3 (±)-iV,A-Diphenyl-2-ethyIsuccinamide 159
159
Using (±)-2-ethylsuccinic acid 138 (67 mg, 0.45 mmol) in General procedure 3 
gave (±)-A,iV-diphenyl-2-ethylsuccinamide 159 (0.11 g, 85%) as white plates from ethyl 
acetate, mp 202-205 °C; (Found: C, 72.8 H, 6.8 N, 9.4%; C18H20N2O2 requires C, 72.95 H,
6.8 N, 9.45%); u ^ K B ry c m ’1 3436 (NH), 1655 (C =0) and 1598 (C=0); 5H(400 MHz; d6- 
DMSO) 0.90 (3 H, t, J  1.4, CH3CH2), 1.51-1.63 (2 H, m, CH3CH2), 2.47 (ABX system, 1 
H, dd, J  6.0 and 15.6, COCHtfCH), 2.72 (ABX system, 1 H, dd, J  8.4 and 15.2, 
COCH//CH), 2.86-2.93 (ABX system, 1 H, m, COCH2CH), 7.01-7.04 (2 H, m, para- 
AiCH), 7.25-7.30 (4 H, m, meta-ArCH), 7.57 (2 H, d, J  8.0, ortho-AiCH), 7.62 (2 H, d, J
8.0, ortho-AiCH), 9.95 (1 H, s, N tf) and 9.98 (1 H, s, NH); 6C(100 MHz; d6-DMSO) 11.8 
(CH3), 25.8 (CH2), 38.6 (CH2), 44.2 (CH), 119.3 (2 x ArCH), 119.5 (2 x ArCH), 123.3 (2 x 
ArCH), 128.9 (2 x ArCH), 129.0 (2 x ArCH), 139.6 (ArC), 139.7 (ArC), 170.2 (C=0) and
173.6 (C=0); m/z (El) 296 (M+, 10%), 204 (M^-ArNH2, 57) and 93 (ArNH2, 100); (Found 
M" 296.1523; C18H20N2O2 requires M+ 296.1525).
8.2.6.4 (2/?)-A^A-Diphenyl-2-ethylsuccinamide 177
177
Using (2i?)-ethylsuccinic acid 167 (70 mg, 0.05 mmol) in General procedure 3 gave 
(2i?)-A,A-diphenyl-2-ethylsuccinamide 177 (80 mg, 57%) as white plates. Spectral data 
were identical to racemate 159. mp 204-206 °C; [a]o -28 (c 0.5, /PrOH); (Found: C, 72.6 
H, 6.8 N, 9.35%; C18H20N2O2 requires C, 72.95 H, 6.8 N, 9.45%); m/z (El) 296 (M+, 10%),
204 (M*-ArNH2, 57) and 93 (ArNH2> 100); (Found M + 296.1526; C18H20N 2O2 requires M+ 
296.1525).
8.2.6.5 (±)-jV,7V-Diphenyl-2-isopropylsuccinamide 160
160
Using (±)-2-isopropylsuccinic acid 139 (0.22 g, 1.38 mmol) in General procedure 3 
gave (±)-Ar,A^-diphenyl-2-isopropylsuccinamide 160 (0.34 g, 79%) as white plates from 
ethyl acetate, mp 194-196 °C; (Found: C, 73.4 H, 7.1 N, 9.0%; C19H22N2O2 requires C,
73.5 H, 7.1 N, 9.0%); u ^ K B r y c m '1 3316 (NH), 1657 (C=0) and 1527 (C=0); 6H(400 
MHz; d6-DMSO) 0.94 (3 H, d, J  6.8, C//3CHCH3), 0.97 (3 H, d, J  6.8, C7T3CHCH3), 1.88- 
1.96 (1 H, m, CH3C//CH3), 2.76-2.85 (3 H, m, COCH2CH), 6.98-7.02 (2 H, m, para- 
AiCH), 7.25-7.29 (4 H, m, meta-ArCH), 7.56 (2 H, d, J  7.6, ortho-AsCH), 7.60 (2 H, d, J
7.6, ortho-ArCH), 9.95 (1 H, s, NTT) and 9.97 (1 H, s, NTT); 8C(100 MHz; d6-DMSO) 19.9 
(CH3), 20.7 (CH3), 30.8 (CH), 35.5 (CH2), 48.7 (CH), 119.2 (2 x ArCH), 119.4 (2 x 
ArCH), 123.2 (2 x ArCH), 128.9 (2 x ArCH), 129.0 (2 x ArCH), 139.6 (ArC), 139.7 
(ArC), 170.6 (C=0) and 173.2 (C=0); m/z (El) 310 (M \ 7%), 218 (lVT-ArNHj, 55) and 93 
(ArNH2, 100); (Found M+ 310.1678; C19H22N2O2 requires M* 310.1681).
8.2.6.7 (2/?)-7V,jV-Diphenyl-2-isopropylsuccinainide 178
178
Using (2R)-isopropylsuccinic acid 168 (0.16 g, 1.0 mmol) in General procedure 3 
gave (2^)-Af,jV-diphenyl-2-isopropylsuccinamide 178 (0.23 g, 74%) as white plates. 
Spectral data were identical to racemate 160. mp 193-195 °C; (Found: C, 73.1 H, 7.2 N, 
9.1%; C19H22N2O2 requires C, 73.5 H, 7.1 N, 9.0%); [a]D +4 (c 1.0, acetone); m/z (El) 310 
(IVT, 10%), 218 (IVT-ArNH^ 74) and 93 (ArNH2, 100); (Found M+ 310.1682; C19H22N2O2 
requires M* 310.1681).
8.2.6.8 (±)-jV,JV-Diphenyl-2-butylsuccinamide 161
161
Using (±)-2-butylsuccinic acid 141 (0.20 g, 1.20 mmol) in General procedure 3 
gave (±)-A(7V-diphenyl-2-butylsuccinamide 161 (0.22 g, 56%) as white plates from ethyl 
acetate, mp 154-157 °C; tw flC B rycm ' 1 3294 (NH), 1652 (C=0) and 1531 (C=0); 6H(400 
MHz; de-DMSO) 0.85 (3 H, t, J  6.9, CH3CH2), 1.28-1.58 (6 H, m, alkyl-H), 2.44-2.51 
(ABX system, 1 H, m, COCH//CH), 2.70 (ABX system, 1 H, dd, J  8.3 and 15.4, 
COCHHCH), 2.92-2.95 (ABX system, 1 H, m, COCH2C//), 6.99-7.03 (2 H, m, para- 
AiCH), 7.22-7.30 (4 H, m, meta-AiCH), 7.57 (2 H, d, J  7.9, ortho-AiCH), 7.62 (2 H, d, J  
7.8, ortho-AiCH), 9.96 (1 H, s, NTT) and 10.0 (1H, s, NH); 5C(100 MHz; d«-DMSO) 14.2 
(CH3), 22.5 (CH2), 29.2 (CH2), 32.4 (CH2), 39.3 (CH2), 43.0 (CH), 119.3 (2 x ArCH),
119.5 (2 x ArCH), 123.2 (2 x ArCH), 128.9 (2 x ArCH), 129.0 (2 x ArCH), 139.5 (ArC),
139.7 (ArC), 170.2 (C=0) and 173.7 (C=0); m/z (El) 324 (M \ 5%), 232 (M"-ArNH2, 56) 
and 93 (ArNH2, 100); (Found M+324,1842; C20H24N 2O2 requires M+ 324.1838).
8.2.6.9 (2fi)-;V,;V-Dipheiiyl-2-buty]succinamide 179
179
Using (2H)-butylsuccinic acid 170 (78 mg, 0.33 mmol) in General procedure 3 gave 
(2H)-Af,7Vr-diphenyl-2-butylsuccinamide 179 (75 mg, 71%) as white plates. Spectral data 
were identical to racemate 161. mp 153-156 °C; [ o ] d  -29 (c 0.6, iPrOH); (Found: C, 73.5 
H, 7.5 N, 8.6%; C20H24N2O2 requires C, 74.0 H, 7.5 N, 8.6%); m/z (El) 324 (M \ 8%), 232 
(M+-ArNH2, 59) and 93 (ArNH2, 100); (Found M + 324.1837; C20H24N 2O2 requires M f
324.1838).
8.2.6.10 (±)-Af,jV-Diphenyl-2-octylsuccinamide 162
Using (±)-2-octylsuccinic acid 142 (0.20 g, 0.87 mmol) in General procedure 3 
gave (±)-Ar,7V-diphenyl-2-octylsuccinamide 162 (0.25 g, 67%) as white plates from ethanol, 
mp 175-178 °C; (Found: C, 75.8 H, 8.5 N, 7.4%; C24H32N2O2 requires C, 75.75 H, 8.5 N, 
7.4%); umax(KBr)/cm‘' 3293 (NH), 1654 (C=0) and 1529 (C=0); 5H(400 MHz; ds-DMSO) 
0.83 (3 H, t, 7  6.8, C //3CH2), 1.22-1.60 (14 H, m, alkyl-H), 2.44-2.50 (ABX system, 1 H, 
m, COCHtfCH), 2.70 (ABX system, 1 H, dd, J  8.0 and 15.2, COCH//CH), 2.92-2.95 
(ABX system, 1 H, m, COCH2C/7), 7.00-7.03 (2 H, m, para-hxCH), 7.25-7.29 (4 H, m, 
meta-ArCH), 7.57 (2 H, d, J7 .6 , ortho-AiCH), 7.61 (2 H, d, J  8.0, para-ArCH), 9.96 (1 H, 
s, NH) and 10.0 (1 H, s, N //); 8C(100 MHz; d«-DMSO) 14.3 (CH3), 22.4 (CH2), 26.9 
(CH2), 28.9 (CH2), 29.2 (CH2), 29.3 (CH2), 31.5 (CH2), 32.6 (CH2), 39.5 (CH2), 43.0 (CH),
119.3 (2 x ArCH), 119.5 (2 x  ArCH), 123.3 (2 x ArCH), 128.9 (2 x ArCH), 129.0 (2 x 
ArCH), 139.5 (ArC), 139.7 (ArC), 170.2 (C=0), and 173.8 (C=0); m/z (El) 380 (M+, 7%), 
288 (M+-ArNH2, 52) and 93 (ArNH2, 100); (Found M* 380.2463; C24H32N20 2 requires M* 
380.2464).
8.2.6.11 (2/?)-A^,A^-Diphenyl-2-octylsuccinamide 181
Using (2i?)-octylsuccinic acid 172 (0.25 g, 1.1 mmol) in General procedure 3 gave 
(2i?)-Af,jV-diphenyl-2-octylsuccinamide 181 (0.26 g, 62%) as white plates. Spectral data 
were identical to racemate 162. mp 174-177 °C; [(x] d  -40 (c 1.0, acetone); (Found: C, 75.7 
H, 8.6 N, 7.4%; C24H32N20 2 requires C, 75.75 H, 8.5 N, 7.4%); m/z (El) 380 (M+, 20%), 
288 (Mt-ArNH2, 100) and 93 (ArNH2, 100); (Found M* 380.2466; C24H32N20 2 requires 
M 4- 380.2464).
8.2.6.12 (±)-Af,Af-Diphenyl-2-cyclohexylsuccinamide 180
180
Using (±)-2-cyclohexylsuccinic acid 171 (0.2 g, 1.0 mmol) in General procedure 3 
gave (±)-A ,^ALdiphenyl-2-cyclohexylsuccinamide 180 (0.25 g, 63%) as white plates from 
ethanol, mp 245-247 °C; (Found: C, 75.25 H, 7.55 N, 8.0%; C22H26N2O2 requires C, 75.4 
H, 7.5 N, 8.0%); \w (K B r)/cm 4 3286 (NH), 1656 (C =0) and 1533 (C=0); 8H(400 MHz; 
ds-DMSO) 0.94-1.21 (5 H, m, alkyl-H), 1.56-1.80 (6 H, m, alkyl-H), 2.50-2.54 (ABX 
system, 1 H, m, COCH//CH), 2.74 (ABX system, 1 H, dd, J  9,9 and 15.0, COCHtfCH), 
2.81-2.85 (ABX system, 1 H, m, COCH2C/7), 6.98-7.02 (2 H, m, para-AiCH), 7.24-7.28 
(4 H, m, meta-hiCH), 7.56 (2 H, d, J  8.0, ortho-AiCH), 7.61 (2 H, d, J  8.0, ortho-AiCH) 
and 9.86 (2 H, s, NTT); 5C(100 MHz; ds-DMSO) 26.3 (3 x CH2), 30.2 (CH2), 30.7 (CH2),
36.0 (CH2), 40.6 (CH), 48.3 (CH), 119.2 (2 x ArCH), 119.4 (2 x ArCH), 123.2 (2 x ArCH),
129.0 (2 x ArCH), 139.0 (ArC), 139.6 (ArC), 170.6 (C=0) and 173.2 (C=0); m/z (El) 350 
(M+, 12%), 258 (M+-ArNH2, 100) and 93 (ArNH2, 100); (Found IVT 350.1994; C22H26N20 2 
requires M + 350.1994).
8.2.6.13 (±)-7V,7V-Diphenyl-2-isobutylsuccinamide 163
163
Using (±)-2-isobutylsuccinic acid 144 (50 mg, 0.28 mmol) in General procedure 3 
gave (±)-A^A^-diphenyl-2-isobutylsuccinamide 163 (52 mg, 58%) as white plates from 
ethanol, mp 196-198 °C; (Found: C, 74.0 H, 7.45 N, 8.6%; C20H24N2O2 requires C, 74.05 
H, 7.5 N, 8.6%); nmax(KBr)/cm‘' 3244 (NH), 1654 (C=0) and 1596 (C=0); 8H(400 MHz; 
ds-DMSO) 0.88 (3 H, d, J6 .3 , C //3CHCH3), 0.94 (3 H, d, J  6.3, CTT3CHCH3), 1.24-1.28 (1
H, m, 6-H), 1.52-1.62 (2 H, m, CH3CHCtf2), 2.44-2.50 (ABX system, 1 H, m, COCH2CH), 
2.66 (ABX system, 1 H, dd, J  8.0, 15.1, COCH//CH), 2.98-3.03 (ABX system, 1 H, m, 
COCH2CH), 7.02 (2 H, t, J  7.4, para-ArCH), 7.27 (4 H, t, J7 .8 , meta-ArCH), 7.57 (2 H, d, 
J  7.8, ortho-AiCH), 7.63 (2 H, d, J l . l ,  ortho-AiCH), 9.96 (1 H, s, NTT) and 10.04 (1 H, s, 
NH); Sc(100 MHz; d«-DMSO) 22.6 (CH3), 23.4 (CH3), 26.0 (CH), 40.3 (CH2), 41.4 (CH),
41.9 (CH2), 119.4 (2 x ArCH), 119.6 (2 x ArCH), 123.3 (2 x ArCH), 128.9 (2 x ArCH),
129.0 (2 x ArCH), 139.5 (ArC), 139.7 (ArC), 170.0 (C =0) and 174.0 (C=0); m/z (El) 324 
(M+, 15%), 268 (M+-'Bu, 42), 232 (M+-ArNH2, 100) and 93 (ArNH2, 100); (Found M+ 
324.1839; C20H24N 2O2 requires M" 324.1838).
8.2.6.14 (2/?)-7V,7V-Diphenyl-2-isobutylsuccinamide 183
183
Using (2R)-isobutylsuccinic acid 174 (0.2 g, 1.15 mmol) in General procedure 3 
gave a crude mixture which was chromatographed (SiC>2, Et20) to give (2R)-Af iV-diphenyl- 
2-isobutylsuccinamide 183 (0.16 g, 43%) as white plates. Spectral data were identical to 
racemate 163. mp 193-195 °C; [a]D -4 (c 0.5, iPrOH); (Found: C, 74.0 H, 7.45 N, 8.6%; 
C20H24N2O2 requires C, 74.05 H, 7.5 N, 8.6%); m/z (El) 324 (M+, 6%), 268 (M+-'Bu, 16), 
232 (M +-ArNH2, 48) and 93 (ArNH2, 100); (Found M* 324.1839; C20H24N2O2 requires M+
324.1838).
8.2.6.15 (±)-A^A/-Diphenyl-2-hexylsuccinamide 165
Using (±)-2-hexylsuccinic acid 145 (0.2 g, 1.0 mmol) in General procedure 3 gave 
(±)-A^,7V-diphenyl-2-hexylsuccinamide 165 (0.18 g, 51%) as white plates after 
recrystallisation from ethanol, mp 167-169 °C; (Found: C, 75.1 H, 8.0 N, 8.0%;
134
C22H28N2O2 requires C, 75.0 H, 8.0 N, 7.95%); umax(KBr)/cm4 3294 (NH), 1651 (C =0) 
and 1531 (C=0); 5H(400 MHz; d«-DMSO) 0.84 (3 H, t, J 6 .8, C //3CH2), 1.24-1.27 (8 H, m, 
alkyl-H), 1.44-1.63 (2 H, m, alkyl-H), 2.44-2.50 (ABX system, 1 H, m, COCH//CH), 2.70 
(ABX system, 1 H, dd, J  8.4, 15.2, COCHHCH), 2.88-2.97 (ABX system, 1 H, m, 
COCH2C//), 7.02-7.06 (2 H, m, para-AxCH), 7.25-7.32 (4 H, m, meta-AiCH), 7.54 (2 H, 
d, J  7.6, ortho-AsCH), 7.62 (2 H, d, J  8.0, ortho-AiCH), 9.96 (1 H, s, NH), and 10.0 (1 H, 
s, NH); 6c(100 MHz; d6-DMSO) 14.3 (CH3), 22.3 (CH2), 27.0 (CH2), 29.0 (CH2), 31.5 
(CH2), 32.7 (CH2), 39.1 (CH2), 43.0 (CH), 119.3 (2 x ArCH), 119.5 (2 x ArCH), 123.3 (2 x 
ArCH), 128.9 (2 x ArCH), 129.0 (2 x ArCH), 139.5 (ArC), 139.7 (ArC), 170.2 (C =0) and
173.8 (C=0); m/z (El) 352 (M+, 6%), 260 (M+-ArNH2, 44) and 93 (ArNH2, 100); (Found 
M+ 352.2150; C22H28N2O2 requires M+ 352.2151).
8.2.6.16 (2J?)-N,N-Diphenyl-2-hexylsuccinamide 184
Using (2/^)-hexylsuccinic acid 175 (0.23 g, 1.14 mmol) in General procedure 3 
gave a crude mixture which was chromatographed (SiC>2, Et20) to give (2R)-N,iV-diphenyl- 
2-hexylsuccinamide 184 (0.18 g, 45%) as white plates. Spectral data were identical to 
racemate 165. mp 167-169 °C; [a]D -10 (c 1.0, iPrOH); m/z (El) 352 (IVT, 8%), 260 (IVT- 
ArNH2, 48) and 93 (ArNH2, 100); (Found M+ 352.2151; C22H28N2O2 requires M + 
352.2151).
8.2.6.17 (±)-iV,A^Diphenyl-2-cyclohexylmethylsuccinamide 166
166
Using (±)-2-cyclohexylmethylsuccinic acid 146 (0.1 g, 0.47 mmol) in General 
procedure 3 gave (±)-7V,7V-diphenyl-2-cyclohexylmethylsuccinamide 166 (90 mg, 53%) as 
white plates from ethanol, mp 172-174 °C; (Found: C, 75.7 H, 7.7 N, 7.8%; C23H28N2O2 
requires C, 75.8 H, 7.7 N, 7.7%); rw C K Brycm '1 3265 (NH), 1655 (C =0) and 1534 
(C=0); Sh(400 MHz; d«-DMSO) 0.88-0.94 (2 H, m, alkyl-H), 1.09-1.32 (5 H, m, alkyl-H), 
1.54-1.90 (6 H, m, alkyl-H), 2.45 (ABX system, 1 H, dd, J  6.5, 15.2, COCHHCH), 2.66 
(ABX system, 1 H, dd, J  8.0, 15.2, COCHHCH), 3.02-3.05 (ABX system, 1 H, m, 
COCH2CH), 7.02-7.04 (2 H, m, para-ArCH), 7.26-7.30 (4 H, m, meta-AiCH), 7.57 (2 H, 
d, J  7.6, ortho-AsCH), 7.62 (2 H, d, J  7.6, ortho-AiCH), 9.96 (1 H, s, NH) and 10.0 (1 H, s, 
NH); Sc(100 MHz; cU-DMSO) 26.0 (CH2), 26.4 (CH2), 33.0 (CH2), 33.6 (CH2), 35.3 (CH),
39.5 (2 x CH2), 39.9 (CH2), 40.7 (CH), 119.4 (2 x ArCH), 119.6 (2 x ArCH), 123.3 (2 x 
ArCH), 128.9 (2 x ArCH), 129.0 (2 x ArCH), 139.5 (ArC), 139.7 (ArC), 170.0 (C=0), and
174.0 (C=0); m/z (El) 364 (M*, 7%), 272 (M+-ArNH2, 54) and 93 (ArNH2, 100); (Found 
M* 364.2148; C23H28N20 2 requires M+ 364.2151).
8.2.6.18 (2i?)-jV,jV-DiphenyI-2-cyclohexylniethylsuccinamide 185
H
N
185
Using (2^)-cyclohexylmethylsuccinic acid 176 (0.42 g, 1.96 mmol) in General 
procedure 3 gave a crude mixture which was chromatographed (Si(>2, Et20) to give (2R)- 
Ar,A7-diphenyl-2-cyclohexylmethylsuccinamide 185 (0.57 g, 80%) as white plates. Spectral 
data were identical to racemate 166. mp 171-173 °C; [(x] d  -12 (c 1.0, iPrOH); m/z (El) 364 
(M+, 7%), 272 (M+-ArNH2) 72) and 93 (ArNH2, 100); (Found M+ 364.2152; C23H28N20 2 
requires M 4^ 364.2151).
8.2.7 Synthesis of 2-substituted succinamides
8.2.7.1 JV,jV-Bis[(2/?)-bornane-10,2-sultam]fumaramide 10080
0 2S
0 2
100
Compound 100 was prepared in 81% yield on a 3.34 mmol scale by the method of 
Bauer and co-workers80 and gave mp 245-247 °C (lit.80 247-248 °C); [a]o -133 (c 1.0, 
CHC13) [lit.80 -135.6, (c 1.18, CHCI3)]; 5h(400 MHz, CDC13) 0.99 (6 H, s, CH3CCH3),
1.16 (6 H, s, CH3CCH3), 1.32-1.47 (4 H, m, alkyl-H), 1.90-1.99 (6 H, m, alkyl-H), 2.09- 
2.20 (4 H, m, alkyl-H), 3.48 (AB system, 2 H, d, J  13.8, Ctf2S 0 2), 3.55 (AB system, 2 H, 
d, J  13.8, C tf2S 0 2), 3.95-3.98 (2 H, m, CHH) and 7.64 (2 H, s, CH=CH).
8.2.7.2 7V,A^'-Bis[(2A)-bornane-10,2-sultamlfumaramide
02
The above compound was prepared in 68% yield on a 11.6 mmol scale by the 
method of Bauer and co-workers80 and gave mp 236-238 °C. Spectral data were identical to 
enantiomer 100. [a]D +145 (c 1.2, CHC13); (Found: C, 56.4 H, 6.7 N, 5.5%; C24H34N20 6S2 
requires C, 56.45 H, 6.7 N, 5.5%); m/z (El) 510 (M+, 4%), 382 (17), 296 (76) and 135 
(100); (Found M^ 510.1859; C24H34N 206S2 requires M+ 510.1858).
G eneral procedure 4 for the 1,4-addition of G rignard reagents to AT,AP-bis[(21?)- 
bornane-10,2-sultam ]fum aram ide 100.
The Grignard reagent (3.5 equiv.) in diethyl ether was added dropwise to a stirred 
solution o f AyV’-bis[(2i?)-bomane-10,2-sultam]fumaramide 100 (1 equiv.) in dry THF 
under N 2 at -78  °C. After 3 h at -78  °C the reaction mixture was quenched with sat. aq. 
NH4CI soln. and then poured onto sat. aq. NH4CI soln. The product was extracted with 
ethyl acetate (2 x 20 cm3). The combined organic extracts were dried (MgS04) and 
concentrated under reduced pressure.
8.2.7.3 (2R)- 186 and (2*S)-A,7V-Bis[(21?)-bornane-10,2-sultain]-2-ethylsuccinamide 
187
0,S
186 187
Using ethyl magnesium bromide (7.0 cm3 of a 2 mol dm'3 solution in Et2<3) and 100 
on a 4.0 mmol scale following General procedure 4 produced a residue which was 
chromatographed [Si(>2, EtOAc-hexane (1:1)] to give (27?)-AyV-bis[(2i?)-bomane-10,2- 
sultam]-2-ethylsuccinamide 186 (1.0 g, 56%) and (25)-A,A,-bis[(2R)-bomane-10,2- 
sultam]-2-ethylsuccinamide 187 (0.35 g, 17%) as white plates.
186 (Major): mp 196-199 °C; [a]o -98 (c 1.2, EtOAc); (Found: C, 57.5 H, 7.4 N, 
5.1%; C26H40N 2O6S2 requires C, 57.75 H, 7.5 N. 5.2%); umax(KBr)/cm'' 2965 (CH), 1687 
(amide), 1330 and 1164 (-SO2-N); 8h (400 MHz; CDCI3) 0.93-0.96 (9 H, m, 6H from CCH, 
and 3H from CH3CH2), 1.13 (3 H, s, CC//3), 1.15 (3 H, s, CCH3), 1.24-1.42 (4 H, m, alkyl- 
H), 1.61-1.70 (1 H, m, alkyl-H), 1.78-1.98 (8 H, m, alkyl-H), 2.05-2.18 (3 H, m, alkyl-H)
2.85 (1 H, dd, J  4.4 and 17.0, CHffCHC(O)N), 3.31 (1 H, dd, J  9.0 and 17.0, 
CHtfCHC(O)N), 3.40-3.49 (5 H, m, 2 x C //2SO2 and CH2C//C(0)N ), 3.86 (1 H, t, J  8.0, 
Cfflsi) and 3.95 (1 H, t , ./ 6.3, C/7N); 5C(100 MHz; CDCI3) 11.4 (CH3), 20.3 (2 x CH3),
21.2 (CH3), 21.3 (CH3), 26.0 (CH2), 26.8 (2 x CH2), 33.2 (CH2), 33.3 (CH2), 36.0 (CH2),
38.8 (CH2), 39.0 (CH2), 42.7 (CH), 45.0 (CH), 45.1 (CH), 48.1 (2 x C), 48.7 (Q , 48.9 (O ,
53.3 (CH2), 53.4 (CH2), 65.6 (CH), 65.7 (CH), 170.0 (C=0) and 174.0 (C=0); m/z (El) 540
(M+), 326 (M+-camphorsultam, 100) and 135 (34); (Found fvT 540.2329; C26H40N2O6S2 
requires M4 540.2328).
187 (Minor): mp 115-117 °C; [a]D -104 (c 1.2, EtOAc); (Found: C, 57.6 H, 7.45 N, 
5.2%; C26H4oN20 6S2 requires C, 57.75 H, 7.5 N, 5.2%); umlx(KBr)/cm' 1 2962 (CH), 1693 
(amide), 1333 and 1134 (-SO2-N); 8H(400 MHz; CDCI3) 0.94-0.98 (12 H, m, 9H from 
CCH, and 3H from CH3CH2), 1.15 (3 H, s, CCH3), 1.31-1.44 (4 H, m, alkyl-H), 1.51-1.58 
(1 H, m, alkyl-H), 1.84-2.16 (11 H, m, alkyl-H), 3.00 (1 H, dd, J  5.0 and 17.0, 
CHffCHC(O)N), 3.14 (1 H, dd, J  8.7 and 17.0, CHffCHC(O)N), 3.35-3.51 (5 H, m, 2 x 
CH2 SO2 and CH2C //C(0)N ), 3.82-3.92 (2 H, m, 2 x C//N); 8C(100 MHz; CDC13) 11.8 
(CH3), 20.3 (CH3), 20.4 (CH3), 21.0 (CH3), 21.2 (CH3), 24.5 (CH2), 26.8 (CH2), 26.9 
(CH2), 33.2 (CH2), 33.3 (CH2), 38.2 (CH2), 38.4 (CH2), 38.7 (CH2), 42.8 (CH), 45.0 (2 x 
CH), 48.1 (Q , 48.2 (C), 48.8 (C), 48.9 (C), 53.2 (CH2), 53.5 (CH2), 65.5 (CH), 65.7 (CH),
170.2 (C =0) and 174.2 (C=0); m/z (FAB+) 541 [(M+H)4, 8%], 326 (M4-camphorsultam, 
100) and 135 (24); [Found (FAB+): (M+H)+541.2405; C26H4oN20 6S2 requires 541.2406],
8.2.7.4 (2R)- 188 and (ZS)-AT,,/V'-Bis[(2.R)-bomane-10,2-sultani]-2- 
isopropylsuccinamide 189
188 189
Using isopropyl magnesium chloride (2.7 cm of a 2 mol dm solution in Et20 )  and 
100 on a 1.6 mmol scale following General procedure 4 gave a residue, 0.83 g. A portion 
o f the residue (0.14 g) was chromatographed [S i02, EtOAc-hexane (1:1)] to give (27?)- 
AyV-bis[(2R)-bomane-10,2-sultam]-2-isopropylsuccinamide 188 (81 mg, 58%) and (28)- 
A,,iY-bis[(27?)-bomane-10,2-sultam]-2-isopropylsuccinamide 189 (43 mg, 31%) as white 
plates.
188 (Major): mp 74-78 °C; [<x]d -142 ( c  0.7, EtOAc); tw O CBrycm '1 2962 (CH), 
1691 (amide), 1330 and 1134 (-SO2-N); 6H(400 MHz; CDCI3) 0.86 (3 H, d, J  7.0, 
CH3CHC//3), 0.92 (3 H, s, CCHz), 0.96 (3 H, s, CC//3), 1.02 (3 H, d, J  6.8, CH3CHC//3),
1.15 (6 H, s, CCH,), 1.24-1.42 (4 H, m, alkyl-H), 1.83-1.89 (6 H, m, alkyl-H), 2.00-2.18 (4 
H, m, alkyl-H), 2.27-2.31 (1 H, m, CH2C //C(0)N ), 2.80 (1 H, dd, J  3.7 and 17.0, 
CHTfCHC(O)N), 3.26 (1 H, dd, J  9.6 and 17.0, CHffCHC(O)N), 3.40-3.49 (4 H, m, 2 x
139
C tf2S 0 2), 3.86 (1 H, t, J  5.0, CfflM) and 3.95 (1 H, t, J  5.4, C//N); 8C(100 MHz; CDC13)
17.9 (CH3), 20.3 (2 x CH3), 21.2 (2 x CH3), 21.3 (CH3), 26.9 (2 x CH2), 30.6 (CH), 32.1 
(CH2), 33.2 (CH2), 33.3 (CH2), 38.7 (CH2), 39.1 (CH2), 45.0 (2 x CH), 47.1 (CH), 48.1 (2 
x C), 48.6 (C), 48.9 (C), 53.3 (CH2), 53.5 (CH2), 65.7 (2 x CH), 170.3 (C=0) and 173.8 
(C=0); m/z (FAB+) 555 [(M+H)+, 10%], 340 (M+-camphorsultam, 100) and 135 (20); 
[Found (M+H)+ 555.2565; C27H42N20 6S2 requires 555.2563],
189 (Minor): mp 256-258 °C; [a]D -83 (c 0.7, EtOAc); (Found: C, 58.45 H, 7.5 N, 
5.0%; C27H42N20 6S2 requires C, 58.5 H, 7.6 N, 5.05%); umax(KBr)/cm'1 2965 (CH), 1693 
(amide), 1324 and 1137 (-S 02-N); 5H(400 MHz; CDC13) 0.92-0.96 (9 H  m, 3H from CCHZ 
and 6H from CH3CHCH3), 1.00-1.02 (3 H, m, CC//3), 1.15 (3 H, s, CCH3), 1.26 (3 H, s, 
CCHi), 1.28-1.44 (4 H  m, alkyl-H), 1.83-1.89 (6 H  m, alkyl-H), 1.95-2.05 (3 H, m, alkyl- 
H), 2.15-2.20 (1 H  m, alkyl-H), 2.29-2.33 (1 H  m, CH2CHC(0)N), 2.95 (1 H, dd, J 3 .9  
and 17.0, CHHCHC(O)N), 3.12 (1 H  dd, J  10.0 and 17.0, CHHCHC(O)N), 3.31-3.36 (1 
H, m, CH2CHC(0)N), 3.39-3.50 (4 H, m, 2 x CH2SO2), 3.82-3.86 (1 H, app t, J 6.3, CHH) 
and 3.90-3.92 (1 H, app t, J 6.3, CHN); 8C(100 MHz; CDC13) 17.9 (CH3), 18.8 (CH3), 20.3 
(CH3), 20.5 (CH3), 21.0 (CH3), 21.3 (CH3), 21.7 (CH3), 26.8 (CH2), 26.9 (CH2), 28.7 (CH),
33.2 (CH2), 33.3 (CH2), 34.3 (CH2), 38.5 (CH2), 38.7 (CH2), 45.0 (CH), 46.4 (CH), 48.1 
(C), 48.2 (Q , 48.8 (C), 48.9 (C), 53.2 (CH2), 53.5 (CH2), 65.6 (CH), 65.7 (CH), 170.5 
(C =0) and 173.8 (C=0); m/z (Cl* mode, isobutane) 555 [(M+H)+, 14%], 340 (M*- 
camphorsultam, 100) and 216 (49); [Found (M+H)+ 555.2563; C27H t2N206S2 requires 
555.2563],
8.2.7.5 (2if)- 190 and (2^)-jV,jV-Bis[(2/?)-bornane-10,2-sultain]-2-propylsuccinamide 
191
o,s
191190
Using propyl magnesium bromide (3.5 cm3 o f a 1 mol dm solution in Et20 )  and 
100 on a 1.0 mmol scale following General procedure 4 produced a residue which was 
chromatographed [SiC>2, EtOAc-hexane (1:1)] to give (2R)-A,7V-bis[(2R)-bomane-10,2-
sultam]-2-propylsuccinamide 190 (0.23 g, 43%) and (2*S)-A,A’-bis[(2^)-bomane-10,2- 
sultam]-2-propylsuccinamide 191 (0.14 g, 26%) as white plates.
190 (Major): mp 198-200 °C; [a]D -90 (c 1.0, EtOAc); (Found: C, 58.2 H, 7.6 N, 
5.0%; C27H42N2O6S2 requires C, 58.5 H, 7.6 N, 5.05%); umax(KBr)/cm‘' 2960 (CH), 1685 
(amide), 1335 and 1133 (-SO2-N); 5H(400 MHz; CDCI3) 0.90 (3 H, t, 7  7.2, CH2C //3), 
0.96 (3 H, s, CCHi), 0.98 (3 H, s, CCj¥3), 1.16 (3 H, s, CCHi), 1.17 (3 H, s, CCH3), 1.31-
1.43 (6 H, m, alkyl-H), 1.55-1.60 (3 H, m, alkyl-H), 1.73-1.77 (1 H  m, alkyl-H), 1.86-1.89 
(5 H, m, alkyl-H), 2.07-2.19 (3 H  m, alkyl-H), 2.86 (1 H, dd, 7  4.5 and 17.2, 
CHHCHC(O)N), 3.32 (1 H  dd, 7  8.9 and 17.2, CHHCHC(O)N), 3.41-3.51 (5 H, m, 2 x 
C //2SO2 and CH2C//C(0)N ), 3.87 (1 H, t, 7  7.4, CHH) and 3.95 (1 H, t, 7  6.2, CHH); 
8C(100 MHz; CDC13) 13.9 (CH3), 19.9 (2 x CH3), 19.9 (CH2), 20.8 (CH3), 20.9 (CH3), 26.4 
(2 x CH2), 32.8 (CH2), 32.9 (CH2), 34.5 (CH2), 36.0 (CH2), 38.4 (CH2), 38.6 (CH2), 41.1 
(CH), 44.7 (2 x CH), 47.7 (2 x C), 48.3 (C), 48.5 (C), 52.9 (CH2), 53.0 (CH2), 65.2 (2 x 
CH), 169.6 (C=0) and 173.8 (C=0); m/z (FAB+) 577 [(M+Na)+, 100%] and 340 (MH+- 
camphorsultam, 33); [Found (M+Na)+ 577.2380; C27H42N2O6S2 requires 577.2382],
191 (Minor): mp 187-189 °C; [a]D -88 (e 1.0, EtOAc); (Found: C, 58.2 H  7.7 N, 
5.0%; C27H42N2O6S2 requires C, 58.5 H  7.6 N, 5.05%); u ^ K B ry c m '1 2960 (CH), 1687 
(amide), 1336 and 1136 (-SO2-N); 8H(400 MHz; CDCI3) 0.90 (3 H, t, 7  7.2, CH2CH3), 
0.95-0.97 (6 H  m, C C H ,\ 1.15 (3 H  s, CCH,), 1.25 (3 H  s, CCHi), 1.31-1.51 (7 H  m, 
alkyl-H), 1.78-1.93 (7 H, m, alkyl-H), 1.96-2.16 (4 H  m, alkyl-H), 3.00 (1 H, dd, J  5.2 
and 17.0, CHHCHC(O)N), 3.13 (1 H, dd, J 8.6 and 17.0, CHHCHC(O)N), 3.39-3.51 (5 H  
m, 2 x CH2SO2 and CH2CHC(0)N), 3.83-3.86 (1 H, app t, 76.3, CHN) and 3.88-3.91 (1 H, 
app t, 76 .3 , CHH)-, 8C(100 MHz; CDC13) 14.3 (CH3), 20.3 (CH3), 20.4 (CH3), 20.5 (CH2),
21.0 (CH3), 21.2 (CH3), 26.8 (CH2), 26.9 (CH2), 33.2 (2 x CH2), 33.3 (CH2), 33.4 (CH2),
38.5 (CH2), 38.7 (CH2), 41.2 (CH), 45.0 (2 x CH), 48.1 (C), 48.2 (C), 48.8 (C), 48.9 (C),
53.2 (CH2), 53.5 (CH2), 65.5 (CH), 65.7 (CH), 170.1 (C=0) and 174.4 (C=0); m/z 
(FAB+) 555 [(M+H)+, 6%] and 340 (MH+-camphorsultam, 100); [Found (M+H)+ 
555.2563; C27H42N2O6S2 requires 555.2563].
8.2.7.6 (2R)- 192 and (2SyN,N'-Bis[(2/?)-bornane-10,2-sultam]-2-butyIsuccinamide
193
193192
Using butyl magnesium chloride (1.7 cm3 o f a 2 mol dm'3 solution in Et20) and 100 
on a 1 mmol scale following General procedure 4 produced a residue which was 
chromatographed [Si(>2, EtOAc-hexane (1:1)] to give (2i?)-A,7V'-bis[(2R)-bomane-10,2- 
sultam]-2-butylsuccinamide 192 (0.28 g, 56%) and (2*S)-A,AM)is[(2R)-bomane-10,2- 
sultam]-2-butylsuccinamide 193 (0.1 g, 20%) as white plates.
192 (Major): mp 73-75 °C; [a]D -75 (c 0.88, EtOAc); (Found: C, 59.0 H, 7.7 N, 
4.95%; C28H44N2O6S2 requires C, 59.1 H, 7.5 N, 4.9%); tw C K B rycm '1 2960 (CH), 1690 
(amide), 1333 and 1135 (-S 02-N); 8H(400 MHz; CDCb) 0.86 (3 H, t, J  7.2, CH2C //3), 0.95 
(3 H, s, CCH,), 0.96 (3 H, s, CCtf3), 1.15 (3 H, s, CCHi), 1.16 (3 H, s, CC//3), 1.23-1.42 (8
H, m, alkyl-H), 1.52-1.62 (1 H, m, alkyl-H), 1.72-1.76 (1 H, m, alkyl-H), 1.85-1.88 (6 H, 
m, alkyl-H), 2.05-2.18 (4 H, m, alkyl-H), 2.85 (1 H, dd, J  2.3 and 17.2, CHffCHC(0)N), 
3.31 (1 H, dd, J  9.0 and 17.2, CHffCHC(O)N), 3.40-3.50 (5 H, m, 2 x CH2S 0 2 and 
CH2CffC(0)N), 3.84-3.88 (1 H, app t, J 6 .3 , C //N) and 3.94 (1 H, t, J6 .3 , CHN), 5C(100 
MHz; CDCI3) 14.2 (CH3), 20.3 (2 x CH3), 21.2 (CH3), 21.3 (CH3), 22.9 (CH2), 26.8 (2 x 
CH2), 29.1 (CH2), 32.5 (CH2), 33.2 (2 x CH2), 36.4 (CH2), 38.8 (CH2), 39.0 (CH2), 41.6 
(CH), 45.0 (2 x CH), 48.1 (2 x Q , 48.7 (Q , 48.8 (C), 53.3 (2 x CH2), 65.6 (2 x CH), 170.0 
(C=0) and 174.2 (C=0); m/z (FAB+) 591 [(M+Na)+, 100%] and 354 (MH*- 
camphorsultam, 33); [Found (M+Na)+591.2535; C28HmN206S2 requires 591.2539],
193 (Minor): mp 131-133 °C; [a]D -82 (c 1.0, EtOAc); (Found: C, 58.9 H, 8.0 N, 
4.75%; C28H44N20 6S2 requires C, 59.1 H, 7.8 N, 4.9%); u ^ K B r y c m '1 2960 (CH), 1695 
(amide), 1331 and 1134 (-S 02-N); 8H(400 MHz; CDC13) 0.91 (3 H, t.7 6 .6 , CH2CH3), 0.97 
(3 H, s, CCH3), 0.98 (3 H, s, CCHi), 1.17 (3 H, s, CCtf3), 1.24-1.50 (13 H, m, alkyl-H),
I.86-1.90 (6 H, m, alkyl-H), 1.98-2.18 (4 H, m, alkyl-H), 3.01 (1 H, dd, J  5.0 and 17.0, 
CHtfCHC(O)N), 3.15 (1 H, dd, J  8.5 and 17.0, CHtfCHC(O)N), 3.41-3.53 (5 H, m, 2 x 
CH2 SO2  and CH2C//C(0)N ), 3.86 (1 H, t, J  7.1, CHN) and 3.91 (1 H, t, J  7.3, C77N); 
8C(100 MHz; CDC13) 14.2 (CH3), 20.3 (CH3), 20.4 (CH3), 20.9 (CH3), 21.2 (CH3), 23.0
(CH2), 26.8 (CH2), 26.9 (CH2), 29.4 (CH2), 31.0 (CH2), 33.2 (CH2), 33.3 (CH2), 38.4 
(CH2), 38.5 (CH2), 38.7 (CH2), 41.5 (CH), 45.0 (2x  CH), 48.1 (C), 48.2 (C), 48.8 (C), 48.9 
(C), 53.3 (CH2), 53.5 (CH2), 65.5 (CH), 65.7 (CH), 170.1 (C=0) and 174.4 (C=0); m/z 
(FAB+) 569 [(M+H)+, 4%] and 354 (MFC-camphorsultam, 100); [Found (M+H)+ 
569.2717; C28H44N20 6S2 requires 569.2719].
8.2.7.7 (2/?)- 194 and (2iS)-A/,Ar-Bis[(2/?)-bornane-10,2-sultam]-2- 
cyclohexylsuccinamide 195
195194
Using cyclohexyl magnesium chloride (6.8 cm3 of a 2 mol dm'3 solution in Et20 )  
and 100 on a 3.9 mmol scale following General procedure 4 afforded a mixture o f 
diastereoisomers 2.52 g. A portion (0.5 g) was chromatographed [S i02, EtOAc-hexane 
(1:1)] to give (2/?)-A,jV,-bis[(2K)-bornane-10,2-sultam]-2-cyclohexylsuccinamide 194 
(0.28g, 56%) and (25)-A,jV,-bis[(2R)-bomane-10,2-sultam]-2-cyclohexylsuccinamide 195 
(0.1 lg, 22%) as white plates.
194 (Major): mp 180-183 °C; [ cx] d  -80 (c 1.0, EtOAc); (Found: C, 60.4 H, 7.9 N, 
4.7%; C30H46N2O6S2 requires C, 60.6 H, 7.8 N, 4.7%); rwCKBrycm '1 2927 (CH), 1686 
(amide), 1333 and 1134 (-S 02-N); 5H(400 MHz; CDC13) 0.86-1.42 (20 H, m, alkyl-H), 
1.60-1.73 (6 H, m, alkyl-H), 1.84-1.89 (7 H, m, alkyl-H), 2.00-2.18 (4 H, m, alkyl-H), 2.83 
(1 H, dd, 7 4 .0  and 17.0, CHflCHC(O)N), 3.25 (1 H, dd, 79 .3  and 17.0, CH//CHC(0)N),
3.39-3.55 (5 H, m, 2 x C ftS O jan d  CH2CtfC(0)N ), 3.86 (1 H, app t, 76.3, CtfN) and 3.94 
(1 H, t, 76 .2 , C7N); 8C(100 MHz; CDCI3) 20.3 (2 x CH3), 21.0 (CH3), 21.2 (CH3), 26.4 
(CH2), 26.8 (2 x CH2), 27.0 (CH2), 28.7 (CH2), 31.4 (CH2), 33.1 (CH2), 33.3 (CH2), 38.8 
(CH2), 39.0 (2 x CH2), 40.8 (CH), 45.0 (CH), 48.1 (CH), 48.6 (2 x C), 48.8 (2 x C), 53.3 
(CH2), 53.4 (CH2), 65.6 (CH), 65.7 (CH), 170.2 (C=0) and 173.6 (C=0); m/z (CI/NH3) 
612 (M+NH,+), 42%), 595 (MH+, 38), 380 (M H+-camphorsultam, 63) and 233 (100).
195 (Minor): mp 244-246 °C; [a]D -84 (c 1.0, EtOAc); (Found: C, 60.65 H, 7.9 N, 
4.8%; C30H46N2O6S2 requires C, 60.6 H, 7.8 N, 4.7%); tw ^K B rycm '1 2929 (CH), 1684 
(amide), 1327 and 1136 (-SO2-N); 8H(400 MHz; CDCb) 0.96-1.43 (21 H, m, alkyl-H),
1.56-2.19 (16 H, m, alkyl-H), 2.97 (1 H, dd, J  4.1 and 17.0, CHtfCHC(O)N), 3.11 (1 H, 
dd, J 9.7 and 16.8, CHtfCHC(O)N), 3.29-3.31 (1 H, m, CH2CtfC(0)N), 3.39-3.51 (4 H, m, 
2 x CH2S 0 2 ), 3.84 (1 H, app t, J  6.2, CHN) and 3.92 (1 H, app t, J  6 .2, C7/N); 5C(100 
MHz; CDC13) 20.3 (CH3), 20.5 (CH3), 21.0 (CH3), 21.3 (CH3), 26.6 (CH2), 26.7 (CH2),
26.8 (2 x CH2), 27.1 (CH2), 28.7 (CH2), 32.1 (CH2), 33.2 (CH2), 33.4 (CH2), 35.2 (CH2),
38.6 (CH2), 38.7 (CH2), 38.9 (CH), 45.0 (CH), 45.1 (CH), 46.4 (CH2), 48.1 (2 x Q , 48.7 
(C), 48.9 (C), 53.2 (CH2), 53.5 (CH2), 65.6 (CH), 65.8 (CH), 170.4 (C =0) and 173.6 
(C=0); m/z (FAB+) 595 [(M+H)+, 4%] and 380 (MtC-camphorsultam, 100); [Found 
(M+H)+595.2878; C3oH46N20 6S2 requires 595.2876].
8.2.7.8 (2/?)- 196 and (2*S)-AyV-Bis[(2/?)-bornane-10,2-sultam]-2-octylsuccinamide 
197
196 197
Using octyl magnesium bromide (6.8 cm3 o f a 2 mol dm'3 solution in Et20 )  and 100 
on a 3.9 mmol scale following General procedure 4 produced a mixture o f 
diastereoisomers 2.76 g. A portion (0.5 g) was chromatographed [Si02, EtOAc-hexane 
(1:1)] to give (2i?)-A,7V'-bis[(27?)-bomane-10,2-sultam]-2-octylsuccinamide 196 (0.39 g, 
78%) as white plates and (2*S)-A,A,-bis[(2R)-bomane-10,2-sultam]-2-octylsuccinamide 197 
(93 mg, 19%) as a colourless oil.
196 (Major): mp 160-163 °C; [a]D -76 (c 1.2, EtOAc); (Found: C, 61.5 H, 8.3 N, 
4.5%; C33H52N 2O6S2 requires C, 61.5 H, 8.4 N, 4.5%); umax(KBr)/cm‘‘ 2923 (CH), 1683 
(amide), 1331 and 1134 (-S 02-N); 8H(400 MHz; CDC13) 0.87 (3 H, t, J7 .1 , CH2Ctf3), 0.95 
(3 H, s, CCHi), 0.96 (3 H, s, C C//3), 1.15 (3 H, s, CC//3), 1.16 (3 H, s, CCH3\  1.23-1.42 
(19 H, m, alkyl-H), 1.73-1.79 (1 H, m, alkyl-H), 1.85-1.88 (5 H, m, alkyl-H), 2.05-2.15 (3 
H, m, alkyl-H), 2.85 (1 H, dd, J  4.6 and 17.1, CHffCHC(O)N), 3.30 (1 H, dd, J  9,0 and
17.1, CHtfCHC(O)N), 3.44-3.50 (5 H, m, 2 x C //2S 0 2and CH2C//C(0)N ), 3.84-3.87 (1 H, 
app t, J6 .3 , CHH) and 3.94 (1 H, t, J6 .3 , C//N); 8C(100 MHz; CDCb) 14.5 (CH3), 20.3 (2 
x CH3), 21.2 (CH3), 21.3 (CH3), 23.0 (CH2), 26.8 (2 x CH2), 26.9 (CH2), 29.6 (CH2), 29.7 
(CHj), 29.9 (CH2), 32.2 (CH2), 32.9 (CH2), 33.2 (CH2), 33.3 (CH2), 36.4 (CH2), 38.8
(CH2), 38.9 (CH2), 41.7 (2 x CH), 45.1 (CH), 48.1 (2 x C), 48.7 (C), 48.8 (C), 53.3 (CH2),
53.4 (CH2), 65.6 (CH), 65.7 (CH), 170.0 (C=0) and 174.2 (C=0); m/z (El) 624 (M+), 410 
(M*-camphorsultam, 100%) and 135 (30); [Found M* 624.3260; C32Hs2N 206S2 requires 
M+ 624.3267],
197 (Minor): [<x]d -83 ( c  1.2, EtOAc); umax(KBr)/cm'1 2932 (CH), 1678 (amide), 
1332 and 1134 (-S 02-N); 8H(400 MHz; CDCb) 0.87 (3 H, t, 77 .0 , CH2C # 3), 0.96 (3 H, s, 
C C #,), 0.97 (3 H, s, CCHi), 1.16 (3 H, s, CCHi), 1.26-1.49 (21 H, m, alkyl-H), 1.85-2.18 
(10 H, m, alkyl-H), 3.00 (1 H, dd, 75.1 and 17.0, CH#CHC(0)N), 3.14 (1 H, dd, 78 .5  and 
17.0, CHffCHC(O)N), 3.40-3.52 (5 H, m, 2 x C # 2S 0 2 and CH2C #C(0)N ), 3.85 (1 H, app 
t, 7 6 .2 , CHN) and 3.90 (1 H, app t, 76 .2 , C#N); 8C(100 MHz; CDCb) 14.1 (CH3), 19.9 
(CH3), 20.0 (CH3), 20.5 (CH3), 20.8 (CH3), 22.6 (CH2), 26.4 (CH2), 26.5 (CH2), 26.9 
(CH2), 29.2 (CH2), 29.3 (CH2), 29.5 (CH2), 30.9 (CH2), 31.8 (CH2), 32.8 (CH2), 32.9 
(CH2), 38.0 (CH2), 38.1 (CH2), 38.3 (CH2), 41.1 (CH), 44.6 (2 x CH), 47.7 (C), 47.8 (C),
48.4 (C), 48.5 (C), 52.9 (CH2), 53.1 (CH2), 65.1 (CH), 65.3 (CH), 169.8 (C =0) and 174.0 
(C O ) ;  m/z (FAB+) 647 [(M+Na)+, 5%], 147 (42) and 73 (100); [Found (M+Na)+ 
647.3166; C32H52N20 6S2 requires 647.3165],
8.2.7.9 (2/f)-;V, V'-His[(2/i)-boriiane-10,2-sultain]-2-benzylsuccinamide 198
198
Using benzyl magnesium chloride (7.0 cm of a 2 mol dm solution in Et20 )  and 
100 on a 4.0 mmol scale following General procedure 4 produced a mixture which was 
chromatographed [S i02, EtOAc-hexane (1:1)] to give (2R)-A.A'-bis[(2R)-bomane-10,2- 
sultam]-2-benzylsuccinamide 198 (1.7 g, 71 %) as white plates, mp 191-193 °C; [a]o -70 
(c 1.0, EtOAc); (Found: C, 61.6 H, 7.1 N, 4.6%; C3iH42N20 6S2 requires C, 61.8 FI, 7.0 N, 
4.65%); umax(KBr)/cm‘1 2958 (CH), 1685 (amide), 1333 and 1135 (-S 02-N); 8H(400 MHz; 
CDCb) 0.92 (3 H, s, C C #3), 0.93 (3 H, s, CCHi), 0.98 (3 H, s, C C #3), 1.07 (3 H, s, 
CCHi), 1.22-1.37 (4 H, m, alkyl-H), 1.80-1.86 (6 H, m, alkyl-H), 2.00-2.06 (4 H, m, alkyl- 
H), 2.67 (1 H, dd, 7  9.4 and 13, ArCCHfl), 2.74 (1 H, dd, 75 .2  and 17.5 CH#CHC(0)N),
3.22 (1 H, dd, J  7.5 and 13, ArCCHff), 3.32 (1 H, dd, J 8 .3  and 17.4, CHtfCHC(O)N), 
3.42-3.51 (4 H, m, 2 x C //2S 0 2), 3.82-3.87 (3 H, m) and 7.17-7.37 (5 H, m, Ar-CH); 
5C(100 MHz; CDC13) 20.3 (2 x CH3), 21.2 (CH3), 21.3 (CH3), 26.8 (2 x CH2), 33.2 (CH2),
33.3 (CH2), 36.3 (CH2), 38.8 (2 x CH2), 43.6 (CH), 45.0 (2 x CH), 48.1 (2 x C), 48.7 (C),
48.8 (C), 53.2 (2 x CH2), 53.4 (CH2), 65.5 (CH), 65.6 (CH), 127.1 (ArCH), 128.9 (2 x 
ArCH), 129.8 (2 x ArCH), 138.2 (A rQ , 169.9 (C =0) and 173.5 (C=0); m/z (El) 602 (M+, 
8%), 346 (100) and 135 (76); [Found M4"602.2487; C3iH42N20 6S2 requires 602.2484],
8.2.7.10 (2R)- 199 and (2A)-AyV'-Bis[(2fl)-bornane-10,2-sultam]-2-
isobutylsuccinamide 200
200199
Using isobutyl magnesium bromide (6.8 cm o f a 2 mol dm' solution in Et20) and 
100 on a 3.9 mmol scale following general procedure 4 produced a mixture o f 
diastereoisomers 2.26 g. A portion (0.5 g) was chromatographed [SiC>2, EtOAc-hexane 
(1:1)] to give (2J^)-jV,A,-bis[(2R)-bornane-10,2-sultam]-2-isobutylsuccinamide 199 (0.16 g, 
32%) and (26)-A,A'-bis[(27?)-boraane-10,2-sultam]-2-isobutylsuccinamide 200 (96 mg, 
19%) as white plates.
199 (Major): mp 239-241 °C; [a]D -76 (c 1.0, EtOAc); (Found: C, 59.1 H, 7.75 N, 
4.9%; C28H44N20 6S2 requires C, 59.1 H, 7.8 N, 4.9%); iw ^K B rycm ’1 2958 (CH), 1685 
(amide), 1333 and 1164 (-S 02-N); 6H(400 MHz; CDC13) 0.90-0.96 (12 H, m), 1.15 (3 H, s, 
CCHi), 1.16 (3 H, s, CCHi), 1.20-1.46 (5 H, m, alkyl-H), 1.59-1.69 (2 H, m, alkyl-H), 
1.84-1.92 (6 H, m, alkyl-H), 2.05-2.19 (4 H, m, alkyl-H), 2.86 (1 H, dd, J  5.2 and 17.2, 
CHHCHC(O)N), 3.26 (1 H, dd, J  8.4 and 17.2, CHHCHC(O)N), 3.40-3.57 (5 H, m, 2 x 
CH2 SO2 and CH2C //C(0)N ), 3.84-3.88 (1 H, app t, J  6.3, C //N) and 3.94 (1 H, t, J  6.3, 
CHH)\ 5C(100 MHz; CDC13) 20.3 (2 x CH3), 21.2 (CH3), 21.3 (CH3), 21.9 (CH3), 23.6 
(CH3), 26.1 (CH), 26.8 (2 x CH2), 33.2 (CH2), 33.3 (CH2), 36.5 (CH2), 38.8 (CH2), 38.9 
(CH2), 40.0 (CH), 41.6 (CH2), 45.1 (2 x CH), 48.1 (2 x C), 48.7 (Q , 48.8 (Q , 53.3 (CH2),
53.4 (CH2), 65.7 (2 x CH), 170.0 (C=Q) and 174.6 (C=Q); m/z (FAB+) 591 [(M+Na)+,
100%] and 354 (MH+-camphorsultam, 15); [Found (M+Na)+ 591.2536; C28H44N2O6S2 
requires 591.2539],
200 (Minor): mp 208-210 °C; [<x]D -80 (c 1.0, EtOAc); (Found: C, 59.05 H, 7.9 N, 
4.9%; C28H44N2O6S2 requires C, 59.1 H, 7.8 N, 4.9%); umax(KBr)/cm'1 2960 (CH), 1685 
(amide), 1336 (-SO2-N); 8H(400 MHz; CDC13) 0.89-0.97 (12 H, m, alkyl-H), 1.15 (3 H, s, 
CCHi), 1.25 (3 H, s, CCHi), 1.29-1.43 (5 H, m, alkyl-H), 1.61-1.68 (2 H, m, alkyl-H), 
1.73-1.80 (1 H, m, alkyl-H), 1.84-1.89 (6 H, m, alkyl-H), 1.94-2.16 (4 H, m, alkyl-H), 3.00 
(1 H, dd, J  5.5 and 17.0, CHffCHC(O)N), 3.09 (1 H, dd, J 7 .9  and 17.0, CH//CHC(0)N),
3.39-3.54 (5 H, m, 2 x CH2SCh and CH2C //C(0)N ), 3.84 (1 H, app t, J 6.2 CHH) and 3.88 
(1 H, app t, J  6 .2, CHH); 6C(100 MHz; CDCI3) 20.3 (CH3), 20.4 (CH3), 20.9 (CH3), 21.2 
(CH3), 22.0 (CH3), 23.5 (CH3), 26.0 (CH), 26.8 (CH2), 26.9 (CH2), 33.2 (CH2), 33.3 (CH2),
38.4 (CH2), 38.5 (CH2), 38.7 (CH2), 39.7 (CH), 40.0 (CH2), 45.0 (2 x CH), 48.1 (C), 48.2 
(C), 48.8 (C), 48.9 (Q , 53.3 (CH2), 53.5 (CH2), 65.6 (CH), 65.7 (CH), 170.1 (C =0) and 
174.5 (C=0); m/z (FAB+) 591 [(M+Na)+, 38%] and 354 (MFC-camphorsultam, 100); 
[Found (M+Na)+ 591.2540; C28H44N2O6S2 requires 591.2539],
8.2.7.11 (21?)- 201 and (25)-A^iV-Bis[(21?)-bornane-10,2-sultam]-2-
hexylsuccinamide 202
201 202
Using hexyl magnesium bromide (6.8 cm o f a 2 mol dm' solution in Et20) and 
100 on a 3.9 mmol scale following General procedure 4 produced a mixture of 
diastereoisomers 2.58 g. A portion (0.5 g) was chromatographed [SiC>2, EtOAc-hexane 
(1:1)] to give (2/?)-A,A'-bis[(2R)-bomane-10,2-sultam]-2-hexylsuccinamide 201 (0.31 g, 
62%) and (2*S)-AyV-bis[(21?)-bomane-10,2-sultam]-2-hexylsuccinamide 202 (89 mg, 18%) 
as white plates.
201 (Major): mp 164-166 °C; [a]D -60 (c 1.0, EtOAc); (Found: C, 60.2 H, 8.1 N, 
4.7%; C3oH48N 206S2 requires C, 60.4 H, 8.1 N, 4.7%); umax(KBr)/cm'‘ 2960 (CH), 1685 
(amide), 1330 and 1164 (-SO2-N); 8H(400 MHz; CDC13) 0.87 (3 H, t, J  7.0, CH2CH3), 
0.96 (3 H, s, CCHi), 0.97 (3 H, m, CCH i), 1.16 (3 H, s, CCH3), 1.17 (3 H, s, CCH 3), 1.24-
147
1.48 (11 H, m, alkyl-H), 1.54-1.62 (4 H, m, alkyl-H), 1.71-1.78 (1 H, m, alkyl-H), 1.85- 
1.92 (5 H, m, alkyl-H), 2.06-2.18 (4 H, m, alkyl-H), 2.86 (1 H, dd, J  4.6 and 17.1, 
CHtfCHC(O)N), 3.31 (1 H, dd, J  9 and 17.1, CHtfCHC(O)N), 3.45-3.55 (4 H, m, 2 x 
C tf2S 0 2), 3.86 (1 H, app t, J  6.3, C7/N) and 3.95 (1 H, t, J  6.3, CtfN); 5C(100 MHz; 
CDC13) 13.8 (CH3), 19.7 (2 x CH3), 20.6 (CH3), 20.7 (CH3), 22.3 (CH2), 26.2 (CH2), 26.3 
(CH2), 28.9 (CH2), 31.4 (2 x CH2), 32.3 (CH2), 32.6 (CH2), 32.7 (CH2), 35.8 (CH2), 38.2 
(CH2), 38.3 (CH2), 41.1 (CH), 44.5 (2 x CH2), 47.5 (2 x C), 48.1 (C), 48.2 (C), 52.7 (CH2),
52.8 (CH2), 65.0 (CH), 65.1 (CH), 169.4 (C=0) and 173.6(C=0); m/z (FAB+) 597 
[(M+H)+, 10%] and 382 (MFC-camphorsultam, 100); [Found (M+H)+ 597.3033; 
C3oH4gN206S2 requires 597.3032].
202 (Minor): mp 76-78 °C; [a]D -66 (c 1.0, EtOAc); (Found: C, 60.55 H, 8.3 N, 
4.6%; C3oH48N20 6S2 requires C, 60.4 H, 8.1 N, 4.7%); ^ ( K B ^ / c m '1 2958 (CH), 1693 
(amide), 1333 and 1134 (-S 02-N); 6H(400 MHz; CDC13) 0.86 (3 H, t, 76 .9 , CH2CH3), 0.95 
(3 H, s, CCHi), 0.97 (3 H, s, CCH3), 1.16 (3 H, s, CCH3), 1.20-1.48 (14 H, m, alkyl-H), 
1.58 (4 H, s, alkyl-H), 1.85-1.94 (6 H, m, alkyl-H), 1.98-2.16 (4 H, m, alkyl-H), 3.00 (1 H, 
dd, 7  5.1 and 17.0, CHtfCHC(O)N), 3.14 (1 H, dd, 7  8.5 and 17.0, CHtfCHC(O)N), 3.39- 
3.52 (4 H, m, 2 x CH2S 0 2), 3.85 (1 H, t, 76.2, CHN) and 3.90 (1 H, t, 76.2, CHN); 5C(100 
MHz; CDC13) 14.0 (CH3), 19.8 (CH3), 20.0 (CH3), 20.5 (CH3), 20.8 (CH3), 22.5 (CH2),
26.4 (2 x CH2), 26.8 (CH2), 29.1 (CH2), 30.9 (CH2), 31.5 (CH2), 32.7 (CH2), 32.8 (CH2),
37.9 (CH2), 38.0 (CH2), 38.2 (CH2), 41.1 (CH), 44.6 (2 x CH), 47.7 (2 x C), 48.4 (C), 48.5 
(C), 52.8 (CH2), 53.0 (CH2), 65.1 (CH), 65.2 (CH), 169.7 (C=0) and 173.9 (C=0); m/z 
(FAB+) 619 [(M+Na)+, 100%] and 382 (MFC-camphorsultam, 25); [Found (M+Na)+ 
619.2855; C3oH4gN206S2 requires 619.2852].
8.2.7.12 (2/?)- 203 and (25)-A,A^r-Bis[(2/?)-bornane-10,2-sultam]-2-
cyclohexylhexylmethylsuccinamide 204
OoS
204203
* • 1  o  ( t
Using cyclohexylmethyl magnesium bromide (6.8 cm of a 2 mol dm' solution in 
Et20 )  and 100 on a 3.9 mmol scale following General procedure 4 produced a mixture of
diastereoisomers 2.37 g. A portion (0.5 g) was chromatographed [S i02, EtOAc-hexane 
(1:1)] to give (2R)-A,A,-bis[(2/?)-bomane-10,2-sultam]-2-cyclohexylmethylsuccinamide 
203 (0.28 g, 56%) and (2*S)-A,A,-bis[(2/?)-bomane-10,2-sultam]-2-
cyclohexylmethylsuccinamide 204 (94 mg, 19%) as white plates.
203 (Major): mp 214-216 °C; [<x]D -60 (c 1.0, EtOAc); (Found: C, 61.0 H, 8.2 N, 
4.7%; C31H48N2O6S2 requires C, 61.15 H, 7.95 N, 4.6%); umax(KBr)/cm‘‘ 2924 (CH), 1685 
(amide), 1334 and 1164 (-S 02-N); 5h(400M H z; CDCb) 0.87-0.96 (8 H, m, alkyl-H), 1.07-
1.18 (8 H, m, alkyl-H) 1.24-1.42 (6 H, m, alkyl-H), 1.60-1.76 (7 H, m, alkyl-H), 1.84-1.93 
(5 H, m, alkyl-H), 2.05-2.19 (5 H, m, alkyl-H), 2.85 (1 H, dd, 7  5.3 and 17.2, 
CHffCHC(O)N), 3.25 (1 H, dd, 7  8.2 and 17.2, CHffCHC(O)N), 3.41-3.50 (4 H, m, 2 x 
CH2S02), 3.71 (1 H, m, CH2C/?C(0)N), 3.87 (1 H, app t, 76 .4 , CHN) and 3.93 (1 H, t, 7
6.3, CHN); 5C(100 MHz; CDCb) 20.3 (2 x CH3), 21.3 (2 x CH3), 26.4 (CH2), 26.6 (CH2),
26.8 (CH2), 26.9 (2 x CH2), 32.6 (CH2), 33.2 (CH2), 33.3 (CH2), 34.1 (CH2), 35.5 (CH),
36.7 (CH2), 38.8 (CH2), 38.9 (CH2), 39.2 (CH), 40.4 (CH2), 45.1 (2 x CH), 48.1 (2 x Q ,
48.7 (C), 48.8 (C), 53.3 (CH2), 53.4 (CH2), 65.7 (2 x CH), 170.0 (C=0) and 174.8 (C=0); 
m/z (FAB+) 609 [(M+H)+, 20%] and 394 (MFC-camphorsultam, 100); [Found (M+H)+ 
609.3032; C3iH4gN206S2 requires 609.3032].
204 (Minor): mp 101-103 °C; [a]D -86 (c 1.0, EtOAc); (Found: C, 61.3 H, 8.0 N, 
4.7%; C3iH48N 20 6S2 requires C, 61.15 H, 7.95 N, 4.6%); UmxOCBrycm'1 2935 (CH), 1687 
(amide), 1328 and 1136 (-S 0 2-N); 5h(400M H z; CDCb) 0.89 (8 H, m, alkyl-H), 1.11-1.44 
(14 H, m, alkyl-H) 1.58-1.89 (12 H, m, alkyl-H), 1.98-2.18 (5 H, m, alkyl-H), 2.99 (1 H, 
dd, 7  5.4 and 17.0, C //2CHC(0)N), 3.10 (1 H, dd, 7 7 .8  and 17.0, CHffCHC(O)N), 3.39- 
3.55 (5 H, m, 2 x C tf2S 0 2 and CH2C//C(0)N ), 3.85 (1 H, t, 76.2, CHN) and 3.90 (1 H, t, 7
6.1, CHN); 8C(100 MHz; CDCb) 19.8 (CH3), 20.0 (CH3), 20.5 (CH3), 20.7 (CH3), 26.0 
(CH2), 26.1 (CH2), 26.4 (2 x CH2), 26.5 (2 x CH2) 32.3 (CH2), 32.7 (CH2), 32.8 (CH2),
33.7 (CH2), 34.9 (CH), 38.0 (CH2), 38.1 (CH2), 38.3 (2 x CH2), 38.5 (CH), 44.5 (CH), 44.6 
(CH), 47.7 (Q , 48.4 (2 x Q , 52.8 (CH2), 53.0 (CH2), 65.1 (CH), 65.2 (CH), 169.6 (C=0) 
and 174.2 (C=0). m/z (FAB+) 609 [(M+H)+, 38%] and 394 (MH+-camphorsultam, 100); 
[Found (M+H)+609.3031; C3iH48N20 6S2 requires 609.3032],
8.3 Experimental for Chapter 5
8.3.1 Synthesis of enantiomerically enriched 2-substituted butane-1,4- 
diols
General procedure 5 for the reduction of 2-substituted succinamides into 2- 
substituted butane-1,4-diols.
- j
The 2-substituted succinamide mixtures (0.5 g) in dry THF (10 cm ) was added 
dropwise to a stirred solution o f lithium aluminium hydride (5 equiv.) in dry THF (50 cm3) 
under N2 at 0 °C. After 3 h at 0 °C the reaction mixture was quenched with sat. aq. NH4CI 
soln. (2 cm ). The mixture was filtered and concentrated under reduced pressure.
8.3.1.1 (2/?)-2-Ethylbutane-1,4-diol 22989
HO,
229
Using the mixture o f 186 and 187 (0.8 g, 1.5 mmol) in General procedure 5 gave a 
mixture o f diol and chiral sultam (0.72 g) which was chromatographed [Si02, acetone- 
hexane (1:1)] to give (2/?)-2-ethylbutane-l,4-diol 229 (80 mg, 39%) as a colourless oil. 
[a]D +12 (c 1.5, CHCI3) [lit.89+14.3, (c 1.5, CHCI3)]; 5H(400 MHz; CDC13) 0.92 (3 H, t, J
7.4, CH2Ctf3), 1.25-1.43 (2 H, m, Ci72CH3), 1.55-1.62 (2 H, m, Ctf2CH2OH), 1.67-1.76 (1 
H, m, CH), 3.00 (2 H, br s, OH), 3.49 (ABX system, 1 H, dd, J  6.7 and 10.8 Hz, 
CHCH//OH), 3.63-3.68 (2 H, m, CH2Ctf2OH) and 3.76-3.81 (1 H, m, CHCH/70H).
8.3.1.2 (2/?)-2-Isopropylbutane-l,4-diol 230109
230
Using the mixture o f 188 and 189 (0.5 g, 0.9 mmol) in General procedure 5 gave a 
mixture (0.24 g) which was chromatographed [Si02, acetone-hexane (2:3)] to give (2R)-2- 
isopropylbutane-l,4-diol 230 (0.05 g, 43 %) as a colourless oil. [a]o -3.3 (c 1.0, MeOH) 
[lit.109-10, (c 1.0, MeOH)]; 8H(400 MHz; CDC13) 0.88 (3 H, d, J7 .2 , CHCff,), 0.89 (3 H,
d, J 7.2, CHCtf3), 1.44-1.61 (2 H, m, C tf2CH2OH), 1.68-1.79 (2 H, m, CH3 CHCH), 3.20 (2 
H, br s, OH), 3.54 (ABX system, 1 H, dd, J 7.8 and 10.6, CHCH/70H), 3.60-3.70 (2 H, m, 
CH2C/72OH), 3.77-3.82 (ABX system, 1 H, m, CHCH//OH).
8.3.1.3 (2/?)-2-Propylbutane-l,4-diol 231109
H O.
OH
231
Using the mixture o f 190 and 191 (0.5 g, 0.9 mmol) in General procedure 5 gave a 
mixture (0.18 g) which was chromatographed [S i02, acetone-hexane (1:1)] to give (2 K)-2 - 
propylbutane-l,4-diol 231 (0.06 g, 46%) as a colourless oil. [cc]d -1 ( c  1.1, MeOH) (lit.109 
-3.6, [c 2.12, MeOH]); 8H(400 MHz; CDC13) 0.93 (3 H, t, J  6.9, CH2Ctf3), 1.21-1.37 (4 H, 
m, CH3CH2CH2), 1.55-1.75 (3 H, m, CHCH2CH2OH), 2.63 (2 H, br s, OH), 3.49 (ABX 
system, 1 H, dd, J  7.0 and 10.8, CHCH//OH), 3.64-3.71 (2 H, m, CH2C //2OH) and 3.76- 
3.81 (ABX system, 1 H, m, CHCH//OH),
8.3.1.4 (2/?)-2-Butylbutane-l,4-diol 232
232
Using the mixture o f 192 and 193 (0.5 g, 0.9 mmol) in General procedure 5 gave a 
mixture (0.17 g) which was chromatographed [S i02, acetone-hexane (2:3)] to give (2R)-2- 
butylbutane-l,4-diol 232 (73 mg, 56%) as a colourless oil. [a]D -1 (c 1.5, EtOH); 
UmaxfNaCiycm'1 3410 (OH), 2946 (CH), 1466 (OH), and 1041 (C-O); 6H(400 MHz; 
CDCb) 0.89 (3 H, t, J  6.8, CH2CH3), 1.21-1.34 (6 H, m, alkyl-H), 1.52-1.73 (3 H, m, 
CHCH2CH2OU), 3.39 (2 H, br s, OH), 3.45 (ABX system, 1 H, dd, J  6.8 and 10.4, 
CHCHffOH), 3.60-3.65 (2 H, m, CH2Ctf2OH) and 3.73-3.78 (ABX system, 1 H, m, 
CHCHffOH); 8C(100 MHz; CDCb) 14.2 (CH3), 23.1 (CH2), 29.5 (CH2), 31.6 (CH2), 36.0 
(CH2), 39.6 (CH), 61.2 (CH2), 66.5 (CH2); m/z (CI+ mode, isobutane) 147 (M H \ 21%) and 
57 (100); (Found M H 1147.1384; C8H l80 2 requires 147.1385).
8.3.1.5 (2/?)-2-Cyclohexylbutane-l,4-diol 233
HO. / s .
o h
233
Using the mixture o f 194 and 195 (0.5 g, 0.8 mmol) in General procedure 5 gave a 
mixture (0.44 g) which was chromatographed [Si02, acetone-hexane (2:3)] to give (2R)-2- 
cyclohexylbutane-l,4-diol 233 (53 mg, 38%) as a colourless oil. [cx]d -7.6 (c 0.5, EtOH); 
\)m«(NaCl)/cm‘‘ 3336 (OH). 2921, 1448 (OH), and 1041 (C-O); 5H(400 MHz; CDCI3) 
0.95-1.74 (14 H, m, alkyl-H), 3.52 (ABX system, 1 H, dd, J 6 .8  and 17.6, CHCH//OH),
3.56-3.62 (1 H, m, CH2CH//OH), 3.66 (ABX system, 1 H, dd, J  4.0 and 10.8, 
CHCH//OH), 3.73-3.78 (1 H, m, CH2CH//OH); 8C(100 MHz; CDC13) 26.6 (CH2), 26.7 (2 
x CH2), 30.0 (CH2), 30.1 (CH2), 33.4 (CH2), 40.1 (CH), 45.0 (CH), 61.7 (CH2), 64.8 
(CH2); m/z (FAB+) 173 (MH+, 100%) and 155 (27); (Found MH+ 173.1541; Ci0H20O2 
requires 173.1542).
8.3.1.6 (2/?)-2-Octylbutane-l,4-dioI 234
HCL
OH
(CH2)7Me
234
Using the mixture o f 196 and 197 (0.6 g, 1.0 mmol) in General procedure 5 gave a 
mixture (0.45 g) which was chromatographed [Si02, acetone-hexane (2:3)] to give (2R)-2- 
octylhexylbutane-l,4-diol 234 (0.15 g, 79%) as a colourless oil. [oi]d +0.5 (c 0.2, EtOH); 
W N a C iy c m -1 3328 (OH), 2924 (CH), 1465 (OH), and 1041 (C-O); 5H(400 MHz; 
CDCb) 0.89 (3 H, t, J  7.0, CH2CH3), 1.26-1.33 (15 H, m, alkyl-H), 1.57-1.77 (2 H, m, 
C //2CH2OH), 2.62 (2 H, br s, OH), 3.52 (ABX system, 1 H, dd, J  6.8 and 10.7, 
CHCHtfOH), 3.68-3.73 (2 H, m, CH2C //2OH), 3.79-3.85 (ABX system, 1 H, m, 
CHCHffOH); 8C(100 MHz; CDCb) 14.1 (CH3), 22.6 (CH2), 27.1 (CH2), 29.3 (CH2), 29.5 
(CH2), 29.9 (CH2), 31.7 (CH2), 31.9 (CH2), 35.8 (CH2), 39.3 (CH), 61.3 (CH2) and 66.4 
(CH2); m/z (El) 202 (M+, 3%), and 154 (100); (Found M+ 202.1934; Ci2H260 2 requires 
202.1933).
8.3.1.7 (2/?)-2-Benzylbutane-l,4-diol 235
235
Using the mixture o f 198 and other diastereomer (0.6 g, 1.0 mmol) in General 
procedure 5 gave a mixture (0.60 g) which was chromatographed [SiC>2, acetone-hexane 
(2:3)] to give (2K)-2-benzylbutane-l,4-diol 235 (0.15 g, 75%) as a colourless oil. [a]o +6.6 
(c 1.5, EtOAc); umlx(NaCl)/cm'1 3348 (OH), 2927 (CH), 1603 (Aromatic ring), 1454 (OH), 
and 1043 (C-O); 8H(400 MHz; CDC13) 1.56-1.75 (2 H, m, ArC//2CH), 1.97-2.01 (1 H, m, 
ArCHjCtf), 2.40 (2 H, br s, OH), 2.53-2.74 (2 H, m C //2CH2OH), 3.47-3.52 (1 H, m, 
CHCHffOH), 3.62-3.68 (2 H, m, CH2C/72OH), 3.75-3.80 (1 H, m, CHCH//OH) and 7.16-
7.30 (5 H, m, Ai-CH); 8C(100 MHz; CDClj) 35.6 (CH2), 38.6 (CH2), 41.6 (CH), 61.5 
(CH2), 66.0 (CH2), 126.4 (ArCH), 128.8 (ArCH), 129.5 (ArCH) and 140.7 (ArC); m/z (El) 
162 (M-H20 , 37%), 91 (M-benzyl, 100) and 84 (90); (Found M+ 162.1046; C nH i60 2 
requires 162.1045).
8.3.1.8 (2/?)-2-Isobutylbutane-l,4-diol 236
HO.
OH
236
Using the mixture o f 199 and 200 (0.5 g, 0.9 mmol) in General procedure 5 gave a 
mixture (0.45 g) which was chromatographed [Si02, acetone-hexane (2:3)] to give (2R)-2- 
isobutylbutane-l,4-diol 236 (0.11 g, 85%) as a colourless oil. [ cx] d  +2.4 (c 4.2, EtOAc); 
UmaxCNaCiycm'1 3334 (OH), 2954 (CH), 1468 (OH), and 1039 (C-O); 6H(400 MHz; 
CDC13) 0.88 (6 H, t, J  6.4, CH3CRCH3), 1.04-1.25 (2 H, m, CH3CHCtf2), 1.50-1.75 (4 H, 
m, alkyl-H), 3.42 (ABX system, 1 H, dd, J  7.2 and 10.8, CHCH//OH), 3.56 (2 H, br s, 
OH), 3.61-3.66 (2 H, m, CH2Ctf2OH) and 3.74-3.79 (1 H, m, CHCH//OH); 6C(100 MHz; 
CDCb) 22.7 (CH3), 22.8 (CH3), 25.2 (CH), 30.1 (CH2), 37.1 (CH), 41.1 (CH2), 61.0 (CH2),
66.5 (CH2); m/z (CI+ mode, isobutane) 147 (MFC, 10%) and 57 (100); (Found MH+ 
147.1386; C8H i80 2 requires 147.1385).
8.3.1.10 (2/?)-2-Hexylbutane-l,4-diol 237
HCL
OH
(CH2)5Me
237
Using the mixture of 201 and 202 (0.54 g, 0.9 mmol) in General procedure 5 gave a 
mixture (0.38 g) which was chromatographed [Si02, EtOAc-hexane (1:1)] to give (2R)-2- 
hexylbutane-l,4-diol 237 (0.12 g, 75%) as a colourless oil. [a]o +2 (c 1.0, EtOAc); 
'Umax(NaCl)/cm' 1 3320 (OH), 2925 (CH), 1466 (OH), and 1043 (C-O); 6H(400 MHz; 
CDCI3) 0.88 (3 H, t, J  7.0, CH2Ctf3), 1.27 (10 H, br s, alkyl-H), 1.52-1.73 (3 H, m, 
C # C tf2CH2OH), 3.27 (2 H, br s, OH), 3.46 (ABX system, 1 H, dd, J  7.0 and 10.7, 
CHCHtfOH), 3.61-3.67 (2 H, m, CH2Ctf2OH) and 3.74-3.80 (1 H, m, CHCHtfOH); 
5C(100 MHz; CDC13) 14.5 (CH3), 23.0 (CH2), 27.4 (CH2), 30.0 (CH2), 32.2 (2 x CH2), 36.2 
(CH2), 39.8 (CH), 61.5 (CH2) and 66.7 (CH2); m/z (FAB+) 175 (MH+, 100%), 137 (30), 83 
(16) and 73 (15); (Found MH+ 175.1697; Ci0H22O2 requires 175.1698).
8.3.1.11 2-Methylbutane-l,4-diol dibenzoate 238107
O
O
238
Compound 238 was prepared in 70% yield on a 3.3 mmol scale by the method o f 
Feringa and co-workers.107 UmaxCHaCiycm’1 3064 (alkyl), 2962 (alkyl), 1736 (C=0), 1603 
(aromatic ring) and 1531 (aromatic ring); 5h(400 MHz; CDCI3) 1.14 (3 H, d, J  6.8, 
CH3CH), 1.61-1.80 (1 H, m, alkyl-H), 1.96-2.08 (1 H, m, alkyl-H), 2.18-2.26 (1 H, m, 
alkyl-H), 4.27 (2 H, d, J 6 .1, CUCH2CO), 4.41-4.51 (2 H, m, COGtf2CH2), 7.42-7.47 (4 H, 
m, AiCH), 7.54-7.59 (2 H, m, ArCH) and 8.03-8.05 (4 H, m, ArCH); m/z (El) 312 (M+, 
2%), 207 (20) 190 (40), 105 (100), 77 (100) and 68 (ArNH2, 100); (Found M+ 312.1362; 
C19H 20O4 requires M^ 312.1362).
8.3.2 Synthesis of Mosher ester derivatives of enantiomerically enriched 
2-substituted butane-1,4-diols
General procedure 6 for the conversion of 2-substituted butane-1,4-diols into Mosher 
diesters.
EDCI (5 equiv.) was added to a mixture o f diol (-20  mg), (R)- or (^-M osher acid 
[methoxytrifluorophenylacetic acid (MTPA)] (2.5 equiv.) and DMAP (1 equiv.) in dry 
DCM (2 cm3) under N2. The mixture was stirred at room temperature for 24 h, then 
quenched with 5% citric acid (2 cm3) and extracted with dichloromethane ( 3 x 5  cm3). The 
combined extracts were washed with sodium hydrogen carbonate (10 cm3) followed by 
water (10 cm3) and brine (10 cm3), dried (MgSC>4) and concentrated under reduced 
pressure.
8.3.2.1 (*S)-MTPA Diester of (±)-2-methylbutane-l,4-diol 239139
MeO CF
239
Using (±)-2-methylbutane-l,4-diol (30 mg, 0.29 mmol) in General procedure 6 
followed by chromatography [S i02, EtOAc-hexane (1:1)] gave (»S)-MTPA diester 239 
(0.12 g, 75%) as a colourless oil. [a]o -65 (c 1.0 , EtOAc); UmaxCNaCiycrn'1 2964 (alkyl) 
and 1747 (C=0); 5H(400 MHz; CDC13) 0.93 (1.5 H, d, J  6.8, Ctf3CH), 0.95 (1.5 H, d, J
6.8, CH3CH), 1.44-1.95 (3 H, m, OCH2CH2CH), 3.53 (6 H, s, OCH3), 4.10 (ABX system, 
1 H, dd, J 5.6 and 8.0, OCHtfCH), 4.19 (ABX system, 1 H, dd, J 8 .0  and 10.8, OCHtfCH), 
4.27-4.41 (2 H, m, O Ci/2CH2), 7.37-7.43 (6 H, m, AiCH) and 7.49-7.51 (4 H, m, ArCtf); 
5C(100 MHz; CDC13) 16.2 (CH3), 29.4 (CH), 31.6 (CH2), 55.4 (2 x OCH3), 63.9 (CH2),
70.4 (CH2), 121.9 (2 x C), 124.7 (2 x C), 127.3 (2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x 
ArCH), 132.2 (2 x ArC) and 166.5 (2 x C=0); 5F(200 MHz; CDC13) -72.01 and -71.96; 
m/z (FAB+) 559 [(M+Na)+, 8%] 303 (14) and 189 (100); [Found (M+Na)+ 559.1526; 
C25H26F606 requires 559.1531].
8.3.2.2 (R)-MTPA Diester of (2/?)-2-ethylbutane-l,4-diol 238
MeO CF
238
Using (2i?)-2-ethylbutane-1,4-diol 229 (22 mg, 0.19 mmol) in General procedure 6 
followed by chromatography [S i02, EtOAc-hexane (1:1)] gave (i?)-MTPA diester 238 (87 
mg, 87%) as a colourless oil. [o l]d  +50 (c 0.8, EtOAc); UmaxCNaCiycm'1 2964 (alkyl) and 
1747 (C=0); 8h(400 MHz; CDC13) 0.85 (3 H, t, J  7.5, Ctf3CH2), 1.27-1.36 (2 H, m, 
CH3Ctf2), 1.67-1.72 (3 H, m, OCH2CH2CH), 3.53 (6 H, s, OCtf3), 4.18 (ABX system, 1 H, 
dd, J 4 .4  and 10.8, OCHtfCH), 4.25-4.40 (3 H, m, OC/72CH2and OCHtfCH), 7.37-7.41 (6 
H, m, ArCH) and 7.48-7.50 (4 H, m, ArCH); 8C(100 MHz; CDC13) 10.8 (CH3), 23.3 (CH2),
29.6 (CH2), 35.7 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 67.8 (CH2), 124.8 (2 x C), 125.8 (2 x 
C), 127.3 (2 x ArCH), 128.4 (4 x ArCH), 129.6 (2 x ArCH), 132.2 (2 x ArC) and 166.5 (2 
x C=0); 8f (200 MHz; CDC13) -71.95, -71.93 and -71.91; m/z (CI+ mode, isobutane) 551 
(MH+, 10%) 317 (45) and 189 ( 100); (Found M fC 551.1870; C26H 28F606 requires
551.1868).
8.3.2.3 (*S)-MTPA Diester of (2/?)-2-ethyIbutane-l,4-diol 239
MeO CF\
239
Using (2fi)-2-ethylbutane-1,4-diol 229 (23 mg, 0.19 mmol) in General procedure 6 
followed by chromatography [SiC>2, EtOAc-hexane (1:1)] gave (S)-MTPA diester 239 (85 
mg, 77%) as a colourless oil. [a]o -42 (c 0.8, EtOAc); UmaxO^aCiycm' 1 2964 (alkyl) and 
1745 (C=0); 5h(400 MHz; CDC13) 0.87 (3 H, t, J  7.5, C/73CH2), 1.29-1.37 (2 H, m, 
CH3C //2), 1.66-1.93 (3 H, m, OCH2CH2CH), 3.53 (6 H, s, OCH3), 4.17 (ABX system, 1 H, 
dd, / 5 .0  and 11 1, OCH//CH), 4.25-4.39 (3 H, m, OCH2CH2 and OCffifCH), 7.37-7.41 (6 
H, m, ArCH) and 7.49-7.51 (4 H, m, ArCH), 8C(100 MHz; CDC13) 10.8 (CH3), 23.4 (CH2),
29.6 (CH2), 35.6 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 67.8 (CH2), 121.9 (2 x C), 124.7 (2 x
C), 127.3 (2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x ArC) and 166.5 (2 
x C =0); 6 f ( 2 0 0  MHz; CDCI3) -71.95, -71.93 and -71.91; m/z (CI+ mode, isobutane) 551 
(MFC, 11%) 317 (36) and 189 (27); (Found MFC 551.1866; C26H28F606 requires
551.1868).
8.3.2.4 (/?)-MTPA Diester of (2.R)-2-isopropylbutane-l,4-diol 240
MeO CF
240
Using (2R)-2-isopropylbutane-l,4-diol 230 (20 mg, 0.15 mmol) in General 
procedure 6 followed by chromatography [S i02, EtOAc-hexane (1:1)] gave (K)-MTPA 
diester 240 (40 mg, 47%) as a colourless oil. [a]o +60 (c 0.4, EtOAc); UmaxCNaCiycm'1 
2964 (alkyl) and 1747 (C=0); 6H(400 MHz; CDCI3) 0.85 (6 H, m, CH3CHCH3), 1.57-1.82 
(4 H, m), 3.53 (6 H, s, OCH3), 4.17 (ABX system, 1 H, dd, J  5.6 and 11.6, OCHtfCH), 
4.22-4.39 (3 H, m, OCH2CH2 and OCH//CH), 7.37-7.41 (6 H, m, ArCH) and 7.49-7.50 (4 
H, m, ArCH); 5C(100 MHz; CDC13) 19.1 (CH3), 19.2 (CH3), 27.2 (CH2), 28.3 (CH), 39.9 
(CH), 55.4 (2 x OCH3), 64.5 (CH2), 66.8 (CH2), 121.9 (2 x C), 124.7 (2 x Q , 127.2 (2 x 
ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x ArC) and 166.5 (2 x C =0); 
5f (200 MHz; CDCI3) -71.96, -71.95 -71.84 and -71.81; m/z (CI+ mode, isobutane) 565 
(MFC, 17%) 331 (69) and 189 (54); (Found MFC 565.2022; C27H3oF606 requires
565.2025).
8.3.2.5 (*S)-MTPA Diester of (2/?)-2-isopropylbutane-l,4-diol 241
MeO CF
241
Using (2R)-2-isopropylbutane-l,4-diol 230 (20 mg, 0.15 mmol) in General 
procedure 6 followed by chromatography [Si02, EtOAc-hexane (1:1)] gave (*S)-MTPA 
diester 241 (66 mg, 78%) as a colourless oil. [a]o -59 (c 0.8, EtOAc); UmaxOMaCiycm'1 
2964 (alkyl) and 1747 (C=0); 5H(400 MHz; CDCI3) 0.85 (6 H, m, CH3CHCH3), 1.52-1.82
(4 H, m), 3.53 (6 H, s, OCH ,\  4.17 (ABX system, 1 H, dd, J  5.6 and 11.6, OCHffCH),
4.25-4.39 (3 H, m, O C //2CH2 and OCHHCH), 7.37-7.42 (6 H, m, AiCH) and 7.49-7.51 (4 
H, m, ArCH); 8C(100 MHz; CDC13) 19.1 (CH3), 19.2 (CH3), 27.2 (CH2), 28.3 (CH), 39.9 
(CH), 55.4 (2 x OCH3), 64.5 (CH2), 66.8 (CH2), 121.9 (2 x C), 124.8 (2 x C), 127.2 (2 x 
ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 ArC) and 166.5 (2 x C=0); 6f(200 
MHz; CDC13) -71.96, -71.94 -71.84 and -71.81; m/z (CI+ mode, isobutane) 565 (MFC, 
27%) 331 (72) and 189 (50); (Found MH+ 565.2026; C27H30F6O6 requires 565.2025).
8.3.2.6 (R)-MTPA Diester of (21?)-2-propylbutane-l,4-diol 242
MeO CF
242
Using (2/?)-2-propylbutane-1,4-diol 231 (25 mg, 0.19 mmol) in General procedure 
6 followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (7?)-MTPA diester 242 
(85 mg, 77%) as a colourless oil. [a]o +70 (c 0.8, EtOAc); iw C N aC iycm '1 2958 (alkyl) 
and 1749 (C=0); 8H(400 MHz; CDC13) 0.79-0.91 (3 H, m, C tf3CH2), 1.23-1.29 (4 H, m, 
CH3C //2C //2), 1.62-1.79 (3 H, m, OCK2CHCH2), 3.53 (6 H, s, OCHi), 4.11-4.19 (1 H, m, 
OCHtfCH), 4.24-4.39 (3 H, m, O C//2CH2 and OCH//CH), 7.37-7.42 (6 H, m, ArCH) and 
7.49-7.51 (4 H, m, ArCH); 8C(100 MHz; CDCb) 14.4 (CH3), 19.6 (CH2), 30.0 (CH2), 32.8 
(CH2), 33.9 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2), 121.9 (2 x C), 124.7 (2 x C),
127.6 (2 x ArCH), 128.3 (4 x ArCH), 129.6 (4 x ArCH), 132.5 (2 x ArC) and 166.5 (2 x 
C=0); 8f(200 MHz; CDCb) -71.94, -71.92 and -71.88; m/z (CI+ mode, isobutane) 565 
(MFC, 33%) 331 (95) and 189 (73); (Found MFC 565.2023; C27H3oF60s requires
565.2025).
8.3.2.7 (<S)-MTPA Diester of (2/?)-2-propylbutane-l,4-diol 243
MeO CF
243
Using (2R)-2-propylbutane-1,4-diol 231 (25 mg, 0.19 mmol) in General procedure 
6 followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (,S)-MTPA diester 243 
(90 mg, 82%) as a colourless oil. [a]o -58 (c 0.8, EtOAc); aw O ^CO /cm *1 2958 (alkyl) 
and 1749 (C=0); 5H(400 MHz; CDC13) 0.80-0.87 (3 H, m, Gtf3CH2), 1.23-1.31 (4 H, m, 
CH3CH2CH2), 1.64-1.79 (3 H, m, OCH2C i/C tf2), 3.53 (6 H, s, OCH3), 4.16 (ABX system, 
1 H, dd, J  5.2 and 11.2, OCHtfCH), 4.24-4.39 (3 H, m, OCtf2CH2 and OCHtfCH), 7.37- 
7.41 (6 H, m, ArCH) and 7.49-7.51 (4 H, m, ArCH); 5C(100 MHz; CDC13) 14.0 (CH3),
19.6 (CH2), 30.0 (CH2), 32.8 (CH2), 33.9 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2),
121.9 (2 x C), 124.7 (2 x C), 127.2 (2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH),
132.5 (2 x ArC) and 166.5 (2 x C=0); 5F(200 MHz; CDC13) -71.94, -71.91 and -71.87; 
m/z (Cl* mode, isobutane) 565 (MFC, 10%) 331 (55) and 189 (28); (Found MFC 565.2023; 
C27H30F6O6 requires 565.2025).
8.3.2.8 (^?)-MTPA Diester of (2/?)-2-butylbutane-l,4-diol 244
O
f 3V .OMe
MeO CF3
244
Using (2i?)-butylbutane-1,4-diol 232 (25 mg, 0.17 mmol) in General procedure 6 
followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (R)-MTPA diester 244 (89 
mg, 91%) as a colourless oil. [a]o +53 (c 0.8, EtOAc); UmaxfNaCiycm'1 2956 (alkyl) and 
1749 (C=0); 5h(400 MHz; CDC13) 0.86 (3 H, t, J 6.9, Ctf3CH2), 1.16-1.31 (6 H, m, alkyl- 
H), 1.62-1.77 (3 H, m, OCH2CHCH2), 3.52 (6 H, s, OCH3), 4.14-4.19 (1 FI, m, OCH^CH),
4.24-4.39 (3 H, m, OCtf2CH2and OCHtfCH), 7.36-7.41 (6 H, m, ArCH) and 7.49-7.51 (4
159
H, m, ArC//); 5C(100 MHz; CDC13) 13.9 (CH3), 22.7 (CH2), 30.0 (CH2), 30.2 (CH2), 30.3 
(CH2), 34.2 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2), 121.9 (2 x C), 124.7 (2 x Q ,
127.2 (2 ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x ArC), 166.5 (C=0) and
166.6 (C=0); 5f(200 MHz; CDCI3) -71.96, -71.95, -71.91 and -71.88; m/z (El) 578 (M+, 
1%), 345 (16) and 189 (100); (Found ^ 5 7 8 .2 1 0 5 ; C28H32F606 requires M+ 578.2103).
8.3.2.9 (*S)-MTPA Diester of (2i?)-2-butylbutane-l,4-dioI 245
MeO CF
245
Using (2/?)-butylbutane-1,4-diol 232 (25 mg, 0.17 mmol) in General procedure 6 followed 
by chromatography [S i02, EtOAc-hexane (1:4)] gave (5)-MTPA diester 245 (75 mg, 77%) 
as a colourless oil. [a]o -45 (c 0.8, EtOAc); UmaxCNaCiycrn'1 2956 (alkyl) and 1749 (C O ); 
5h(400 MHz; CDC13) 0.86 (3 H, t, J6 .9 , C //3CH2), 1.16-1.31 (6 H, m, alkyl-H), 1.62-1.77 
(3 H, m, OCH2C //C //2), 3.52 (6 H, s, O C//3), 4.14-4.19 (1 H, m, OCHZ/CH), 4.24-4.39 (3 
H, m, OC//2CH2 and OCHZ/CH), 7.36-7.41 (6 H, m, ArC//) and 7.49-7.51 (4 H, m, 
ArC//); 6C(100 MHz; CDC13) 13.9 (CH3), 22.7 (CH2), 30.0 (CH2), 30.2 (CH2), 30.3 (CH2),
34.2 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2), 121.9 (2 x C), 124.7 (2 x C), 127.2 (2 
ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x ArC), 166.5 (C O )  and 166.6 
(C O ); 5f(200 MHz; CDC13) -71.96, -71.95, -71.91 and -71.88; m/z (El) 578 (M+, 1%), 
345 (19) and 189 (100); (Found M+ 578.2104; C28H32F606 requires M+ 578.2103).
8.3.2.10 (Z?)-MTPA Diester of (2/?)-cyclohexylbutane-l,4-diol 246
MeO CF
246
Using (2//)-cyclohexylbutane-1,4-diol 233 (22 mg, 0.13 mmol) in General 
procedure 6 followed by chromatography [SiC>2, EtOAc-hexane (1:4)] gave (A)-\1TPA 
diester 246 (65 mg, 84%) as a colourless oil. [a]o +52 (c 0.8, EtOAc); UmaxCNaCiycm'1 
2927 (alkyl) and 1748 (C=0); 8H(400 MHz; CDCb) 0.84-0.99 (2 H, m, alkyl-H), 1.01-1.16 
(3 H, m, alkyl-H), 1.24-1.35 (1 H, m, alkyl-H), 1.50-1.83 (8 H, m, alkyl-H), 3.52 (6 H, s, 
O C//3), 4.18 (ABX system, 1 H, dd, J  5.2 and 11.2, OCH//CH), 4.22-4.38 (3 H, m, 
0 C //2CH2 and OCH//CH), 7.37-7.44 (6 H, m, ArC//) and 7.49-7.51 (4 H, m, ArC/7); 
8C(100 MHz; CDCb) 26.3 (CH2), 26.4 (CH2), 27.4 (CH2), 27.5 (CH2), 29.6 (CH2), 29.8 
(CH2), 38.6 (CH), 39.4 (CH), 55.4 (OCH3), 64.6 (CH2), 67.2 (CH2), 121.9 (2 x C), 124.7 (2 
x Q , 127.6 (2 ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x ArC), 166.5 (C=0) 
and 166.6 (C=0); 8 f ( 2 0 0  MHz; CDCb) -71.95, -71.85 and —71.76; m/z (El) 604 (M+, 
0.3%), 189 (100) and 137 (42); (Found M + 604.2261; CsoHmFOs requires M+ 604.2260).
8.3.2.11 (.S)-MTPA Diester o f (2/?)-2-cyclohexylbutane-l,4-diol 247
MeO CF
247
Using (2R)-2-cyclohexylbutane-1,4-diol 233 (22 mg, 0.13 mmol) in General 
procedure 6 followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (8)-MTPA 
diester 247 (71 mg, 92%) as a colourless oil. [a]o -63 (c 0.8, EtOAc); umax(NaCl)/cm'1 
2927 (alkyl) and 1748 (C O ); 8H(400 MHz; CDCb) 0.87-0.99 (2 H, m, alkyl-H), 1.05-1.18 
(3 H, m, alkyl-H), 1.25-1.38 (1 H, m, alkyl-H), 1.53-1.85 (8 H, m, alkyl-H), 3.53 (6 H, s, 
OC//3), 4.18 (ABX system, 1 H, dd, J  5.2 and 11.2, OCH//CH), 4.22-4.43 (3 H, m, 
OCZ72CH2 and O C//2CH), 7.37-7.44 (6 H, m, ArC//) and 7.49-7.51 (4 H, m, ArC//); 
Sc(100 MHz; CDCb) 26.4 (CH2), 26.5 (CH2), 27.4 (CH2), 27.5 (CH2), 29.6 (CH2), 29.9 
(CH2), 38.6 (CH), 39.3 (CH), 55.4 (2 x OCH3), 64.6 (CH2), 66.8 (CH2), 121.9 (2 x C),
124.8 (2 x C), 127.2 (2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x ArC),
166.5 ( C O )  and 166.6 (C O ); 8F(200 MHz; CDCb) -71.96, -71.85 and -71.76; m/z (El) 
604 (M*, 1%), 371 (15) 189 (100) and 137 (42); (Found M+604.2257; C3oH34F60 6 requires 
M t 604.2260).
8.3.2.12 (/?)-MTPA Diester of (2/?)-2-octyIbutane-l,4-diol 248
MeO CF
Using (2K)-2-octylbutane-1,4-diol 234 (30 mg, 0.15 mmol) in General procedure 6 
followed by chromatography [Si02, EtOAc-hexane (1:4)] gave (i?)-MTPA diester 248 (76 
mg, 80%) as a colourless oil. [a]o +58 (c 0.8, EtOAc); UmaxCNaCiycm'1 2929 (alkyl) and 
1749 (C=0); 6h(400 MHz; CDC13) 0.90 (3 H, t, J7.Q, CH3CH2), 1.14-1.33 (14 H, m, alkyl- 
H), 1.62-1.77 (3 H, m, OCH2CHCH2\  3.53 (6 H, s, OCH3\  4.14-4.19 (1 H, m, OCH//CH),
4.25-4.39 (3 H, m, OCtf2CH2 and OCHtfCH), 7.38-7.43 (6 H, m, ArCH) and 7.49-7.51 (4 
H, m, ArCH); 8c(100 MHz; CDC13) 14.1 (CH3), 22.6 (CH2), 26.5 (CH2), 29.2 (CH2), 30.0 
(CH2), 30.3 (CH2), 30.9 (CH2), 31.0 (CH2), 31.8 (CH2), 34.2 (CH), 55.4 (OCH3), 64.0 
(CH2), 68.1 (CH2), 121.9 (2 x Q , 124.7 (2 x C), 127.2 (2 x ArCH), 128.4 (4 x ArCH),
129.6 (4 x ArCH), 132.2 (2 x ArC), 166.5 (C=0) and 166.6 (C=0); 6F(200 MHz; CDC13)
37.56, 37.57, 37.60 and 37.63; m/z (El) 634 (IVT, 0.5%), 401 (8) and 189 (100); (Found M + 
634.2728; C32H40F6O6 requires M+ 634.2729).
8.3.2.13 (*S)-MTPA Diester of (2.K)-2-octylbutane-l,4-diol 249
MeO CF
Using (2R)-2-octylbutane-l,4-diol 234 (30 mg, 0.15 mmol) in General procedure 6 
followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (*S)-MTPA diester 249 (78 
mg, 82%) as a colourless oil. [(x] d  -62 (c 0.8, EtOAc); OmaxCNaCiycm'1 2929 (alkyl) and 
1749 (C=0); 5h(400 MHz; CDC13) 0.89 (3 H, t, J 7.0, C ^ 3CH2), 1.14-1.35 (14 H, m, alkyl- 
H), 1.65-1.77 (3 H, m, OCH2CHCH2), 3.53 (6 H, s, OCH3), 4.12-4.19 (1 H, m, OCH7/CH),
4.24-4.39 (3 H, m, O C ^2CH2 and OCH7/CH), 7.37-7.41 (6 H, m, ArCH) and 7.49-7.51 (4 
H, m, ArCH); 6C(100 MHz; CDC13) 14.1 (CH3), 22.6 (CH2), 26.5 (CH2), 29.2 (CH2), 30.0 
(CH2), 30.3 (CH2), 30.9 (CH2), 31.0 (CH2), 31.8 (CH2), 34.2 (CH), 55.4 (2 x OCH3), 64.0
(CH2), 68.1 (CH2), 121.9 (2 x C), 124.7 (2 x C), 127.2 (2 x ArCH), 128.4 (4 x ArCH),
129.6 (4 x ArCH), 132.2 (2 x ArC), 166.5 (C=0) and 166.6 (C=0); Sf(200 MHz; CDC13)
37.56, 37.57, 37.60 and 37.63; m/z (El) 634 (Mf, 1%), 401 (15) and 189 (100); (Found M4 
634.2729; C32H4oF606 requires M+ 634.2729).
8.3.2.14 (/?)-MTPA Diester of (2/?)-2-benzylbutane-l,4-diol 250
*OMe
MeO CF
250
Using (2i?)-2-benzylbutane-1,4-diol 235 (30 mg, 0.15 mmol) in General procedure 
6 followed by chromatography [Si02, EtOAc-hexane (1:4)] gave (7?)-MTPA diester 250 
(87 mg, 92%) as a colourless oil. [oi]d +70 (c 0.4, EtOAc); UmaxfNaCiycm'1 2951 (alkyl) 
and 1750 (C=0); 5H(400 MHz; CDC13) 1.76-1.78 (2 H, m, alkyl-H), 2.06-2.19 (1 H, m, 
OCH2CtfCH2), 2.52 -2.60 (2 H, m, alkyl-H), 3.52 (3 H, s, OCH3), 3.53 (3 H, s, OCH3), 
4.13 (2 H, d, 74 .5 , OCtf2CH), 4.25-4.43 (2 H, m, OCtf2CH2), 6.95-6.97 (2 H, m, ArCH), 
7.19-7.27 (3 H, m, ArCH), 7.39-7.44 (6 H, m, ArCH) and 7.50-7.52 (4 H, m, ArCH)- 
5C(100 MHz; CDC13) 29.9 (CH2), 36.2 (CH), 36.9 (CH2), 55.4 (2 x OCH3), 63.8 (CH2),
67.1 (CH2), 121.9 (2 x C), 124.8 (2 x C), 126.4 (2 x ArCH), 127.2 (ArCH), 127.3 (ArCH),
128.5 (4 x ArCH), 128.9 (3 x ArCH), 129.7 (4 x ArCH), 132.2 (2 x ArC), 138.6 (2 ArC) 
and 166.5 (2 x O O ); 6F(200 MHz; CDC13) -71.93, -71.85, -71.70 and -71.66; m/z (FAB+) 
613 (MFC, 4%), 379 (15) and 189 (100); (Found MFC 613.2020; C3iH30F6O6 requires
613.2025).
8.3.2.15 (*S)-MTPA Diester of (2/?)-2-benzylbutane-l,4-diol 251
Me<? CF
251
Using (2/?)-2-benzylbutane-1,4-diol 235 (30 mg, 0.15 mmol) in General procedure 
6 followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (S)-MTPA diester 251 
(75 mg, 79%) as a colourless oil. [oi] d  -69 ( c  0.8, EtOAc); twCNaCiycm '1 2951 (alkyl) 
and 1748 (0= 0); 8H(400 MHz; CDCI3) 1.70-1.73 (2 H, m, alkyl-H), 2.01-2.10 (1 H, m, 
OCH2C77C/72), 2.51-2.64 (2 H, m, alkyl-H), 3.50 (3 H, s, O C//3), 3.52 (3 H, s, O C ft),
4.02 (1 H, dd, 7 4 .4  and 11.2, OCH//CH), 4.24 (1 H, dd, 74 .8  and 11.2, OCH/7CH), 4.28- 
4.40 (2 H, m, O C ftC H 2), 6.98 (2 H, d, 76 .6 , ArCH), 7.18-7.27 (3 H, m, ArCH), 7.34-7.44 
(6 H, m, ArCH) and 7.48-7.52 (4 H, m, A rC ft; 8C(100 MHz; CDCI3) 29.6 (CH2), 36.0 
(CH), 37.1 (CH2), 55.4 (2 x OCH3), 63.7 (CH2), 66.9 (CH2), 121.9 (2 x C), 124.8 (2 x C),
126.5 (2 x ArCH), 127.2 (ArCH), 127.4 (ArCH), 128.5 (4 x ArCH), 128.9 (2 x ArCH),
129.7 (4 x ArCH), 132.2 (2 x ArC), 138.5 (2 x A rQ , 166.4 (C=0) and 166.5 (C=0); 
5f(200 MHz; CDCI3) -71.92, -71.84, -71.70 and -71.65; m/z (FAB+) 613 (MH+, 6%), 379 
(16) and 189 (100); (Found MH4613.2024; C31H30F6O6 requires 613.2025).
8.3.2.16 (R)-MTPA Diester o f (2//)-2-isobutylbutane-l,4-diol 252
MeO CF
252
Using (2f t - 2-isobutylbutane-1,4-diol 236 (8 mg, 0.05 mmol) in General procedure 
6 followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (ft-M TPA  diester 252 
(19 mg, 66%) as a colourless oil. [a]D +60 (c 0.8, EtOAc); UmaxCNaCiycm' 1 2956 (alkyl) 
and 1749 (C=0); 8H(400 MHz; CDCI3) 0.79 (3 H, d, 7  6.8, C ftC H CH ,), 0.81 (3 H, d, 7
6.8, C //3CHCH3), 1.03-1.20 (2 H, m, C H jC H C ft), 1.51-1.75 (3 H, m, alkyl-H), 1.83-1.89 
(1 H, m, CH2C/7CH20 ), 3.53 (6 H, s, O C ft), 4.13-4.19 (1 H, m, OCHtfCH), 4.24-4.38 (3 
H, m, OC772CH2 and OCHtfCH), 7.36-7.44 (6 H, m, ArCH) and 7.49-7.51 (4 H, m, 
ArC//); 8C(100 MHz; CDCI3) 22.1 (CH3), 22.8 (CH3), 25.0 (CH), 29.5 (CH2), 30.8 (CH),
39.1 (CH2), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2), 121.9 (2 x C), 124.7 (2 x C), 127.3 
(2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.1 (2 x ArC) and 166.5 (2 x C=0); 
8f(200 MHz; CDCI3) -71.97, -71.91, -71.90 and -71.86; m/z (El) 578 (M4, 3%), 345 (30) 
and 189 (100); (Found M 4 578.2104; C28H32F606 requires M 4 578.2103).
8.3.2.17 (S)-MTPA Diester of (2/?)-2-isobutylbutane-l,4-diol 253
MeO CF
253
Using (2R)-2-isobutylbutane-l,4-diol 236 (8 mg, 0.05 mmol) in General procedure 
6 followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (S)-MTPA diester 253 
(23 mg, 66% ) as a colourless oil. [<x]d -62 (c 0.8, EtOAc); twOSIaCiycm'1 2956 (alkyl) 
and 1749 (C=0); 5H(400 MHz; CDC13) 0.79 (3 H, d, 76 .8 , C //3CHCH3), 0.81 (3 H, d, 7
6.8, C ftC H C H 3), 1.03-1.20 (2 H, m, CH3CHC//2), 1.51-1.75 (3 H, m, alkyl-H), 1.83-1.89 
(1 H, m, CH2Cf/CH20 ), 3.53 (6 H, s, O C //3), 4.13-4.19 (1 H, m, OCHffCH), 4.24-4.38 (3 
H, m, O C//2CH2 and OCHHCH), 7.36-7.44 (6 H, m, ArCH) and 7.49-7.51 (4 H, m, 
ArC/f); 8c(100 MHz; CDCI3) 22.1 (CH3), 22.8 (CH3), 25.0 (CH), 29.5 (CH2), 30.8 (CH),
39.1 (CH2), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2), 121.9 (2 x C), 124.7 (2 x Q , 127.3 
(2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.1 (2 x ArC) and 166.5 (2 x C=0); 
8f(200 MHz; CDC13) -71.97, -71.91, -71.90 and -71.86; m/z (El) 578 (M+, 0.5%), 345 (5) 
and 189 (100); (Found M f 578.2101; C28H32F60 6 requires M" 578.2103).
8.3.2.18 (A)-MTPA Diester of (2f?)-2-hexylbutane-l,4-diol 254
MeO CF
Using (2/?)-2-hexylbutane-1,4-diol 237 (19 mg, 0.11 mmol) in General procedure 6 
followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (ft)-MTPA diester 254 (32 
mg, 48%) as a colourless oil. [<x]d +74 (c 0.8, EtOAc); UmaxCNaCiycm' 1 2929 (alkyl) and 
1749 (C=0); 5h(400 M H z ; CDC13) 0.88 (3 H, t, 77.1, C //3CH2), 1.21-1.29 (10 H, m, alkyl- 
H), 1.64-1.77 (3 H, m, OCH2CHCH2), 3.52 (6 H, s, OCH}), 4.14-4.19 (1 H, m, OCHHCH),
4.24-4.39 (3 H, m, O C//2CH2 and OCHffCH), 7.36-7.43 (6 H, m, ArCH) and 7.49-7.51 (4 
H, m, ArCH), 5C(100 MHz) 14.0 (CH3), 22.5 (CH2), 26.4 (CH2), 29.3 (CH2), 30.1 (CH2),
30.7 (CH2), 31.6 (CH2), 34.2 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2), 121.9 (2 x 
C), 124.7 (2 x C), 127.2 (2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x 
ArC), 166.5 (C =0) and 166.6 (C=0); 6F(200 MHz; CDCU) -71.95, -71.94, -71.90 and -  
71.87; m/z (El) 606 (M \ 3%), 373 (58) and 189 (100); (Found M* 606.2418; CmHjsFeOs 
requires M+ 606.2416).
8.3.2.19 (i)-M TPA Diester o f (2Jf)-2-hexylbutane-l,4-diol 255
MeO CF
Using (2R)-2-hexylbutane-l,4-diol 237 (19 mg, 0.11 mmol) in General procedure 6 
followed by chromatography [S i02, EtOAc-hexane (1:4)] gave (5)-MTPA diester 255 (55 
mg, 82%) as a colourless oil. [a]o -68 (c 0.8, EtOAc); iw C N aC iycm '1 2929 (alkyl) and 
1749 (C=0); 8h(400 MHz; CDC13) 0.89 (3 H, t, J  7.1, CH3CH2), 1.22-1.29 (10 H, m), 
1.64-1.67 (2 H, m, OCH2CHC//2), 1.74-1.77 (1 H, m, OCH2C//CH2), 3.53 (6 H, s, O C//3),
4.16 (ABX system, 1 H, d d ,J5 .2  and 11.2, OCHffCH), 4.24-4.37(3 H, m, O C//2CH2 and 
OCHtfCH), 7.37-7.41 (6 H, m, ArCH) and 7.49-7.51 (4 H, m, ArCH), 8C(100 MHz; 
CDC13) 14.0 (CH3), 22.6 (CH2), 26.4 (CH2), 29.3 (CH2), 30.1 (CH2), 30.7 (CH2), 31.6 
(CH2), 34.2 (CH), 55.4 (2 x OCH3), 64.0 (CH2), 68.1 (CH2), 121.8 (2 x C), 124.7 (2 x C),
127.2 (2 x ArCH), 128.4 (4 x ArCH), 129.6 (4 x ArCH), 132.2 (2 x ArC), 166.5 (C=0) and
166.6 (0= 0); 8f(200 MHz; CDC13) -71.95, -71.93, -71.90 and -71.87; m/z (El) 606 (M*,
1.6%), 373 (29) and 189 (100); (Found M" 606.2415; C30H36F6O6 requires M* 606.2416).
8.4 Experimental for Chapter 6
8.4.1 Synthesis of 2-substituted succinamides
8.4.1.1 (-)-(2/?)-A7-[(£)-3-(Ethoxycarbonyl)prop-2-enoyl]bornane-10,2-sultam 264116
o2
264
Compound 264 was prepared in 77% yield on a 69 mmol scale by the method of 
Curran and co-workers116 and gave mp 118-120 °C (lit.116 119-121 °C); [a]o -90  (c 1.2, 
CHC13) [lit.116-93.5, (c 1.2, CHCI3)]; 6h(400 MHz, CDC13) 0.99 (3 H, s, CH3CC//3), 1.17 
(3 H, s, CH3 CC//3), 1.32 (3 H, t, J7 .1 , C //3CH20 ), 1.36-1.47 (2 H, m, alkyl-H), 1.90-1.99 
(3 H, m, alkyl-H), 2.09-2.17 (2 H, m, alkyl-H), (2 H, AB system, J  13.8, C7/2S 0 2), 3.95- 
3.98 (1 H, m, CHN\ 4.22-4.30 (2 H, m, OGtf2CH3), 6.93 (1 H, d, J  15.3, CH=CH) and 
7.54 (1 H, d, J  15.3, CH=CR).
G eneral procedure 7 for the 1,4-addition of G rignard  reagents to (-)-(2R)-N-[(E)-3- 
(ethoxycarbonyl)prop-2-enoyl]bornane-10,2-sultam 264.
The Grignard reagent (2.2 equiv.) in diethyl ether was added dropwise to a stirred 
solution o f (-)-(2i?)-Ar-[(£)-3-(ethoxycarbonyl)prop-2-enoyl]bomane-10,2-sultam 264 (1 
equiv.) in dry THF (20 cm3) under N2 at -78  °C. After 3 h at -78  °C the reaction mixture 
was quenched with sat. aq. NH4 CI soln. (15 cm3) and then poured onto sat. aq. NH4CI soln 
(15 cm3). The product was extracted with ethyl acetate (2 x 20 cm3). The combined organic 
extracts were dried (MgS0 4 ) and concentrated under reduced pressure.
8.4.1.2 (-)-(2/?)-Ar-[(3/?)-3-(Ethoxycarbonyl)-3-ethyIpropanoyl]bornane-10,2-sultam
271
0 2
271
Using ethyl magnesium chloride (1.1 cm of a 3 mol dm solution in Et20 )  and 264 
on a 1.46 mmol scale following General procedure 7 gave a mixture o f diastereoisomers
271 (0.23 g, 43%) as a colourless oil. [ o ] d  -94.6 (c 1.2, CHCI3); UmaxfNaCiycm’1 2932 
(CH), 1686 (amide), 1322 and 1135 (-S 0 2-N); 5H(400 MHz; CDCI3) 0.89-0.98 (6 H, m, 
CH3CC//3 and C //3CH2), 1.17 (3 H, s, C //3CCH3), 1.24-1.29 (3 H, m, OCH2C //3), 1.32-
1.43 (2 H, m, alkyl-H), 1.56-1.74 (2 H, m, alkyl-H), 1.87-1.96 (3 H, m, alkyl-H), 2.04-2.16 
(2 H, m, alkyl-H), 2.78-2.89 (2 H, m, alkyl-H), 3.16 (1 H, dd, J 8 .9  and 16.6, COCHtfCH),
3.44 (AB system, 1 H, d, /  13.8, CH//SO2), 3.50 (AB system, 1 H, d, J  13.8, CH//SO2), 
3.87 (1 H, app t, J  7.6, CAN) and 4.10-4.27 (2 H, m, O C//2CH3); 8C(100 MHz; CDCU)
11.7 (CH3), 14.4 (CH3), 20.1 (CH3), 21.0 (CH3), 25.2 (CH2), 26.6 (CH2), 33.0 (CH2), 36.7 
(CH2), 38.5 (CH2), 42.6 (CH), 44.8 (CH), 47.9 (C), 48.7 (C), 53.1 (CH2), 60.7 (CH2), 65.4 
(CH), 170.3 (C=0) and 174.7 (C=0); m/z (El) 371 (M \ 0.5%), 326 (12) and 157 (100); 
(Found M f 371.1765; C18H29NO5S requires M+ 371.1766).
8.4.1.3 (-)-(2/J)-lV-[(3/J)-3-(Ethoxycarbonyl)-3-benzy Ipropanoyl] bornane-10,2-sultam
272
272
Using benzyl magnesium chloride (7.2 cm3 o f a 1 mol dm solution in Et20 )  and 
264 on a 3.25 mmol scale following General procedure 7 gave a mixture of 
diastereoisomers 272 (1.34 g, 96%) as a colourless oil. [a]o -73 (c 1.5, EtOAc);
W N a C l) /c m - ' 2962 (CH), 1695 (amide), 1333 and 1134 (-S 02-N); 8H(400 MHz; CDC13) 
0.97 (3 H, s, CH3C C//3), 1.13 (3 H, s, C //3CCH3), 1.17 (3 H, t, J  7.2, C //3CH20 ), 1.86- 
1.96 (3 H, m, alkyl-H), 2.01-2.07 (2 H, m, alkyl-H), 2.79-2.90 (2 H, m, alkyl-H), 3.05 
(ABX system, 1 H, dd, J  6.8 and 13.7, COCH/7CH), 3.13-3.25 (2 H, m, alkyl-H), 3.39- 
3.51 (2 H, m, alkyl-H), 3.82-3.87 (1 H, m, C//N), 4.07-4.17 (2 H, m, OC//2CH3) and 7.19-
7.31 (5 H, m, ArC//); 8C(100 MHz; CDC13) 14.2 (CH3), 20.1 (CH3), 21.0 (CH3), 26.6 
(CH2), 30.0 (CH2), 36.9 (CH2), 37.9 (CH2), 38.6 (CH2), 43.1 (CH), 44.8 (CH), 47.9 (C),
48.7 (O , 53.0 (CH2), 60.8 (CH2), 65.4 (CH), 126.8 (ArCH), 128.6 (2 x ArCH), 129.3 (2 x 
ArCH), 138.6 (ArC), 170.1 (C =0) and 174.1 (C=0); m/z (El) 433 (M \ 30%), 190 (76) and 
135 ( 100); (Found M *433.1924; C23H3iN 0 5S requires M" 433.1923).
8.4.1.4 (-)-(2JR)-Ar-[(3jR)-3-(Ethoxycarbonyl)-3-isopropylpropanoyl]bornane-10,2- 
sultam 273
273
Using isopropyl magnesium chloride (3.2 cm3 of a 2 mol dm’3 solution in Et20) and 
264 on a 2.9 mmol scale following General procedure 7 produced a mixture of 
diastereoisomers 273 (0.73 g, 65 %) as a colourless oil. [a]o -75 (c 1.5, EtOAc); 
Umax(NaCl)/cm'' 2962 (CH), 1730 (ester), 1697 (amide), 1333 and 1134 (-S 02-N); 8H(400 
MHz; CDC13) 0.94 (9 H, m, CH3CC773, C //3C C//3), 1.16 (3 H, s, C //3CCH3), 1.23-1.43 (7 
H, m, alkyl-H), 1.86-2.13 (4 H, m, alkyl-H), 2.75-2.87 (2 H, m, alkyl-H), 3.17 (ABX 
system, 1 H, dd, J 2.8 and 10.8, COCH//CH), 3.44 (ABX system, 1 H, dd, J 6.8 and 14.0, 
COCH/7CH), 3.49-3.54 (1 H, m, COCH2C//), 3.83-3.89 (1 H, m, CHN) and 4.10-4.20 (2 
H, m, O C //2CH3); 8c(100 MHz; CDC13) 14.4 (CH3), 19.8 (CH3), 20.1 (CH3), 20.3 (CH3),
21.0 (CH3), 26.7 (CH2), 30.3 (CH), 32.9 (CH2), 34.1 (CH2), 35.0 (CH2), 38.6 (CH2), 47.0 
(CH), 47.4 (CH), 48.7 (C), 53.1 (Q , 60.5 (CH2), 65.3 (CH), 170.7 (C=0) and 174.2 
(C=0); m/z (FAB+) 386 [(M+H)+, 59%] 171 (100) and 135 (14); [Found (M+Na)+ 
408.1833; Ci9H3iN 0 5S requires 408.1821],
8.4.1.5 (-)-(2/?)-Ar-[(37?)-3-(Ethoxycarbonyl)-3-butylpropanoyl]bornane-10,2-sultam
274
O
274
Using butyl magnesium chloride (3.2 cm3 of a 2 mol dm'3 solution in Et20) and 264 
on a 2.9 mmol scale following General procedure 7 produced a mixture o f 
diastereoisomers 274 (0.97 g, 84%) as a colourless oil. [a]o -69 (c 1.5, EtOAc); 
iw (N aC l)/cm -‘ 2960 (CH), 1733 (ester), 1695 (amide), 1336 and 1135 (-S 0 2-N); 6H(400 
MHz; CDCI3) 0.89 (3 H, t, 7  7.1, C tf3CH2), 0.98 (3 H, s, C //3CCH3), 1.17 (3 H, s, 
C //3CCH3), 1.24-1.43 (10 H, m, alkyl-H), 1.50-1.68 (2 H, m, alkyl-H), 1.87-1.96 (2 H, m, 
alkyl-H), 2.04-2.18 (2 H, m, alkyl-H), 2.84-2.93 (2 H, m, alkyl-H), 3.15 (ABX system, 1 
H, dd, 7  10.2 and 17.8, COCH//CH), 3.41-3.52 (2 H, m, alkyl-H), 3.85-3.89 (1 H, m, 
CHN) and 4.10-4.22 (2 H, m, O C //2CH3); 6C(100 MHz; CDCI3) 13.8 (CH3), 14.2 (CH3),
20.7 (CH3), 21.6 (CH3), 23.3 (CH2), 27.2 (CH2), 29.9 (CH2), 32.4 (CH2), 33.6 (CH2), 38.1 
(CH2), 39.1 (CH2), 41.8 (CH), 48.6 (C), 49.3 (Q , 53.7 (CH2), 53.9 (C), 61.2 (CH2), 65.9 
(CH), 171.0 (C =0) and 175.5 (C=0); m/z (El) 399 (M \ 30%), 185 (M+- camphorsultam, 
100); (Found M* 399.2080; C2oH33N 0 5S requires M+ 399.2079).
8.4.1.6 terf-Butyl ethyl fum arate  268140
268
Compound 268 was prepared in 53% yield on a 0.14 mol scale by the method of 
Steglich and co-workers.140 8H(400 MHz, CDC13) 1.32 (3 H, t, J 12, C //3CH20), 1.51 (9 
H, s, OCCHi), 4.26 (2 H, q, 77 .1 , CH3C //2O), 6.75 (1 H, d, 7  15.8, Ctf=CH) and 6.79 (1 
H, d, 715.8, C7f=CH).
8.4.1.7 terf-Butyl fumaric acid141
HO
At 0 °C, tert-butyl ethyl fumarate 268 ( 12.6 g, 63 mmol) was dissolved in 
tetrahydrofuran (50 cm3) before lithium hydroxide (2.6 g, 63 mmol) was added. The 
reaction mixture was stirred for 5 h at 0 °C, then sat. aq. NH4CI (10 cm3) was added. The 
mixture was stirred for a further 10 min, after which ethyl acetate (20 cm3) was poured 
onto the reaction mixture. The aqueous layer was extracted and acidified to pH 2 using 1M 
HC1. The aqueous layer was extracted using ethyl acetate (3 x 20 cm3). The combined 
organic extracts were washed with brine (20 cm3), dried (MgS04) and concentrated under 
reduced pressure to give tert-butyl fumaric acid as a white solid (7.7 g, 71%). mp 127 °C; 
umax(KBr)/cm'1 3012 (CH) and 1700 (C=0); 6H(400 MHz, CDC13) 1.52 (9 H, s, OCCtf3), 
6.76 (1 H, d, J  15.7, Gtf=CH) and 6.79 (1 H, d, J  15.8, Ctf=CH); m/z (CI+ mode, 
isobutane) 173 (MH4, 100%) and 145 (10); (Found M H4 173.0795; C8H i20 4 requires 
173.0814).
8.4.1.8 tert-Butyl fumaroyl chloride 269
269
tert-Butyl fumaric acid and thionyl chloride (4 equiv.) were placed in a round- 
bottomed flask, equipped with water condenser, HC1 trap, and assembled under nitrogen. 
The reaction was heated to reflux until no more gas was given off. The excess thionyl 
chloride was removed under reduced pressure and the product was used with no further 
purification.
8.4.1.9 (-)-(2/?)-7V-[(£)-3-(te#'*-Butoxycarbonyl)prop-2-enoyl]bornane-10,2-sultam 265
265
(l£,2R)-(-)-2,10-Camphorsultam 111 (2.2 g, 10 mmol, 1 equiv.) in toluene (30 cm3) 
was added dropwise to a suspension o f NaH (0.37 g, 15 mmol, 1.5 equiv.) and stirred for 2 
h at room temperature. Then fumaroyl chloride tertbutyl ester 269 (2.2 g, 12 mmol, 1 
equiv.) in toluene (5 cm3) was added dropwise and the mixture was stirred for 10 min, 
quenched by addition o f saturated ammonium chloride (10 cm3) and poured onto saturated 
ammonium chloride (10 cm3). The aqueous layer was washed with toluene (3 x 25 cm3). 
The combined organic extracts were washed with brine (30 cm3), dried (MgS04), 
concentrated under reduced pressure and chromatographed [Si(>2, EtOAc-hexane (3:7)] to 
give the fumarate 265 (1.5 g, 40%) as an orange oil. [a]o -57.9 (c 2 .0, EtOAc); 
UmaxCNaCiycm' 1 2937 (CH), 1735 (ester), 1684 (amide), 1319 and 1153 (-S 02-N); 5H(400 
MHz; CDC13) 0.99 (3 H, s, CCH3), 1.18 (3 H, s, CCH3), 1.25-1.49 (4 H, m, alkyl-H), 1.51 
(9 H, s. [C(Ctf3)3], 1.91-1.95 (2 H, m, alkyl-H), 2.09-2.15 (1 H, m, alkyl-H), 3.51 (2 H, AB 
system, J  13.8, C tf2S 0 2), 3.94-3.96 (1 H, m, CHN), 6.85 (1 H, d, J  15.2, Ctf=CH) and 
7.47 (1 H, d, J  15.2, Ctf=CH); 5C(100 MHz; CDC13) 20.3 (CH3), 21.2 (CH3), 26.9 (CH2),
28.3 (3 x CH3), 33.3 (CH2), 38.7 (CH2), 45.0 (CH), 48.3 (Q, 49.1 (Q, 53.4 (CH2), 65.5 
(CH), 82.4 (C), 131.7 (CH), 136.6 (CH), 163.1 (C=0) and 164.2 (C=0); m/z (El) 369 (M*, 
4%), 135 (63) and 99 (100); (Found M+369.1609; C i8H27N 0 5S requires M+ 369.1610).
General procedure 8 for the 1,4-addition of Grignard reagents to (-)-(2/?)-A-[(2i)-3- 
(terf-Butoxycarbonyl)prop-2-enoyl]bornane-10,2-sultam 265.
The Grignard reagent (2.2 equiv.) in diethyl ether was added dropwise to a stirred 
solution o f (-)-(2K)-A-[(£)-3-(fert-butoxycarbonyl)prop-2-enoyl]bomane-10,2-sultam 265 
(1 equiv.) in dry THF (20 cm3) under N2 at -78  °C. After 3 h at -78 °C the reaction 
mixture was quenched with sat. aq. NH4CI soln. (15 cm3) and then poured onto sat. aq.
1/Z
NH4CI soln (15 cm3). The product was extracted with ethyl acetate (2 x 20 cm3). The 
combined organic extracts were dried (MgSC>4) and concentrated under reduced pressure.
8.4.1.10 (-)-(27?)-/V-|(3R)-3-(r<:'rt-Butoxycarbonyl)-3-ethylpropanoyl]bornane-
10,2-sultam 275
0 2
275
Using ethyl magnesium chloride (1.0 cm3 o f a 3 mol dm solution in Et20 )  and 265 
on a 1.36 mmol scale following General procedure 8 produced a mixture of 
diastereoisomers 275 (0.45 g, 83%) as a colourless oil. [<x] d  -53 ( c  1.0, EtOAc); 
tw (N aC l)/cm  ‘ 2968 (CH), 1724 (C=0), 1701 (C=0), 1333 and 1134 (-SO2-N); 6H(400 
MHz; CDCI3) 0.94 (3 H, t, J  7.2, C //3CH2), 0.98 (3 H, s, CH3CC//3), 1.17 (3 H, s, 
CffsCCHj), 1.47 (9 H, s, C(C//3)3), 1.54-1.70 (2 H, m, alkyl-H), 1.88-1.94 (4 H, m, alkyl- 
H), 2.05-2.12 (2 H, m, alkyl-H), 2.68-2.74 (1 H, m, alkyl-H), 2.81 (ABX system, 1 H, dd, J
4.8 and 17.2, COCH//CH), 3.09 (ABX system, 1 H, dd, J  9.3 and 17.0, COCHffCH), 3.42-
3.51 (3 H, m, C //2SO2 and COCHHC//) and 3.85-3.89 (1 H, m, C//N); 8C(100 MHz; 
CDCI3) 11.8 (CH3), 20.3 (CH3), 21.2 (CH3), 25.5 (CH2), 26.8 (CH2), 28.4 (3 x CH3), 33.2 
(CH2), 37.5 (CH2), 38.8 (CH2), 43.7 (CH), 45.0 (CH), 48.2 (Q , 48.9 (Q , 53.3 (CH2), 65.6 
(CH), 80.7 (C), 170.6 (C O )  and 174.0 (C O ) ;  m/z (CI+ mode, isobutane) 400 (MH*, 9%) 
344 (78) and 216 (56); (Found MFC 400.2156; C20H33NO5S requires 400.2158).
8.4.1.11 (-)-(2R)-/V-[(3R)-3-(n?rf-Butox\carbonyl)-3-benzy]propanoyl]bornane-
10,2-sultam 276
276
Using benzyl magnesium chloride (3 .0 cm o f a 1 mol dm solution in Et20) and 
265 on a 1.36 mmol scale following General procedure 8 produced a mixture o f 
diastereoisomers 276 (0.38 g, 60%) as a colourless oil. [a]n -40 (c 1.0, EtOAc); 
tw tN a C iy c m 1 2964 (CH), 1726 (C=0), 1701 (C=0), 1333 and 1134 (-S 02-N); 6H(400 
MHz; CDCU) 0.95 (3 H, s, CH3CC//3), 1.14 (3 H, s, C //3CCH3), 1.36 (9 H, s, C(C# 3)3), 
1.41-1.52 (3 H, m, alkyl-H), 1.86-1.92 (4 H, m, alkyl-H), 2.77-3.15 (5 H, m, alkyl-H), 
3.37-3.50 (2 H, m, CH2S02), 3.85-3.89 (1 H, m, CAN) and 7.11-7.32 (5 H, m, ArCH); 
5C(100 MHz; CDCI3) 20.3 (CH3), 21.3 (CH3), 26.8 (CH2), 28.3 (3 x CH3), 33.2 (CH2), 37.4 
(CH2), 38.3 (CH2), 38.8 (CH2), 44.0 (CH), 45.0 (CH), 48.1 (C), 48.9 (C), 53.2 (CH2), 65.5 
(CH), 81.0 (Q , 126.8 (ArCH), 128.7 (2 x ArCH), 129.1 (2 x ArCH), 139.0 (ArC), 170.3 
(C =0) and 173.4 (C=0 ); m/z (El) 461 (M4, 2%), 405 (40), 257 (74), 216 (45) and 135 
(100); (Found M4 461.2236; C25H35NO5S requires M+ 461.2236).
8.4.1.12 (-)-(2/?)-iV-[(3/J)-3-(tert-Butoxycarbonyl)-3-
isopropylpropanoyl]bornane-10,2-sultam  277
277
Using isopropyl magnesium chloride (2.0 cm3 o f a 2 mol dm solution in THF) and 
265 on a 1.8 mmol scale following General procedure 8 produced a mixture of 
diastereoisomers 277 (0.65 g, 86%) as a colourless oil. [a]o -59 (c 1.5, EtOAc); 
tw (N aC l)/cm '1 2966 (CH), 1725 (C=0), 1701 (C=0), 1331 and 1134 (-SO2-N); 8H(400 
MHz; CDCI3) 0.95-0.97 (9 H, m, C ftC H C ffj and CH3CC//3), 1.16 (3 H, s, CH3CC//3), 
1.44 (9 H, s, C(CHih), 1.86-2.12 (8 H, m, alkyl-H), 2.62-2.82 (2 H, m, COCH2CH), 3.06- 
3.16 (1 H, m, COCH2CH), 3.40-3.52 (2 H, m, C//2SO2) and 3.83-3.88 (1 H, m, CHN); 
5C(100 MHz; CDCI3) 20.2 (CH3), 20.5 (2 x CH3), 21.2 (CH3), 26.9 (CH2), 28.4 (3 x CH3),
30.5 (C), 30.6 (CH), 33.2 (CH2), 34.7 (CH2), 38.8 (CH2), 45.0 (CH), 48.2 (CH), 48.9 (C),
53.3 (CH2), 65.6 (CH), 80.7 (C), 171.2 (C =0) and 173.4 (C=0); m/z (CI+ mode, isobutane) 
414 (MH4, 30%) 358 (100) and 216 (82); (Found MH+ 414.2312; C21H35NO5S requires 
414.2314).
8.4.1.13 (-)-(2/?)-A-[(3/?)-3-(terf-Butoxycarbonyl)-3-butylpropanoyl]bornane-
10,2-sultam 278
278
Using butyl magnesium chloride (2.2 cm3 o f a 2 mol dm'3 solution in Et20) and 265 
on a 2.0 mmol scale following General procedure 8 produced a mixture o f 
diastereoisomers 278 (0.75 g ,  88%) as a colourless oil. [ cx] d  -50 (c 1.5, EtOAc); 
W N a C O /c m -1 2963 (CH), 1724 (C=0), 1701 (C=0), 1332 and 1134 (-S 02-N); 8H(400 
MHz; CDCI3) 0.89 (3 H, t, J  7.2, C //3CH2), 0.98 (3 H, s, CH3CCtf3), 117 (3 H, s, 
C773CCH3), 1.23-1.41 (8 H, m, alkyl-H), 1.45 (9 H, s, C(C//3)3), 1.48-1.68 (2 H, m, alkyl- 
H), 1.87-1.94 (2 H, m, alkyl-H), 2.04-2.12 (1 H, m, alkyl-H), 2.73-2.83 (2 H, m, alkyl-H),
3.09 (ABX system, 1 H, dd, J  9.2 and 16.8, COCHffCH) 3.47 (2 H, AB system, J  13.8, 
CtfjSOz) and 3.85-3.88 (1 H, m, C//N); 8C(100 MHz; CDC13) 14.1 (CH3), 20.1 (CH3), 21.0 
(CH3), 22.7 (CH2), 26.6 (CH2), 28.3 (3 x CH3), 29.3 (CH2), 31.9 (CH2), 33.0 (CH2), 37.7 
(CH2), 38.5 (CH2), 42.1 (CH), 44.9 (CH), 48.0 (Q , 48.7 (C), 53.1 (CH2), 65.4 (CH), 80.5 
(C), 170.4 (C O )  and 174.0 (C O ) ;  m/z (CI+ mode, isobutane) 428 (MH+, 33%) 372 ( 100) 
and 216 (78); (Found MH*428.2473; C22H37N 0 5S requires 428.2471).
8.5 Experimental for Chapter 7
8.5.1 Synthesis of 2-substituted butane-1,4-diols
General 9 procedure for the reduction of 2-substituted succinic acids into 2- 
substituted butane-1,4-diols.
Borane (1.0 mol dm'3 solution in THF, 5 equiv.) was added dropwise to a stirred 
solution o f 2-substituted succinic acid (1.0 g) in dry THF (20 cm3) under N2 at 0 °C. After 
4 h at 0 °C the excess borane was quenched with addition o f methanol (20 cm3) and the 
reaction mixture was concentrated under reduced pressure. The residue was redissolved in 
methanol (20 cm3) and concentrated under reduced pressure (x3).
8.5.1.1 (±)-2-Methylbutane-l,4-diol 301142
H O .
y '  0 H
301
Using (±)-2-methylsuccinic acid 7.6 mmol following General procedure 9 gave a 
residue which was chromatographed [Si02, acetone-hexane ( 1:1)] to give (±)-2- 
methylbutane-l,4-diol 301 (0.68 g, 85 %) as a colourless oil. 6h (400 MHz; CDCI3) 0.94 (3 
H, d, J 6.8, C//3CH), 1.56-1.69 (2 H, m, Ctf2CH2OH), 1.79-1.85 (1 H, m, CH3Ctf), 1.44 (2 
H, br s, OH), 3.45 (ABX system, 1 H, dd, J1.6  and 10.8, CHCHtfOH), 3.58 (ABX system, 
1 H, dd, J4 A  and 10.8, CHCHtfOH) 3.64-3.70 (1 H, m, CH2CHtfOH) and 3.76-3.81 (1 H, 
m, CH2CH//OH).
8.5.1.2 (2/?)-2-Methylbutane-l,4-diol 302143
H O .
Y  0 H
302
Using (2R)-2-methylsuccinic acid 7.6 mmol following General procedure 9 gave a 
residue which was chromatographed [Si02, acetone-hexane (1:1)] to give (2R)-2- 
methylbutane-l,4-diol 302 (0.60 g, 75 %) as a colourless oil. Spectral data were identical 
to racemate 301. [a]D +11 (c 3.3, MeOH) [lit.143 +13.6, (c 3.3, MeOH)].
8.5.1.3 (2A)-2-MethyIbutane-l,4-diol 303143
HO
OH
303
Using 2*S'-2-methylsuccinic acid (1.0 g, 7.6 mmol) following General procedure 9 
gave a residue which was chromatographed [Si02, acetone-hexane (1:1)] to give (2S)-2- 
methylbutane-l,4-diol 303 (0.76 g, 95%) as a colourless oil. Spectral data were identical to 
racemate 301. [a]D -12 (<c 3.3, MeOH) [lit.143- 13.4, (c 3.3, MeOH)].
8.5.1.4 (±)-2-EthyIbutane-l,4-diol 304144
304
Ethyl tert-butyl succinate 129 (0.80 g, 4.0 mmol) in dry THF (10 cm3) was added
pressure. The residue was chromatographed [Si02, acetone-hexane (2:3)] to give (±)-2- 
ethylbutane-l,4-diol 304 (0.38 g, 81%) as a colourless oil. UmaxCNaCiycrn' 1 3367 (OH) and 
2927 (alkyl); 5H(400 MHz; CDC13) 0.93 (3 H, t, J  7.5, Ctf3CH2), 1.25-1.45 (2 H, m, 
CH3Gtf2), 1.54-1.64 (2 H, m, Ctf2CH2OH), 1.68-1.77 (1 H, m, CH), 2.48 (2 H, br s, OH),
3.52 (ABX system, 1 H, dd, J6.6  and 10.8, CHCHtfOH), 3.65-3.61 (2 H, m, CH2C ^ 2OH) 
and 3.78-3.83 (1 H, m, CHCHtfOH); 6C(100 MHz; CDC13) 11.5 (CH3), 24.4 (CH2), 35.4 
(CH2), 40.9 (CH), 61.2 (CH2) and 66.0 (CH2); m/z (CI+ mode, isobutane) 119 (MH+, 
100%) 101 (64) and 83 (19); (Found M t f  119.1073; C6Hi40 2 requires 119.1072).
8.5.1.5 (2/?)-2-EthyIbutane-l,4-diol 305145
(2R)-A,A'-Bis[(2R)-bomane-10,2-sultam]-2-ethylsuccinamide 186 (1.10 g, 2.0
dropwise to a stirred solution o f lithium aluminium hydride (0.75 g, 20 mmol) in dry THF 
(50 cm3) under N2 at 0 °C. After 3 h at 0 °C the reaction mixture was quenched with sat. 
aq. NH4CI soln. (4 cm3). The mixture was filtered and concentrated under reduced
HO
OH
305
mmol) in dry THF (10 cm3) was added dropwise to a stirred solution o f lithium aluminium
hydride (0.38 g, 10 mmol) in dry THF (50 cm3) under N2 at 0 °C. After 3 h at 0 °C the 
reaction mixture was quenched with sat. aq. NH4CI soln. (4 cm3). The mixture was filtered 
and concentrated under reduced pressure. The mixture was chromatographed [SiC>2, 
acetone-hexane (2:3)] to give (2R)-2-ethylbutane-1,4-diol 305 (0.14 g, 58%) as a 
colourless oil. Spectral data were identical to racemate 304. [a]o +11 (c 1.5, CHCI3) [lit.141 
+14, (c 1.5, CHCI3)]; m/z (FAB+) 141 [(M+Na)+, 100%] and 119 [(M+H)+, 26]; [Found 
(M+Na)+ 141.0892; C6H i40 2 requires 141.0891].
8.5.1.6 (2*S)-2-EthyIbutane-l,4-dioI 306145
306
(2iS)-Ar,A^-Bis[(25)-bomane-10,2-sultam]-2-ethylsuccinamide (1.18 g, 2.2 mmol) in 
dry THF (10 cm3) was added dropwise to a stirred solution o f lithium aluminium hydride 
(0.42 g, 11 mmol) in dry THF (50 cm3) under N2 at 0 °C. After 3 h at 0 °C the reaction 
mixture was quenched with sat. aq. NH4CI soln. (4 cm3). The mixture was filtered and 
concentrated under reduced pressure. The mixture was chromatographed [SiC>2, acetone- 
hexane (2:3)] to give (25)-2-ethylbutane-l,4-diol 306 (0.16 g, 62%) as a colourless oil. 
Spectral data were identical to racemate 304. [a]o -14.2 (c 1.5, CHCI3); m/z (CI+ mode, 
isobutane) 119 (MH^ 100%) 101 (40) and 83 (12); (Found M fT 119.1070; C6H 14O2 
requires 119.1072).
8.5.1.7 (±)-2-Phenylbutane-l,4-diol 307
HO
146
OH
A
307
Using (±)-2-phenylsuccinic acid 5.2 mmol) following General procedure 9 gave a 
residue which was chromatographed [Si02, acetone-hexane (2:3)] to give (±)-2- 
phenylbutane-l,4-diol 307 (0.68 g, 79 %) as a colourless oil. 5h (400 MHz; CDCI3) 1.69 (2 
H, br s, OH), 1.87-1.95 (1 H, m, CH/7CH2OH), 2.00-2.08 (1 H, m, CH//CH2OH), 2.95- 
3.02 (1 H, m, GtfCH2OH), 3.57-3.63 (1 H, m, CH2CH//OH), 3.68-3.74 (1 H, m,
CH2CH/70H) 3.80 (2 H, d, J 6.6, CHGtf2OH), 7.23-7.27 (3 H, m, ArC//) and 7.35 (2H, t, 
J  7.5, ArC//).
8.5.1.8 (±)-2-Benzylbutane-l,4-diol 308149
308
tert- Butyl benzyl succinate 134 (1.15 g, 4.4 mmol) in dry THF (10 cm3) was added 
dropwise to a stirred solution o f lithium aluminium hydride (0.83 g, 22 mmol) in dry THF
pressure. The residue was chromatographed [S i02, acetone-hexane (2:3)] to give (±)-2- 
benzylbutane-l,4-diol 308 (0.45 g, 58 %) as a colourless oil. UmaxCNaCiycrn' 1 3340 (OH) 
and 2927 (alkyl); 6H(400 MHz; CDC13) 1.58-1.67 (1 H, m, ArCHZ/CH), 1.70-1.77 (1 H, m, 
ArCH//CH), 1.97-2.06 (1 H, m, ArCH2C//), 2.16 (2 H, br s, OH), 2.58 (1 H, dd, J 7 .4  and 
13.6, CH//CH2OH), 2.70 (1 H, dd, J 7 .6  and 13.7, CHZ/CH2OH), 3.53 (1 H, dd, J  6.5 and
10.9 CHCHZ/OH), 3.65-3.70 (2 H, m, CH2C //2OH), 3.77-3.83 (1 H, m, CHCHZ/OH) and 
7.18-7.31 (5 H, m, AiCH), 5C(100 MHz; CDC13) 35.2 (CH2), 38.2 (CH2), 41.1 (CH), 61.1. 
(CH2), 65.6 (CH2), 126.0 (ArCH), 128.4 (2 x ArCH), 129.1 (2 x ArCH) and 138.1(ArC); 
m/z (CI+ mode, isobutane) 181 (MH+, 100%) 163 (70) and 145 (27); (Found MFC 
181.1228; C hH i60 2 requires 181.1229).
8.5.2 Synthesis of 2-substituted butane-1,4-ditosylates
General procedure 10 for the conversion of 2-substituted butane-1,4-diols into 2- 
substituted butane-1,4-ditosylates.
To an ice-cooled solution o f benzensulfonyl chloride or p-toluenesulfonyl chloride 
(3 equiv.) in dry pyridine (5 cm3) was added dropwise a solution of diol (-0.5 g) in dry 
pyridine (5 cm3). The mixture was stirred at 0 °C for 3 h, then poured into ice-cooled water 
(30 cm3) and extracted with ethyl acetate ( 3 x 3 0  cm3). Organic extracts were washed with
HO
OH
(50 cm3) under N 2 at 0 °C. After 3 h at 0 °C the reaction mixture was quenched with sat.
' j
aq. NH4CI soln. (4 cm ). The mixture was filtered and concentrated under reduced
1M HC1 (40 cm3), water (40 cm3) and sodium bicarbonate solution (40 cm3). The 
combined organic extracts were dried (MgSC>4) and concentrated under reduced pressure. 
The combined organic extracts were dried (MgSC>4) and concentrated under reduced 
pressure.
8.5.2.1 (±)-2-Methyl-l,4-bis(benzenesulfonyloxy)butane 309
•s-
II
o
o—s
309
Using benzenesulfonyl chloride and (±)-2-methylbutane-l,4-diol 301 on a 5.4 
mmol scale following General procedure 10 gave a residue which was chromatographed 
[SiC>2, EtOAc-hexane (1:1)] to give (±)-2-methyl-l,4-bis(benzenesulfonyloxy)butane 309 
(0.8 g, 39%) as a colourless oil. UmaxCNaCiycm' 1 2970 (alkyl), 1357 and 1189 (-SO2-O); 
Sh(400 MHz; CDCI3) 0.87 (3 H, d, J 6.8, C/73CH), 1.45-1.54 (1 H, m, CHtfCH20), 1.73- 
1.82 (1 H, m, CH//CH2O), 1.92-2.00 (1 H, m, CH3CH), 3.82-3.90 (2 H, m, CHCtf20),
4.01-4.09 (2 H, m, CH2Ctf20 ), 7.55-7.59 (4 H, m, ArCH), 7.66-7.70 (2 H, m, ArCH) and 
7.88-7.91 (4 H, m, ArCH); 5C(100 MHz; CDC13) 16.3 (CH3), 29.9 (CH), 32.2 (CH2), 68.4 
(CH2), 77.5 (CH2), 128.1 (2 x ArCH), 128.2 (2 x ArCH), 129.7 (4 x ArCH), 134.2 (2 x 
ArCH), 136.2 (ArC) and 136.3 (ArC); m/z (CI+ mode, isobutane) 385 (MFC, 6%) 149 (28) 
and 87 (100); (Found MFC385.0779; C17H20O6S2 requires 385.0780).
8.5.2.2 (2/?)-2-Methyl-l,4-bis(benzenesulfonyloxy)butane 310
s -o o - s
310
Using benzenesulfonyl chloride and 2i?-methylbutane-l,4-diol 302 on a 2.3 mmol 
scale following General procedure 10 gave a residue which was chromatographed [SiC>2, 
EtOAc-hexane (1:1)] to give (2R)-2-methyl-1,4-bis(benzenesulfonyloxy)butane 310 (0.23 
g, 26 %) as a colourless oil. Spectral data were identical to racemate 309. [a]o +0.7 (c 1.0, 
CHC13); m/z (CI+ mode, isobutane) 385 (MTC, 17%) 227 (28) and 87 ( 100); (Found MFC 
385.0778; C17H20O6S2 requires 385.0780).
8.5.2.3 (2*S)-2-Methyl-l,4-bis(p-toluenesulfonyloxy)butane 311
s -o o - s
311
Using /7-toluenesulfonyl chloride and (21S)-2-methylbutane-l,4-diol 303 on a 2.9 
mmol scale following General procedure 10 gave a residue which was chromatographed 
[S i02, EtOAc-hexane (2:3)] to give (25)-2-methyl-1,4-bis(p-toluenesulfonyloxy)butane 
311 (0.61 g ,  51%) as a colourless oil. [ cx] d  -0.5 (c 0.3, CHCI3); UmaxCNaCiycrn'1 2968 
(alkyl), 1358 and 1190 (-SO2-O); 6H(400 MHz; CDC13) 0.86 (3 H, d, J 6.8, C //3CH), 1.43-
1.52 (1 H, m, CHHCH2O), 1.71-1.79 (1 H, m, CH/7CH20), 1.90-1.98 (1 H, m, CH3CH), 
2.46 (6 H, s, 2 x CH3), 3.78-3.86 (2 H, m, CHC//20 ), 4.00-4.05 (2 H, m, CH2CH20 ), 7.36 
(4 H, d, J  8.0, AiCH), and 7.69 (4 H, d, J  8.3, AiCH), 5C(100 MHz; CDC13) 16.1 (CH3),
21.8 (2 x CH3), 29.6 (CH), 32.0 (CH2), 68.0 (CH2), 74.2 (CH2), 128.1 (4 x ArCH), 130.1 (4 
x ArCH), 134.0 (2 x ArCH) and 145.3 (2 x ArC); m/z (El) 412 (M+, 6%), 241 (24), 173 
(22), 155 (74), 91 (100) and 69 (90); (Found M* 412.1013; C19H24O6S2 requires M+ 
412.1014).
8.5.2.4 (±)-2-Ethyl-l,4-bis(j?-toIuenesuIfonyloxy)butane 312
s - o o - s
312
Using/7-toluenesulfonyl chloride and (±)-2-ethylbutane-l,4-diol 304 on a 2.5 mmol 
scale following General procedure 10 gave a residue which was chromatographed [Si02, 
EtOAc-hexane (2:3)] to give (±)-2-ethyl-1,4-bis(p-toluenesulfonyloxy)butane 312 (0.8 g, 
73%) as a colourless oil. UmaxCNaCiycm'1 2966 (alkyl), 1358 and 1174 (-SO2-O); 6h (400 
MHz; CDCI3) 0.77 (3 H, t, J  1.2, CH3CH2), 1.25-1.33 (2 H, m, CH2CH20), 1.62-1.69 (3 H, 
m, CHCH2CH3), 2.47 (6 H, s, 2 x AiCCH3), 3.87-3.95 (2 H, m, CHC7720), 4.01-4.04 (2 H, 
m, CH2Gtf20), 7.36 (4 H, d, J  8.0, AiCH) and 7.75-7.78 (4 H, m, ArC//); 5c(100 MHz; 
CDCI3) 10.8 (CH3), 21.7 (2 x CH3), 23.0 (CH2), 29.9 (CH2), 35.7 (CH), 68.0 (CH2), 71.2 
(CH2), 127.9 (4 x ArCH), 130.0 (4 x ArCH), 133.0 (2 x ArC) and 142.0 (2 x ArC); m/z (El)
426 (M+, 6%), 255 (19), 155 (59) and 83 (100); (Found M* 426.1172; C2oH2606S2 requires 
M +426.1171).
8.5.2.5 (2/?)-2-Ethyl-l,4-bis(p-toluenesuIfonyloxy)butane 313110
s -o o - s
313
Using /7-toluenesulfonyl chloride and (2i?)-ethylbutane-1,4-diol 305 on a 1.4 mmol 
scale following General procedure 10 gave a residue which was chromatographed [S i02, 
EtOAc-hexane (2:3)] to give (2K)-2-ethyl-l,4-bis(p-toluenesulfonyloxy)butane 313 (0.35 
g, 65%) as a colourless oil. Spectral data were identical to racemate 312. [ oi] d  -5 (c 1.0, 
EtOAc); m/z (El) 426 (IVT, 6%), 255 (20), 155 (57) and 83 (100); (Found 426.1172; 
C20H26O6S2 requires h/T 426.1171).
8.5.2.6 (2A)-2-Ethyl-l,4-bis(p-toluenesulfonyloxy)butane 314110
s - o o - s
314
Using /7-toluenesulfonyl chloride and (2*S)-2-ethylbutane-l,4-diol 306 on a 1.0 
mmol scale following General procedure 10 gave a residue which was chromatographed 
[Si02, EtOAc-hexane (2:3)] to give (2*S)-2-ethyl-l,4-bis(p-toluenesulfonyloxy)butane 314 
(0.2 g, 61%) as a colourless oil. Spectral data were identical to racemate 312. [(x] d  +3.1 (c
1.0, EtOAc); m/z (El) 426 (IVT, 8%), 255 (20), 155 (55) and 83 (100); (Found M+ 
426.1172; C20H26O6S2 requires h/T 426.1171).
8.5.2.7 (±)-2-Phenyl-l,4-bis(/?-toluenesulfonyloxy)butane 315148
s - o o - s
r i l
315
Using ^-toluenesulfonyl chloride and (±)-2-phenylbutane-l,4-diol 307 on a 2.2 
mmol scale following General procedure 10 gave a residue which was chromatographed 
[Si02, EtOAc-hexane (2:3)] to give (±)-2-phenyl-l,4-bis(p-toluenesulfonyloxy)butane 315 
(0.28 g, 32%) as a colourless oil. UmaxCNaCiycrn'1 2958 (alkyl), 1360 and 1176 (-SO2-O); 
5h(400 MHz; CDC13) 1.82-1.90 (1 H, m, CH//CHCH20), 2.12-2.21 (1 H, m, 
CH//CHCH2O), 2.43 (3 H, s, ArCCH3), 2.46 (3 H, s, ArCCH3), 2.99-3.06 (1 H, m, 
C//CH20 ), 3.84-3.89 (1 H, m, CHCH//O), 4.05-4.10 (1 H, m, CHCH/70), 4.13-4.21 (2 H, 
m, CH2CH2O), 7.07-7.09 (2 H, m, ArC//), 7.32-7.35 (3 H, m, ArC//), 7.40-7.44 (4 H, m, 
ArCH), 7.77 (2 H, d, J  8.3, ArCH) and 7.82 (2 H, d, J  8.3, ArC//); 6C(100 MHz; CDC13)
21.8 (2 x CH3), 31.2 (CH2), 41.3 (CH), 67.8 (CH2), 73.1 (CH2), 127.7 (ArCH), 128.0 (6 x 
ArCH), 129.0 (2 x ArCH), 130.0 (4 x ArCH), 132.8 (ArC), 133.0 (ArC), 138.4 (ArC) and
145.0 (2 x ArC); m/z (El) 475 (M+, 14%), 303 (40) and 131 (100); (Found M+ 475.1247; 
C24H26O6S2 requires M^ 475.1249).
8.5.2.8 (±)-2-Benzyl-l,4-bis(p-toluenesulfonyloxy)butane 316
s - o o - s
316
Using p-toluenesulfonyl chloride and (±)-2-benzylbutane-l,4-diol 308 on a 1.6 
mmol scale following General procedure 10 gave a residue which was chromatographed 
[Si02, EtOAc-hexane (2:3)] to give (±)-2-benzyl-1,4-bis(p-toluenesulfonyloxy)butane 316 
(0.29 g, 38%) as white crystals, mp 98-99 °C; UmaxO^aCiycm’1 2937 (alkyl), 1353 and 
1176 (-SO2-O); 5h(400 MHz; CDC13) 1.69-1.75 (2 H, m, C/72CHCH20), 2.01-2.10 (1 H,
m, CH2C//C H 20 ), 2.46 (3 H, s, ArCCH3), 2.47 (3 H, s, A rC C ft), 2.54-2.56 (2 H, m, 
ArCCH2), 3.78 (1 H, dd, 7  4.4, 10.0, CHCHHO), 3.87 (1 H, dd, 7  4.0, 9.6, CHCHffO),
4.01-4.03 (2 H, m, CH2C7/20 ), 6.95-6.97 (2 H, m, ArCH), 7.17-7.22 (3 H, m, ArCH), 7.36 
(4 H, m, ArCH), 1.1 A (2 H, d, 76 .4 , ArCH) and 7.76 (2 H, d, 76 .4 , ArCH)-, 5C(100 MHz; 
CDCb) 21.8 (2 x CH3), 30.1 (CH2), 36.4 (CH), 36.8 (CH2), 68.0 (CH2), 70.8 (CH2), 126.6 
(ArCH), 127.7 (2 x ArCH), 128.1 (2 x ArCH), 128.7 (2 x ArCH), 129.2 (2 x ArCH), 130.1 
(4 x ArCH), 132.8 (ArC), 133.0 (ArC), 138.3 (ArC), 138.5 (ArC) and 145.1 (2 x ArC); m/z 
(El) 511 (M+, 84%), 145 (100), 92 (38) and 74 (35); (Found M* 511.1224; C25H280 6S2 
requires M+ 511.1225).
8.5.3 Synthesis of 2-substituted butane-1,4-diazides
General procedure 11 for the conversion o f 2-substituted butane-1,4-ditosylates into 
2-substituted butane-1,4-diazides.
The sulfonate diester (~0.2 g, 1 equiv.) was dissolved in dry DMF (5 cm3) and 
added to this was sodium azide (6 equiv.). The reaction mixture was stirred at 60 °C 
overnight. After cooling the reaction mixture was diluted with water (5 cm3) and extracted 
with hexane (3 x 10 cm3). The combined organic extracts were dried (MgS04) and 
concentrated under reduced pressure.
8.5.3.1 (±)-2-MethyIbutane-l,4-diazide 317
317
Using (±)-2-methyl-l,4-bis(benzenesulfonyloxy)butane 309 on a 1 mmol scale 
following General procedure 11 gave (±)-2-methylbutane-l,4-diazide 317 (0.14 g, 95%) as 
a colourless oil. UmaxCNaCiycrn'1 2933 (alkyl), 2106 and 1265 (N3); 5h(400 MHz; CDCI3)
1.00 (3 H, d, J6.1, CH3CH), 1.42-1.51 (1 H, m, alkyl-H), 1.69-1.78 (1 H, m, alkyl-H), 
1.82-1.91 (1 H, m, alkyl-H), 3.20-3.29 (2 H, m, CHCtf2N3) and 3.31-3.42 (2 H, m, 
N3C ^ 2CH2).
8.5.3.2 (27?)-2-Methylbutane-l,4-diazide 318
N
318
Using (2R)-2-methyl-l,4-bis(benzenesulfonyloxy)butane 310 on a 0.6 mmol scale 
following General procedure 11 gave (2i?)-2-methylbutane-1,4-diazide 318 (51 mg, 55%) 
as a colourless oil. Spectral data were identical to racemate 317.
8.5.3.3 (2iS)-2-Methylbutane-l,4-diazide 319
319
Using (2iS)-2-methyl-1,4-bis(/?-toluenesulfonyloxy)butane 311 on a 1.5 mmol scale 
following General procedure 11 gave (2*S)-2-methylbutane-1,4-diazide 319 (0.12 g, 52%) 
as a colourless oil. Spectral data were identical to racemate 317.
8.5.3.4 (±)-2-Ethylbutane-l,4-diazide 320
Using (±)-2-ethyl-1,4-bis(p-toluenesulfonyloxy)butane 312 on a 0.5 mmol scale 
following General procedure 11 gave (±)-2-ethylbutane-l,4-diazide 320 (68 mg, 81%) as a 
brown oil. UmaxfNaCiycm'1 2966 (alkyl), 2100 and 1265 (N3); 5h(400 MHz; CDCI3) 0.95 
(3 H, t, J1.5, C//3CH2), 1.33-1.46 (2 H, m, alkyl-H), 1.60-1.70 (3 H, m, alkyl-H) and 3.28- 
3.38 (4 H, m, N3Ctf2CH2and CHC//2N3).
320
8.5.3.5 (2/?)-2-Ethylbutane-l,4-diazide 321
183
Using (22?)-2-ethyl-l,4-bis(/?-toluenesulfonyloxyl)butane 313 on a 0.5 mmol scale 
following General procedure 11 gave (2K)-2-ethylbutane-1,4-diazide 321 (55 mg, 65%) as 
a colourless oil. Spectral data were identical to racemate 320.
8.5.3.6 (2A)-2-Ethylbutane-l,4-diazide 322
Using (25)-2-ethyl-1,4-bis(p-toluenesulfonyloxyl)butane 314 on a 0.56 mmol scale 
following General procedure 11 gave (2*S)-2-ethylbutane-1,4-diazide 322 (50 mg, 53%) as 
a colourless oil. Spectral data were identical to racemate 320.
8.5.3.7 (±)-2-Phenylbutane-l,4-diazide 323
N
Using (±)-2-phenyl-l,4-bis(^-toluenesulfonyloxy)butane 315 on a 0.86 mmol scale 
following General procedure 11 gave (±)-2-phenylbutane-l,4-diazide 323 (0.14 g, 74%) as 
a colourless oil. UmaxfNaCiycm'1 2931 (alkyl), 2094 and 1287 (N3); 5h(400 MHz; CDCI3) 
1.81-1.92 (1 H, m, N3CH2CHH), 2.03-2.12 (1 H, m, N3CH2CHH), 2.94-3.02 (1 H, m, 
CHCH2N3), 3.05-3.14 (1 H, m, N3CHtfCH2), 3.23-3.29 (1 H, m, N3CHtfCH2), 3.47 (1 H, 
dd, J  6.8 and 12.0, CHCH//N3), 3.55 (1 H, dd, J1.2  and 12.0, CHCH^N3) and 7.21-7.39 
(5 H, m, ArCH).
8.5.3.8 (±)-2-Benzylbutane-l,4-diazide 324
N
322
323
324
Using (±)-2-benzyl-1,4-bis(p-toluenesulfonyloxy)butane 316 on a 0.37 mmol scale 
following General procedure 11 gave (±)-2-benzylbutane-l,4-diazide 324 (45 mg, 53%) as 
a colourless oil. \)m»x(NaCl)/cm‘l 2931 (alkyl), 2100 and 1286 (N3); 6H(400 MHz; CDCU) 
1.61-1.76 (2 H, m, N3CH2Ctf2), 1.98-2.08 (1 H, m, C//CH2N3), 2.58 (2 H, dd, J  3.2 and
8.0, Ai CCH2\  3.25 (2 H, dd, J  5.6 and 12.4, N3CH//CH2 and CHCHflN3) and 7.17-7.34 
(5 H, m, ArCH).
8.5.4 Conversion of diazides into diamines
General procedure 12 for the conversion of 2-substituted butane-1,4-diazides into 2- 
substituted butane-1,4-diamines.
Lithium aluminium hydride (3 equiv.) was added dropwise to a stirred solution o f 
2-substituted-butane-l,4-diazide (1 equiv.) in dry THF (10 cm3) under N2 at room 
temperature. The reaction mixture was stirred at 60 °C overnight and then treated slowly 
with 15% NaOH solution until a white, granular precipitate was formed. After filtration 
through Celite, the mixture was partitioned between 2 M hydrochloric acid (20 cm3) and 
dichloromethane (20 cm3). The aqueous layer was further extracted with dichloromethane 
(2 x 20 cm3). The aqueous layer was evaporated to dryness under reduced pressure and 
crystallised from aqueous ethanol to give 2-substituted butane-1,4-diamine 
dihydrochloride.
8.5.4.1 (±)-2-Methylbutane-l,4-diamine dihydrochloride 325149
Using (±)-2-methylbutane-l,4-diazide 317 on a 1 mmol scale following General 
procedure 12 gave (±)-2-methylbutane-1,4-diamine dihydrochloride 325 (72 mg, 40%) as 
a brown solid, mp 148-150 °C; 'umax(KBr)/cm'1 3016 (-NH3+), 2869 (alkyl), 1608 and 1479 
(-NH3+); 6h(400 MHz; D20 )  0.97 (3 H, d, J  6.7, C tf3CH), 1.37-1.47 (1 H, m, NCH2CHtf),
1.57-1.66 (1 H, m, NCH2CHtf), 1.73-1.83 (1 H, m, CH3CH), 2.69 (1 H, dd, J8 .5  and 12.9, 
CHCH7/N) and 2.83-2.98 (3 H, m, N Ctf2CH2 and CHCH/7N); 5C(100 MHz; D20 )  15.6 
(CH3), 28.9 (CH), 30.9 (CH2), 37.1 (CH2) and 44.6 (CH2).
325
8.5.4.2 (2/?)-2-Methylbutane-l,4-diamine dihydrochloride 3261S0
NH2.2HC1
326
Using (2i?)-2-methylbutane-1,4-diazide 318 on a 0.4 mmol scale following General 
procedure 12 gave (2/?)-2-methylbutane- 1,4-diamine dihydrochloride 326 (31 mg, 51%) 
as a brown hygroscopic solid.
8.5.4.3 (2*S)-2-Methylbutane-l,4-diamine dihydrochloride 32778
Using (2*S)-2-methylbutane-l,4-diazide 319 on a 0.8 mmol scale following General 
procedure 12 gave (2iS)-2-methylbutane- 1,4-diamine dihydrochloride 327 (40 mg, 29%) as 
a white solid. Spectral data were identical to racemate 325. mp 143-145 °C; [a]o -4 (c 1.0, 
H2O); m/z (CI+ mode, isobutane) 103 (MfT, 100%) and 86 (58); (Found MFC 103.1235; 
CgHi6N2 requires 103.1235).
8.5.4.4 (±)-2-Ethylbutane-l,4-diamine dihydrochloride 328149
Using (±)-2-ethylbutane-l,4-diazide 320 on a 0.4 mmol scale following General 
procedure 12 gave (±)-2-ethylbutane-1,4-diamine dihydrochloride 328 (50 mg, 66%) as a 
brown hygroscopic solid. 8h(400 MHz; D2O) 0.82 (3 H, t, J  7.5, C//3CH2), 1.34-1.47 (2 H, 
m, CH3CH2), 1.58-1.78 (2 H, m, NCH2Ctf2) and 2.93-3.02 (4 H, m, N C //2CH2 and 
CHCtf2N); 5C(100 MHz; D20 )  9.2 (CH3), 22.5 (CH2), 35.1 (CH), 37.4 (CH2) and 42.1 
(CHa).
327
328
8.5.4.5 (2*S)-2-Ethylbutane-l,4-diamine dihydrochloride 329
H2N
NH2.2HC1
329
Using (2*S)-2-ethylbutane-l,4-diazide 322 on a 0.3 mmol scale following General 
procedure 12 gave (2AS)-2-ethylbutane-1,4-diamine dihydrochloride 329 (28 mg, 49%) as a 
brown hygroscopic solid. Spectral data were identical to racemate 325.
8.5.4.6 (±)-2-Phenylbutane-l,4-diamine dihydrochloride 330151
procedure 12 gave (±)-2-phenylbutane-1,4-diamine dihydrochloride 330 (52 mg, 35%) as 
a white powder, mp 253-255 °C (lit.151 254-257 °C); (Found: C, 50.4 H, 7.6 N, 11.3%; 
CioHi8N2C12 requires C, 50.6 H, 7.65 N, 11.8%); u ^ K B ry c m ’1 3027 (-NH3+), 2900 
(alkyl) and 1602 (-NH3+); 6H(400 MHz; D20 )  1.84-2.00 (2 H, m, NCH2Ctf2), 2.51-2.59 (1 
H, m, NCHtfCH2), 2.74-2.81 (1 H, m, CtfCH2N), 2.86-2.94 (1 H, m, CHCHtfN) 3.08-3.14 
(1 H, m, NCHtfCH2), 3.21 (1 H, dd, J  5.0 and 12.0, CHCHtfN) and 7.21-7.34 (5 H, m, 
ArCtf); 8C(100 MHz; D20 )  30.7 (CH2), 37.4 (CH2), 41.3 (CH), 44.3 (CH2) 128.0 (2 x 
ArCH), 128.6 (2 x ArCH), 129.6 (2 x ArCH) and 137.8 (ArC); m/z (CI+ mode, isobutane) 
165 (MFC, 100%) and 148 (45); (Found MFC 165.1391; C8Hi6N2 requires 165.1392).
330
Using (±)-2-phenylbutane-l,4-diazide 323 on a 0.65 mmol scale following General
18.5.5 Extraction of Diamine Oxidase from Pea Seedlings
This was carried out by Ms Isabel Freer.
8.5.5.1 Extraction Of Crude extract from Pea seedlings
A quantity o f pea seeds (500 g), variety ‘Fillbasket’, were soaked in tap water for 
24 h. The tap water was changed four times. The pea seeds were then sown thickly in 
Perlite (4-6 cm deep) and covered in Perlite (2-3 cm). The seeds were then left to 
germinate and grow in the dark for 10-14 days until the shoots were 5-19 cm tall. During 
this time the Perlite was kept moist. The shoots were stripped o f their roots, washed free o f 
Perlite, drained and weighed (1-1.5 kg). The harvested shoots were always kept cool 
throughout the following process. The seedlings were minced using a pre-cooled Waring 
blender. The seedlings were strained through cotton mesh and the juice was squeezed out. 
The solid residue was mixed with 0.1M potassium phosphate buffer (pH 7, 1 ml/g o f 
material) and the juice squeezed as before. A second extract using the same potassium 
phosphate buffer (0.5 ml/g of material) was performed. The combined extracts (2-3 ml) 
were cooled to < 5 °C.
8.5.5.2 Isolation of Crude Organic Extract
A solution o f ethanol/chloroform (2:1 v/v, 30 ml per 100 ml o f extract) was cooled 
to 10 °C and added to the extract over 30 min. Care was taken to ensure that the 
temperature of the extract did not rise above 5 °C during this addition. The mixture was 
allowed to stand for 1 h at 0 °C to 5 °C after which the inactive precipitate was removed by 
centrifugation at 3000-4000 g for 20 min. The supernatant liquid was collected and 
saturated with ammonium sulfate (45 g/100 ml) and the temperature was allowed to rise to 
10 °C. A solid separated and floated. The lower liquid was siphoned off and discarded. The 
slurry was centrifuged at 3000 g for 10-15 min. The curd collected was mixed with 0.02M 
phosphate buffer (pH 7, 400-500 ml) and allowed to stand overnight.
8.5.5.3 Dialysis of the Organic Extract
The dialysis tubing was pre-soaked in distilled water for 2 h. The solution was 
stirred for 1.5 h at 15-18 °C and the precipitate was removed by centrifugation at 3000- 
4000 g for 20 min. The supernatant was again saturated with ammonium sulfate (200-300 
g) and left for 1.5 h at 8-10 °C. It was then centrifuged at 3000-4000 g for 20 min. The 
curd was mixed with 0.2M phosphate buffer (pH 7, 20 ml). The solution was dialysed in a 
30 cm tube (diameter 15 mm) for 2-3 h with cold running water. Dialysis was then carried 
out with 0.005M phosphate buffer (pH 7, 1 1) over 36 h at 0-4 °C. The buffer was changed 
twice during this period.
8.5.5.4 Final Purification Steps
The dialysed material was centrifuged at 3000 g for 10-20 min to remove inactive 
precipitate. The supernatant liquid was adjusted to pH 5 by slow addition o f 0.05M acetic 
acid at 5 °C and then allowed to stand for 1 h at 0-4 °C. The precipitate was collected by 
centrifugation and triturated with water (20 ml). The pH was adjusted to pH 7 using 0.05M 
potassium hydroxide to dissolve the precipitate and then to pH 5 with 0.05M acetic acid. 
The solution was left for 1 h and centrifuged to collect the precipitate. The precipitate 
obtained was taken up in 0.01M phosphate buffer (pH 7, 1 ml/100 g o f seedlings 
harvested). It was stored in the freezer (in 0.5 ml batches) at -20 °C and was stable for 
many months.
The yield was approximately 30 mg per kg of peas. The concentration o f PSAO in 
the samples used was 0.12 mg m l'1.
8.5.6 Determination of Protein Concentration153
Coomassie brilliant blue G was prepared as a 0.06% (w/v) solution in 3% perchloric 
acid. The solution was stirred overnight and filtered to remove any undissolved material.
A standard graph was determined using Bovine Serum Albumin (BSA, 1 mg/ml 
phosphate buffer pH 6.3).
The experiment was carried out three times and the average value used to plot a 
graph. This was used to determine the protein concentration o f unknown DAO samples by 
replacing BSA with DAO in the cuvette.
8.5.7 Spectrophotometric Assay
The kinetics o f the DAO catalysed oxidation o f potential substrates was determined 
according to the method of Stoner.154 This involved a peroxidase coupled assay 
(horseradish peroxidase, E.C 1.11.1.7, from Sigma) to continuously monitor the hydrogen 
peroxide released during oxidation at 25 °C, 70 mM phosphate buffer (pH 6.3), in the 
prescence o f 3-methyl-2-benzothiazoline hydrazone (MBTH) and 3- 
(dimethylamino)benzoic acid (DMAB). Oxidative coupling generated stoichiometric 
quantities o f an indiamine dye with a characteristic absorbance maximum at 595 nm. Rates 
were determined directly in the spectrophotometer.
Stock solutions were prepared as follows:
DMAB 18mM (29.7 mg/ 10 ml phosphate buffer pH 6.3)
MBTH 0.6mM (12.9 m g /100 ml distilled water)
Peroxidase 0.68 mg/ 2 ml phosphate buffer pH 6.3
Pea Seedling- 0.000615 mg m l'1 (0.12 mg m l'1 as 5-fold dilution in distilled
Diamine oxidase DAO water)
A typical cuvette o f pathlength 1 cm contained 3 ml o f solution, made up as follows:
1.68 ml phosphate
100 pi MBTH
170 pi DMAB
50 pi peroxidase
25 pi PSAO
300 pi substrate at varying concentrations
The reaction was initiated by addition of standard enzyme to the thermally equilibrated 
reaction mixture, followed by the substrate addition. This minimises the possibly inhibitory 
effects o f extensive preincubation of DAO with chromatographic agents.153 Initial rates 
were determined over a range o f substrate concentrations from linear absorbance changes
observed during the first minute in the reaction. Rate data were analysed for Km and Vmax 
by least squares fitting o f Lineweaver-Burke, Eadie-Hofstee and Hanes plots. All 
experiments were carried out three times with all data quoted being the mean o f nine 
determinations.
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